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Abstract 
Chronic obstructive pulmonary disease (COPD) the third leading cause of 
death, with an estimated 65 million cases worldwide. Despite this, most research to 
date has focused on treating the symptoms of COPD rather than the underlying 
mechanisms. Recently, we have shown that exposure to cigarette smoke (CS), the 
leading cause of COPD, results in an increase in cytosolic calcium and the rapid 
internalization and insolublization of the cystic fibrosis transmembrane conductance 
regulator (CFTR). Normal ion transport is imperative for mucus hydration and 
clearance, and its dysfunction after CS exposure may be responsible for the mucus 
dehydration and accumulation seen in COPD patients. Thus, the primary aim of this 
thesis was to establish the mechanism(s) behind the CS-induced internalization of 
CFTR. 
 Confocal imaging and Förster resonance energy transfer demonstrated that 
CFTR-CFTR interactions were reduced upon internalization of CFTR, and that 
CFTR was internalized with a T1/2 of 27.7 min. U0126, an inhibitor of MEK1 and 
MEK2, abolished the internalization of CFTR by CS. Furthermore, U0126 had no 
effect on CS-induced Ca2+ release. These data implicate the necessity of 
MAPK/ERK kinases in CS-induced internalization, and suggest that this kinase 
activity is downstream of Ca2+ release. Furthermore, CS caused dephosphorylation 
of plasma membrane CFTR, and CS-induced internalization of CFTR was 
prevented by forskolin, suggesting that dephosphorylation of CFTR by CS may lead 
to its internalization.  
CS-induced CFTR internalization was ablated by inhibitors of endocytosis, 
hypertonic sucrose and dynasore. Consistent with results demonstrating that CS-
internalized colocalization CFTR with clathrin light chain, these data suggest that 
CS-induced internalization of CFTR is both clathrin- and dynamin-dependent. CS-
internalized CFTR colocalized substantially with markers of the endoplasmic 
reticulum. Partial colocalization of CS-internalized CFTR with markers of the early 
endosomes, late endosomes, and the Golgi apparatus but not recycling 
endosomes, suggest that CFTR is trafficked in a retrograde pathway from the 
plasma membrane to the endoplasmic reticulum. 
This thesis provides new insights into the mechanism of CS-induced CFTR 
internalization, and may help in the development of new therapies for CFTR 
correction and airway surface liquid rehydration in patients with COPD. 
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1.0 Introduction 
1.1 Anatomy and physiology of the airways 
The primary purpose of the lungs is to facilitate oxygen intake and carbon 
dioxide output between the outside world and the circulatory system. The lungs 
inspire approximately 10,000 – 20,000 L  each day during normal breathing 
(Tamashiro et al., 2009). The structural design of the lungs is therefore functionally 
important and allows for efficient respiration. The initial inhalation occurs through 
either the nasal cavity or the mouth, past the pharynx and larynx, into the trachea. 
These structures are known as the upper airways. The trachea is lined with horse 
shoe-shaped cartilage rings embedded in dense connective tissue, surrounded by 
a layer of transverse smooth muscle. This structure allows for air conduction into 
the lower airways. The trachea splits into two main stem bronchi, one for each lung, 
which are characterized by the presence of smooth muscle and tubuloalveolar 
glands, surrounded by a fibrocartilage layer (Barnes, 2009). The bronchi branch off 
with irregular dichotomy into bronchioles and eventually terminal bronchioles, 
respiratory bronchioles and alveoli (Bai et al., 1994). The path of air from the 
trachea through to the alveoli may pass through up to 25 generations of branches. 
This branching structure allows for proper airflow, provides a physical barrier for 
particle deposition and allows regulation of the humidity and cleaning of the air.  
The airway lumen surface is lined with epithelia. Throughout the airways the 
epithelium forms the first point of contact for inhaled factors such as particles, 
microbes and pollutants, and provides a physical barrier between the body and 
outside world. The variety of cell types present in the epithelium and their 
characteristics provide a host of innate defence mechanisms to protect the body 
from insult. In the alveoli, the epithelium is comprised of type I and type II 
pneumocytes which lay in close proximity to the pulmonary capillaries to allow for 
gaseous exchange (Whitsett and Alenghat, 2015). In the distal airways, i.e. the 
terminal and respiratory bronchioles, the cells become more cuboidal and club cells 
replace the goblet cells (Mercer et al., 1994). In the proximal airway, tall columnar 
pseudostratified mucocilliary epithelia consisting primarily of intermediate, basal, 
mucus secretory (goblet) and ciliated cells line the trachea to the 6th-10th generation 
bronchi (Barnes, 2009). The predominant cell type in the proximal airway is the 
ciliated epithelial cell. Each ciliated cell lining the trachea and bronchi has 
approximately 300 cilia (Erle and Sheppard, 2014). Cilia are membrane bound 
structures formed around a microtubule cytoskeleton known as the anexome 
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(Popatia et al., 2014). The importance of mechanical clearance by the cilia is 
apparent in patients with primary ciliary dyskinesia (PCD), an inherited disorder of 
cilia. The clinical phenotype of PCD can be severe and can lead to chronic sinusitis 
and bronchiectasis as well as infertility and abnormal organ patterning (Whitsett 
and Alenghat, 2015). The cilia beat in a coordinated, rhythmic fashion which, when 
combined with ion and water transport across the epithelium, mucus secretion from 
goblet cells, and coughing, can facilitate the propulsion of mucus and foreign 
particles towards the mouth. This process is known as mucocilliary clearance, and 
it is essential for the removal of pathogens and debris from the airways.  
 
 
 
 
 
 
 
 
 
 
 
Air is breathed in through the mouth or nose, it passes through the trachea, into the bronchi, and 
down to the small conducting airways. In the alveoli, oxygen exchange occurs. The bronchi allow 
mucocilliary clearance, they are lined with smooth muscle cells which facilitate coughing and blood 
vessels which supply the surrounding cells with oxygen. The epithelium lining the bronchi is 
comprised of goblet cells which secrete mucins and other proteins from granules into the ASL, and 
ciliated cells, which facilitate mucus clearance by ciliary beat and ion transport. 
Figure 1-1. The structure of the conducting airways.  
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1.2  Mucociliary clearance 
Efficient mucocilliary clearance is maintained by an aqueous environment that 
bathes the surface epithelium known as the airway surface liquid (ASL). The 
composition of the ASL is sustained by ion transport at both the basolateral (blood 
side) and apical (luminal side) membranes of ciliated epithelia, as well as the 
secretion of mucins and other proteins from goblet cells and submucosal glands. 
The ASL is comprised of two layers, the periciliary layer (PCL) and the mucus layer. 
Membrane spanning mucins and tethered mucopolysaccharides protrude from the 
cilia into the periciliary layer (PCL), providing cell surface lubrication and are critical 
for propelling the mucus layer through the airway (Erle and Sheppard, 2014). The 
constituents of the PCL prevent the penetration of the mucus layer into the 
interciliary space (Button et al., 2012). The mucus layer is considered the ‘transport 
layer’. It is mainly comprised of mucins, MUC5AC and MUC5B, and functions to 
trap any bacteria and particles that deposit on the surface of the airways, allowing 
for their clearance from the airways. 
Coordinated mucocilliary clearance relies on the mucus layer, the PCL and the 
cilia, and the properties and mechanisms behind the coordination of these 
components are complex. The mucus layer must be malleable and able to adapt to 
a full range of insults within its environment. Furthermore, it must be able to trap 
pathogens and particles, and maintain its viscoelastic properties which allow the 
trapped particles and pathogens to be transported towards the mouth (Randell et 
al., 2006, Cone, 2009). To regulate these diverse properties, the mucus layer acts 
as a sink for water and can accept or donate liquid in an effort to maintain its 
hydration status (Tarran et al., 2001a). The hydration status is required for efficient 
and lubricated ciliary beating, and to maintain the supple properties of mucus which 
allow it to function as the transport layer.  When additional water is added to the 
airway surface, the rate of mucocilliary clearance increases above that of normal 
(Tarran et al., 2001b, Tarran et al., 2001a). However, when the mucus layer and 
PCL lose water and dehydrate, the osmotic pressure of the mucus layer causes the 
PCL to collapse, and the cilia lose their ability to beat. This dehydration results in 
an ablation of mucus clearance, and can be seen in diseases such as cystic 
fibrosis (CF) and chronic obstructive pulmonary disease (COPD). 
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1.3  Ion transport regulation of the airway surface liquid 
Hydration of the ASL is maintained by a balance of transepithelial isotonic 
electrolyte absorption and secretion, which allows salt and water to flow into and 
out of the ASL as required. The secretion of Cl- and the absorption of Na+ across 
the epithelia govern the mass of NaCl within the ASL, which in turn regulate the 
diffusion of water by osmosis into the ASL. The airway epithelium provides a barrier 
for water transport, between the ASL and the pulmonary vasculature. However, the 
presence of aquaporins in the basolateral (AQP3) and apical membranes (AQP5) 
of epithelial cells (Kreda et al., 2001), as well as water transport across the tight 
and adherent junctions, results in the so called ‘leaky epithelium’, which enables 
the epithelium to be highly permeable.  Maintaining the hydration status of the ASL 
is of particular importance in lung health, and dysregulation of the ion channels 
involved in hydration can lead to mucus dehydration, mucus stasis, and chronic 
bacterial infections which are common phenotypes of chronic bronchitis (CB) and 
cystic fibrosis (CF) lung disease.  
The osmotic gradients required for water transport across the epithelium are 
primarily set up by apical and basolateral membrane ion channels in epithelial cells 
(Boucher, 1994). On the apical surface, the epithelial sodium channel (ENaC) is the 
rate limiting step in sodium absorption, and the cystic fibrosis transmembrane 
conductance regulator (CFTR) and calcium-activated chloride channels (CaCCs) 
are the apical conduits for chloride secretion (Figure 1-2). These channels directly 
regulate the ion content, and therefore the hydration levels of the ASL.  
ENaC is expressed in the epithelia of several organs including the kidney, 
colon, sweat ducts and lungs and is the primary channel responsible for sodium 
absorption in airway epithelia (Donaldson and Boucher, 2007). ENaC was originally 
believed to consist of three different subunits, α β γ, but more recently an additional 
subunit, δ, has been identified with known isoforms δ1 and δ2 (Giraldez et al., 2007, 
Waldmann et al., 1995). Differential expression of these subunits may provide an 
alternative method of regulation for ENaC channel function (Haerteis et al., 2009). 
ENaC is regulated by intracellular second messengers such as cAMP, PIP2, and 
PIP3 (Gaillard et al., 2010). In addition to this, CFTR is thought to inhibit ENaC 
through both direct and indirect mechanisms. Examples include indirect regulation 
of ENaC through NHERF1 binding to yes-associated-protein-65 and the c-Src 
kinase cYes, which inhibits ENaC (Peters et al., 2001), or elevations in intracellular 
cAMP and PKA (Boucher et al., 1986), or direct regulation of ENaC through 
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interaction with the intracellular domains of CFTR (Schreiber et al., 1999, Gentzsch 
et al., 2010). In normal lungs, the ASL is maintained at a relatively consistent depth 
and level of hydration, and ENaC and CFTR are reciprocally regulated in order to 
coordinate this volume control. Unregulated ENaC activity is known to deplete ASL 
volume (Mall et al., 2004). However, CFTR acts as a negative regulator of ENaC, 
and is able to limit ENaC activity and secrete Cl- ions leading to hydration of the 
ASL.  
The driving force for sodium absorption is established primarily by the removal 
of sodium from the cell at the basolateral membrane by the Na+/K+ ATPase 
exchanger (Crump et al., 1995). Na+/K+ ATPase exchanges intracellular Na+ for 
extracellular K+. Potassium is then recycled by potassium channels expressed on 
the basolateral membrane. The basolateral membrane possesses three types of 
calcium-activated potassium channel, the large conductance (BKCa), intermediate 
conductance (IK/KCa3.1) and small conductance (SK) channels. Sodium/potassium 
exchange at the basolateral membrane by the Na+/K+ ATPase and potassium 
channels determines the basolateral membrane potential and plays a role in the 
setup of an electrochemical gradient for the secretion of chloride through CFTR.  
The secretion of Cl- through CFTR at the apical membrane is passive, and is 
driven by an electrochemical gradient set up primarily by the electroneutral 
Na+/K+/2Cl- cotransporter (NKCC1). Sodium is taken up by NKCC1 and recycled 
out of the cell by Na+/K+ ATPase, due to its electrochemical gradient. This allows 
potassium entry into the cell through NKCC1, which facilitates the entry of 2Cl- ions, 
and allows for the secretion of Cl- at the apical plasma membrane through CFTR. 
The coordination of CFTR with ENaC at the apical membrane allows for a balance 
of absorption and secretion which regulates ASL height and hydration. A study to 
show that both ENaC and CFTR were involved in ASL volume regulation was 
carried out by depositing a known amount of liquid onto the epithelial surface-liquid 
interface and measuring both ASL height and the transepithelial potential 
difference. After liquid deposition, Na+ absorption predominantly allowed for the 
absorption of excess liquid. Once a height of ~7µm was reached, Cl- secretion 
increased as Na+ absorption decreased, which lead to a steady state ASL height of 
~7µm (Tarran et al., 2005). 
CaCCs are also responsible for a portion of Cl- secretion into the ASL, and are 
located in the apical membrane of the airway epithelium (Tarran, 2004). Until 
recently the molecular identity of CaCCs had not been established. However, in 
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2008, Anoctamin 1 (Ano1) was found to be located in the airways and was 
identified independently by three different groups as having similar physiological 
and pharmacological properties to native CaCCs (Caputo et al., 2008, Schroeder et 
al., 2008, Yang et al., 2008). CaCCs are both voltage-gated and activated by 
increases in intracellular Ca2+. These properties allow for tight regulation such that 
CaCCs are not thought to be responsible for basal changes in ASL height, but are 
important in regulating changes in ASL height in response to mucosal nucleotides 
(Tarran et al., 2006). 
 
Mucus clearance requires efficient hydration of the ASL. The ASL is composed of a mucus layer and 
a pericilliary layer.  The volume and composition of the ASL is maintained by epithelial ion transport. 
Water is taken into the cell down its osmotic gradient at the apical membrane by AQP5, and at the 
basolateral membrane by AQP3, and across the plasma membrane through epithelial tight junctions. 
At the apical membrane ENaC regulates sodium absorption and CFTR and CaCC channels facilitate 
secretion. The net movement of these ions facilitates the movement of water across the cell. Na+-K+-
ATPase and potassium channels (BK, SK, and IK) at the basolateral membrane maintain an 
electrochemical gradient and provide a driving force for sodium absorption and chloride secretion at 
the apical membrane. BK and SK channels at the plasma membrane also have a role in ASL volume 
regulation.  
 
 
 
 
Figure 1-2. A model of ion transport in the airway epithelium. 
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1.4 The properties of CFTR 
CFTR is essential for chloride secretion in the airways. The channel is tightly 
regulated to allow hydration of the ASL and effective mucocilliary clearance. As 
such, the structure and regulatory factors of CFTR discussed in this section are 
incredibly complex and play an important role in CFTR function. 
1.4.1 CFTR structure and function 
CFTR is a member of the ATP-binding cassette (ABC) transporter superfamily, 
a large group of transmembrane proteins which use ATP hydrolysis to facilitate the 
translocation of substrates across the plasma membrane (Sheppard and Welsh, 
1999).  CFTR is unique as it is the only family member that works as an ion channel 
and not an ATP-dependent pump. However, consistent with typical ABC transporter 
structure, CFTR has two membrane spanning domains (MSD1 and MSD2) and two 
nucleotide-binding domains (NBD1 and NBD2; Figure 1-3). CFTR additionally has a 
regulatory (R) domain, important for channel activation. Furthermore, CFTR has 
many motifs which have been identified to play important roles in the trafficking and 
function of the channel. An example of this are the endocytic motifs present on the 
C-terminus of CFTR; the tyrosine-based motif, the dileucine motif and the PDZ 
domain (Figure 1-3). The role of these motifs in endocytosis will be further 
discussed in section 1.4.3.  
 
 
 
 
 
 
CFTR has two membrane spanning domains and two nucleotide binding domains, as well as a 
regulatory domain. CFTR has two sites of glycosylation on the extracellular surface as well as three 
intracellular endocytic motifs; the tyrosine-based motif, the dileucine motif and the PDZ binding motif, 
represented by their amino acid codes 1424YDSI, 1430LL and 1476DTRL, respectively.  
Figure 1-3. The topology of CFTR.  
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The electrophysiological properties of CFTR channel function are determined 
by the structure of the channel. The two MSDs assemble to form the pore of the 
channel for the transport of anions (Hwang and Sheppard, 2009). The pore of the 
channel is permeable to anions as large as lactobionate, suggesting that the 
diameter of the channel must be 10 – 13 Å (Linsdell et al., 1998). CFTR has a low 
single channel conductance of 6-10 pS and a linear current voltage (I-V) 
relationship (Gray et al., 1988). CFTR is preferentially selective for anions over 
cations, with an anion permeability sequence of Br- ≥ Cl- > I- in whole cell patch 
clamp experiments (Anderson et al., 1991b). The channel is both time- and voltage-
dependent, and the activity of CFTR is dependent on cAMP-dependent 
phosphorylation (Picciotto et al., 1992). 
CFTR gating is coupled to ATP binding and hydrolysis at the NBDs, allowing 
the channel to transition between multiple open and closed states (Vergani et al., 
2005, Csanady et al., 2010, Hwang and Sheppard, 2009). In the resting state, one 
ATP molecule is bound to a NBD. Vergani and colleagues (2005) demonstrated 
that binding of an additional ATP molecule drives dimerization of the NBDs allowing 
for a conformational change to be transmitted to the MSDs to open the channel 
pore for anion transport (Vergani et al., 2005). A second open state occurs after 
hydrolysis of one of the ATP molecules, leading to dissociation of the NBD dimers 
and entry into a closed state. Furthermore, Corradi and colleages (2015) recently 
demonstrated using homology modelling, that the amino acid residue Phe 337 
plays a role in gating CFTR in the closed state by blocking the anion pore. 
Phosphorylation of the R domain by PKA is a prerequisite for channel gating by 
ATP and is required for channel activation (Anderson et al., 1991a). The R domain 
contains many consensus sites for phosphorylation by PKA five of which, plus 
another in NBD1, are phosphorylated in vivo (Cheng et al., 1991, Hegedus et al., 
2009). CFTR has extremely low activity when it is not phosphorylated. However, in 
the presence of PKA the open probability of the channel increases significantly 
(Mathews et al., 1998, Wang et al., 2000). There are conflicting reports of how 
phosphorylation by PKA affects channel gating. Mense and colleagues (2006) 
demonstrated that PKA phosphorylation is necessary for NBD dimerization. Other 
groups have demonstrated that phosphorylation effects on gating are not only 
determined by NBD dimerization, but also the interaction of the R domain with the 
MSDs (Zhang et al., 2011, Hegedus et al., 2008). Thirdly, Kanelis et al. (2010) have 
proposed that phosphorylation of PKA sites in NBD1 may coordinate an interaction 
between NBD1 and the transmembrane domains. These hypotheses are not 
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necessarily exclusive, and CFTR gating may be affected by any combination of 
these events. After gating has occurred, subsequent dephosphorylation of the 
channel by protein phosphatase (PP) 2C and PP2B controls deactivation and 
returns the channel to the closed state. 
1.4.2 CFTR biosynthesis 
Immature CFTR is synthesized in the endoplasmic reticulum (ER). CFTR 
undergoes complex folding and core glycosylation within the ER. Core 
glycosylation is the addition of N-linked glycans to the extracellular loop spanning 
TMD7 and TMD8, resulting in a mannose-enriched protein (Figure 1-3). After 
processing at the ER, core-glycosylated CFTR is sent to the Golgi apparatus where 
complex oligosaccharide chains are added to the structure resulting in a mature, 
fully glycosylated channel (Cheng et al., 1990, Glozman et al., 2009). Maturation of 
CFTR is somewhat inefficient with only 30% of the wild type CFTR synthesized into 
a fully mature glycosylated ion channel (Lukacs et al., 1994, Ward and Kopito, 
1994). CFTR conformational maturation is mediated by calnexin, calreticulin, and 
other cytosolic chaperones including Hsc70/Hsp70, Hsp40 and Hsp90. Any protein 
that is incorrectly folded may be sent for degradation. When the maturation of 
CFTR is complete, the channel is trafficked to the plasma membrane.   
1.4.3 CFTR trafficking  
CFTR current (I) is a product of N x Po x i where N is the number of channels at 
the plasma membrane, Po is the open probability and i is the single channel 
conductance. As such, the presence of CFTR at the plasma membrane is tightly 
regulated. The life cycle of CFTR is considered lengthy, with a total life cycle from 
synthesis to degradation of more than 24 hours (Lukacs, 1993). Each stage of the 
life cycle; biosynthesis, exocytosis, function at the plasma membrane, endocytosis, 
recycling and degradation, is tightly regulated. Following biosynthesis, CFTR is 
trafficked from the Golgi apparatus to the plasma membrane in coat protein 
complex (COP) II transport vesicles (Wang et al., 2004). This exocytosis occurs in a 
syntaxin 3-dependent manner. Syntaxin 3 is a vesicle fusion protein and member of 
the soluble N-ethylmalemide-sensitive fusion protein attachment protein receptor 
(SNARE) protein family (Collaco et al., 2010). Stimulation of exocytosis can occur 
in a number of different manners, for example, in addition to phosphorylating the R 
domain leading to activation of CFTR, PKA can also stimulate the exocytosis of 
CFTR to the membrane (Ameen et al., 2003). 
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At the plasma membrane, active CFTR maintains Cl- secretion allowing 
hydration of the ASL. Once CFTR has carried out its function, it is internalized by 
endocytosis. Despite the lengthy total life cycle of CFTR, chemical labelling 
demonstrated that CFTR is actually removed from the plasma membrane fairly 
rapidly, with 25% of CFTR internalized in 2.5 min (Prince et al., 1994, Lukacs et al., 
1997). The rate of CFTR internalization is comparable to that of other receptors that 
undergo clathrin-mediated endocytosis. As discussed in section 1.4.1, CFTR has a 
number of highly conserved endocytic signals on its C-terminus which assist in 
allowing CFTR to be endocytosed at such a rapid rate (Hu et al., 2001). Noticeably, 
two types of endocytic signal have been well characterized, a tyrosine-based motif 
and a di-leucine-based motif. The tyrosine-based motif has a consensus sequence 
of YXXϕ, where X is any amino acid and ϕ is a bulky hydrophobic amino acid. In 
CFTR this sequence is 1424YDSI. Deletion of the tyrosine motif in CFTR resulted in 
an increase in surface expression of CFTR suggesting that internalization of CFTR 
was diminished (Weixel and Bradbury, 2000).  Di-leucine motifs have consensus 
sequences D/EXXXLL/I and DXXLL and can be found as 1430LL in CFTR. Mutation 
of this signal increased the cell surface density of CFTR suggesting that the di-
leucine motif facilitates internalization (Hu et al., 2001).  
The above signalling motifs mediate the recruitment of CFTR to clathrin-coated 
vesicles through binding of endocytic adaptors such as adaptor protein (AP) 2 (Hu 
et al., 2001, Weixel and Bradbury, 2000). Endocytosis is integral to the regulation of 
cell surface density of many different plasma membrane receptors, transport 
proteins and ion channels. Of the different types of endocytosis; phagocytosis, 
micropinocytosis, calveolae-mediated and clathrin-mediated, clathrin-mediated 
endocytosis is best characterized. Clathrin was first discovered in 1976 (Pearse, 
1976), and has since been found to have a triskelion structure comprised of three 
clathrin-heavy chains which are linked by their C-termini (Brodsky et al., 2001). 
When the triskelia assemble into a clathrin coated vesicle they form a polygonal 
lattice which itself cannot bind to the plasma membrane. The clathrin heavy chain 
within the triskelion formation binds to clathrin light chain, which is oriented into the 
cytosol and thought to interact with many intracellular adaptor proteins which allow 
curvature of the plasma membrane and formation of a vesicle (Fotin et al., 2004). 
Once the vesicle is formed dynamin, a mechanochemical enzyme, oligomerizes in 
a ring around the plasma membrane stalk that attaches the vesicle to the plasma 
membrane. It then uses GTP hydrolysis to provide a mechanical force, which 
22 
 
severs the membrane tube allowing entry of the clathrin coated vesicle into the 
cytoplasm.  
Isolation of clathrin coated vesicles from airway epithelial cells revealed a large 
amount of CFTR present in the vehicles (Dharmsathaphorn et al., 1984). Once 
CFTR is recruited to clathrin coated vesicles, the vesicle buds off from the plasma 
membrane. Once the clathrin coated vesicle is taken into the cytosol, the vesicle 
un-coats. This energy-dependent step is carried out by cofactors including heat 
shock cognate-70 and auxillin. After un-coating, the vesicles fuse with early 
endosomes, which are enriched with phosphotidylinositol-3-phosphate and other 
protein constituents which can play a role in determining the destination of the 
contents of the endosome (Le Roy and Wrana, 2005). The early endosome is 
weakly acidic (pH 6.8-5.9) (Maxfield and Yamashiro, 1987) and has low levels of 
calcium (Gerasimenko et al., 1998). Ras related protein (rab) 5a, a protein that 
resides primarily in early endosomes, facilitates the trafficking of CFTR to the early 
endosomes (Roberts et al., 1999, Stenmark et al., 1994, Ameen et al., 2007). The 
early endosome is known as the main sorting station in the endocytic machinery 
(Helenius et al., 1983). It primarily functions to sort cargo and target its contents for 
recycling back to the plasma membrane or for degradation. The different pathways 
of endocytosis allow the cell to manage the number of CFTR molecules at the cell 
membrane. 
It has been demonstrated in Chinese hamster ovary cells and in polarized T84 
epithelial cells that forskolin-stimulated CFTR activity is maintained up to 24 h 
following stimulation, even in the presence of a protein synthesis inhibitor, 
cyclohexamide (Lukacs et al., 1993, Ameen et al., 2003). Given that exocytosis of 
nascent CFTR is slow, and endocytosis of the channel is rapid, these data provide 
evidence that internalized CFTR must be trafficked back to the plasma membrane. 
This concept of recycling has been further confirmed using cell surface 
biotinylation, demonstrating that approximately 50% of internalized CFTR is cycled 
back to the plasma membrane (Weixel and Bradbury, 2002). Recycling of 
internalized CFTR allows subapical pools of mature CFTR to form and be rapidly 
trafficked to the membrane when a dramatic increase in Cl- secretion is necessary 
(Thiagarajah and Verkman, 2003). As such, CFTR internalized to the early 
endosomes can be sent directly back to the plasma membrane through a rab4 
dependent mechanism. Alternatively, CFTR is trafficked to recycling endosomes, 
whereby rab11 functions to traffic CFTR back to the plasma membrane, or to the 
Golgi apparatus. 
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Alternatively, CFTR can be targeted for degradation. CFTR can be sorted in the 
early endosome for degradation. Early endosomes mature into late endosomes, 
which typically have an oval shape and are approximately 250 – 1000 nm (Poole 
and Black, 2006). Late endosomes are formed in the periphery of the cell, and 
move to the perinuclear region for fusion with other endosomes and lysosomes. 
Early-to-late endosome and late endosome-to-lysosome trafficking is regulated by 
Rab7. The presence of dominant negative Rab7 caused intracellular CFTR to 
accumulate since it was unable to traffic to the lysosome (Gentzsch et al., 2004). 
Upon fusing with lysosomes, the late endosomes provide a unidirectional pathway 
to degradation (Huotari and Helenius, 2011).  
Post synaptic density protein (PSD95), Drosophila disc large tumor suppressor 
(Dlg1), and zonula occludens-1 protein (zo-1) (PDZ) motifs play a role in 
polarization localization of membrane proteins, ion channel function and 
endocytosis by allowing the formation of protein-protein interactions with many PDZ 
binding proteins (Guggino and Stanton, 2006). Proteins containing PDZ domains 
often contain other protein interacting modules, and facilitate the interaction of 
many protein-protein hetero- and homo-typic interactions within macromolecular 
complexes (Guggino and Stanton, 2006). The C-terminus of CFTR contains a PDZ-
interacting motif, 1467DTRL, which binds to proteins containing PDZ domains such 
as Na+/H+ exchanger regulatory factor isoform-1 (NHERF1, otherwise known as the 
ezrin-binding protein EPB50), NHERF2, and  CFTR associated ligand  (CAL). 
NHERF1 and NHERF2 have C-terminal ERM binding domains, which provides a 
binding site for ezrin, and function to connect CFTR and other membrane proteins 
to the actin cytoskeleton (Monterisi et al., 2012). In addition to this, NHERF1 has an 
ezrin-radixin-moesin domain, which allows binding to ezrin, radixin and moesin and 
subsequently tethers CFTR to the actin cytoskeleton, thus stabilizing CFTR at the 
apical membrane (Short et al., 1998). Overexpression of CAL decreases the 
expression of CFTR at the cell membrane, and is thought to play a role in the 
trafficking of CFTR (Cheng et al., 2002). Furthermore, there is some evidence to 
suggest that the PDZ binding domain of CFTR is required for recycling of CFTR 
back to the plasma membrane (Swiatecka-Urban et al., 2002).  
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CFTR is synthesized and undergoes quality control in the endoplasmic reticulum. Misfolded proteins are 
ubiquitinated and trafficked to the proteasome for degradation. Correctly folded CFTR is transported to the 
Golgi apparatus where N-linked glycosylation occurs. Mature CFTR is trafficked to the membrane to carry 
out Cl- secretion. CFTR undergoes endocytosis and can be either recycled or targeted for lysosomal 
degradation. There are five classes of CFTR mutation which can affect different aspects of these 
processes. Class I mutations involve premature termination of the production of CFTR, leading to little or 
no functioning CFTR protein in the membrane. Class II mutations have incorrect folding and affect the 
trafficking of CFTR to the apical membrane of the cell. Class III mutations include the defective regulation 
of CFTR at the cell surface, the gating mechanism of CFTR is defective (Walsh, 1993). Class IV mutations 
reach the cell surface, but Cl- transport through the cell is impaired due to narrowing of the pore. In class V 
mutations, mRNA processing is impaired due to defects in splicing. (Image taken and adapted from Rogan 
et al. (2011). 
 
 
Figure 1-4. CFTR mutations and how they affect biosynthesis, trafficking and endocytosis. 
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1.5  When CFTR processing goes awry: Airway diseases 
As discussed above, the role of CFTR structure, trafficking, and regulation by 
different factors is crucial for effective mucocilliary clearance. Dysfunction of these 
components can lead to a variety of disease phenotypes as discussed below. 
1.5.1 Cystic fibrosis  
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in 
the CFTR gene, which cause a loss of function of the CFTR protein (Donaldson, 
2007). There are approximately 2000 identified mutations of CFTR, 242 of which 
are disease causing (US CF Foundation, 2015). There are five classes of CFTR 
mutation which lead to changes in CFTR function resulting in a disease phenotype, 
see Figure 1-4 (Rogan et al., 2011). The most common mutation of CFTR 
associated with CF is delF508, a class II inframe deletion of the phenylalanine at 
position 508 (Riordan, 1989). The deletion of phenylalanine 508 results in abnormal 
folding of CFTR during translation. The misfolded protein is recognized by 
molecular chaperones which facilitate targeting of the abnormally folded CFTR to 
proteasomes for degradation (Cheng et al., 1990). Additionally, delF508 has 
reduced open probability (Denning et al., 1992, Dalemans et al., 1991) and 
residency time in the plasma membrane upon temperature correction (Lukacs et 
al., 1993). 
Since delF508 CFTR is unable to reach the plasma membrane, secretion of Cl-  
into the ASL by CFTR is absent compared to non-CF airways. Though the loss of 
Cl- secretion contributes to CF ASL dehydration, the lack of normal CFTR leads to 
ENaC hyperactivity, which also contributes to dehydration of the airways and 
ultimately mucus stasis. The combination of both of these factors results in 
excessive absorption of Na+, Cl- and water across the epithelium, leading to 
depletion of the ASL depth. This depletion directly affects the properties of the ASL, 
resulting in increased viscosity and decreased elasticity. Mucus transport is 
impeded and mucus can begin to accumulate. This accumulation in the airways is 
further exacerbated by the hypersecretion of mucins by goblet cells and 
submucosal cells. Patients with CF experience chronic inflammation and 
colonization by microbes, which eventually lead to lung damage and mortality. 
Although del508 is the most common mutation, other mutations in CFTR can 
also cause serious disease phenotypes. Class I mutations are typically nonsense 
mutations which result in the introduction of premature stop codons into the protein. 
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This results in unstable truncated proteins, which are non-functional, and are 
unable to reach the plasma membrane. Class II mutations, like that of delF508 
CFTR, also cause CFTR dysregulation by misfolding, leading to premature 
degradation. Class III mutations are typically caused by missense mutations, 
leading to the production of CFTR proteins that are able to traffic to the plasma 
membrane, but have defects in the regulation of CFTR by phosphorylation and 
ATP. One example of a Class III mutation is G551D-CFTR. This CFTR mutant is 
folded correctly and trafficked to the plasma membrane, but the gating of the 
channel, normally regulated by NBD dimerization and ATP binding and hydrolysis, 
is defective. Class IV mutations are able to traffic to the plasma membrane, but the 
channels have decreased open probability, and reduced chloride secretion. Class V 
mutations cause dysregulation of transcription, leading to defects in splicing, and a 
reduction in the quantity of normally functioning CFTR channels at the plasma 
membrane (Rogan et al., 2011).  
Current therapies for CF patients include anti-inflammatory agents, antibiotics, 
hypertonic saline and mucolytics (Quon and Rowe, 2016). However, these 
treatments only address the symptoms rather than treat the underlying cause of the 
disease. Concerted effort has been undertaken to discover the cellular mechanisms 
underlying this disease, so that people with CF can have not only medication to 
treat the symptoms, but to increase the ability of CFTR to reach the membrane in 
its functional form, and to improve Cl= secretion across the epithelial surface. To 
this end, a number of companies within the last five years have produced 
compounds to directly treat defects of mutant CFTR. Although folding of delF508 is 
impaired, several studies have demonstrated that when delF508 is able to arrive at 
the plasma membrane it retains function, although its function is reduced compared 
to that of wild-type CFTR (Brown et al., 2014, Pedemonte et al., 2005, Denning et 
al., 1992).  
Thus, two types of drugs have been the focus in this effort thus far; potentiators 
and correctors. Potentiators are intended to improve the ability of mutant CFTR to 
secrete Cl- at the plasma membrane. This category of CFTR modulator is primarily 
targeted at CF patients with class III gating mutations, such as that of G551D. The 
first compound of this category, Ivacaftor, was approved for patient care in 2012 
after results from a randomized controlled trial showed in patients with at least one 
G551D allele, a 10.6% increase in FEV1% predicted, and significantly reduced 
pulmonary exacerbations (Ramsey et al., 2011). However, Ivacaftor alone had no 
improvements in patients with the delF508 mutation. Correctors function to fix the 
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cellular misprocessing of CFTR, allowing the protein to fold in its correct form. As 
such, patients with class II mutations such as delF508 CFTR are primary targets for 
this therapy. Despite a four-fold increase in delF508 CFTR-mediated chloride 
secretion in human bronchial epithelial cells (HBECs) (Van Goor et al., 2011), a 
phase IIa clinical trial demonstrated no improvement in delf508 CFTR homozygous 
patients (Clancy et al., 2012). A combination co-therapy using both the corrector 
and the potentiator, to not only improve delF508 CFTR trafficking to the plasma 
membrane but also to improve channel function, has been shown to have 
significant effect on CF patients. The combination therapy, Orkambi, was approved 
for clinical use in 2015, after approximately 3% improvement in FEV1% predicted in 
delF508 homozygous patients (Wainwright et al., 2015). Despite the recent 
success of these drugs in the treatment of CF, many investigations are still being 
undertaken to discover different and more sophisticated compounds for the 
correction and potentiation of CFTR, and to address different aspects of CF 
pathology, with the hope of even more improvements in the lives of patients with 
CF. 
1.5.2 COPD  
Chronic obstructive pulmonary disease (COPD) is the third leading cause of 
death in the world, with a 50% prevalence in heavy smokers (Mannino et al., 2002, 
Rennard and Vestbo, 2006). COPD is caused by long-term exposure to inhaled 
pollutants and particles, of which 90% of cases in the developed world are caused 
by smoke from cigarettes (Barnes, 2000). Two major phenotypes of COPD are 
emphysema and CB, of which CB is the most prevalent (Hogg et al., 2004).  
Clinically, CB is known to reflect a chronic productive cough, which lasts for two 
months over two consecutive years (Boucher, 2004). This productive cough is 
characterized by sputum production, mucus hypersecretion and the formation of 
mucus plugs, and can lead to progressive lung function decline and death (Hogg, 
2004).  
Smoking tobacco stimulates the innate defense system in the lung, which 
protects against aberrant stimuli. This response involves an acute inflammatory 
response (Simani, 1974) and mucocilliary clearance (Knowles and Boucher, 2002). 
Inflammation in CB is located in the central airways and is associated with an 
increased number of neutrophils, macrophages, and inflammatory mediators such 
as transforming growth factor (TGF) β (Vignola et al., 1997, Sethi et al., 2006). 
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Furthermore, the bronchial walls are thickened by the deposition of connective 
tissue (Thurlbeck and Angus, 1964).  
Mucocilliary clearance is deficient in CB and there are many different 
components that contribute to this. COPD patients undergo delayed mucus 
clearance demonstrated by reduced mucus velocity in the trachea and a slower 
removal of radio nuclear particles from the lungs (Morgan et al., 2004, Brown et al., 
2002, Moller et al., 2008). This may in part be due to mucus hypersecretion, a 
common factor of CB. Mucus hypersecretion is multifactorial, and is caused by an 
increased number of goblet cells (goblet cell hyperplasia) (Saetta et al., 2000), and 
enlarged mucus glands (glandular hypertrophy) (Reid, 1960). Accordingly, 
MUC5AC expression in the central airway is increased in patients with COPD 
(Caramori et al., 2009). Another contributor to deficient mucocilliary clearance is 
ciliary dysfunction. Patients with COPD exhibit reduced ciliary beat frequency 
(Yaghi et al., 2012), a phenomenon that is mimicked in smoke exposed subjects 
(Agius et al., 1998). Also, CS causes shortening of the cilia and impaired 
ciliogenesis (Tamashiro et al., 2009). The final component of deficient mucocilliary 
clearance to be addressed here is the hydration status of mucus. Mucus from 
patients with CB is dehydrated, as determined by increased in percent solids of the 
mucus of CB patients to ~7% compared to ~2% in normal patients (Clunes et al., 
2012, Rubin et al., 1992). When percent mucus solids increases to ~6%, mucus 
clearance slows down, and the pressure of the mucus layer on the PCL causes the 
PCL to collapse, leading to the adherence of mucus to the epithelial surface (Button 
et al., 2012). This phenomenon may be partially responsible for the formation of 
mucus plugs in the airway. 
Current treatments for COPD have centred on inhaled long-acting bronchodilators 
and corticosteroids. These drugs relax airway smooth muscle, resulting in reduced 
bronchial obstruction and airflow limitation (Cazzola, 2014). While treatment with 
inhaled long-acting bronchodilators and corticosteroids reduce exacerbations in CB 
patients, they do not completely abolish them, and long-term use of long-acting 
bronchodilators can lead to increased risk of pneumonia (Hurst et al., 2010, 
Calverley et al., 2011). Ultimately, these treatments are only palliative, and do not 
address the underlying causes of pathogenesis. Research into new therapeutics for 
CB has primarily focused on the role of inflammation in the airways in response to 
CS. Unlike in the treatment of asthma, corticosteroids have no effect on the level of 
neutrophilic inflammation, and no decrease in inflammatory mediators in COPD 
(Barnes, 2000). More recently, inhibitors of phosphodiesterase 4 (PDE4) have been 
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studied in the context of reducing inflammation in patients with COPD and CB, 
demonstrating improved lung function and reduced exacerbations (Calverley et al., 
2009, Fabbri et al., 2009, Rennard et al., 2011, Martinez et al., 2015).  
Although some progress is being made by reducing inflammation, new targets 
for pharmaceuticals are always being investigated. A new focus area for CB 
therapeutics stems from the concept that CB pathologically resembles CF. Much 
like CF, the prominent defect in CB is airflow limitation. As discussed in sections 
1.5.1 and 1.5.2, patients with CF and CB undergo mucus hypersecretion, mucus 
accumulation, and goblet cell hyperplasia. These symptoms lead to reduced 
mucocilliary clearance, chronic neutrophilic inflammation and chronic bacterial 
colonization (Sethi et al., 2006, Barnes, 2004). As such, some treatments used in 
CF, i.e. like azithromycin, have also provided marked improvements in symptoms of 
patients with COPD. On the other hand, the use of mucolytics in CF reduces 
exacerbations and improves lung function, whereas in CB mucolytics have had few 
benefits (Decramer et al., 2005, Zheng et al., 2008, Poole and Black, 2006).  
More recently, it has become apparent that patients with COPD have 
dysfunctional CFTR activity. This dysregulation of CFTR activity has been recorded 
in both nasal potential difference studies and lower airway potential difference 
studies (Sloane et al., 2012, Cantin et al., 2006b). Interestingly, healthy smokers 
and COPD smokers exhibit a more severe ablation of CFTR activity compared to 
COPD former smokers, in which the reduction of CFTR activity is less prominent. 
These data imply that CFTR deficiency in COPD is a more direct effect of smoke 
exposure, rather than a downstream effect in COPD pathology. Indeed, healthy ex-
smokers that acutely smoke a cigarette also exhibit a rapid decline in nasal 
potential difference in the presence of low Cl-/isoprenaline (Clunes et al., 2012). 
However, the effects of smoke exposure on both healthy smokers and COPD 
smokers are sustained, even in the absence of acute CS exposure, suggesting 
there may be long-term effects of CS on CFTR. As such, the expression of CFTR 
protein was much lower in the bronchial epithelium of COPD GOLD 4 patients 
(FEV1/FVC < 70%, FEV1 < 30% predicted) when compared to GOLD 0 patients 
(non-smokers, asymptomatic with normal lung function), indicating that decreases 
in CFTR function may be attributed to decreases in both mRNA and protein levels. 
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1.6  Cigarette smoke and CFTR – What do we know so far? 
1.6.1  In vitro effects of cigarette smoke on CFTR 
The effects of smoke on CFTR can not only be measured in COPD patients and 
smokers, but have also been recorded in vivo across different species. Indeed, the 
first observation that cigarette smoke (CS) affected chloride secretion was provided 
by Welsh in 1983, before the identification of the CFTR gene. Welsh demonstrated 
a decrease in short-circuit current due to an inibition in chloride secretion after 
acute CS exposure in canine trachea, both in vivo and in vitro (Welsh, 1983). The 
ability to measure the effects of CS on CFTR in vitro provides a valuable method for 
investigating the underlying causes of CS-induced CFTR dysfunction. Additionally, 
in vitro studies provide a platform for pharmaceutical manipulation of the smoke 
response, paving a first step toward the use of CFTR targeted pharmaceuticals in 
the treatment of CB. 
Since the discovery that Cl- secretion is blunted by smoke exposure in canine 
trachea (Welsh, 1983), the effects of CS on Cl- secretion and CFTR in vitro, in a 
variety of different cell types, have been the subject of an increasing number of 
studies over the last 15 years. In 2005, Kreindler and colleagues presented 
evidence in HBECs, using measurements of short-circuit current as well as ion flux 
studies, that net chloride secretion, and specifically cAMP-mediated Cl- secretion 
through stimulation by forskolin, was inhibited by CS extract (Kreindler et al., 2005). 
Sloane and colleagues repeated this work in 2012, again demonstrating a decrease 
in forskolin-stimulated Cl- secretion in HBECs by CS extract (Sloane et al., 2012). 
This data was supplemented by western blots showing that 2% CS extract caused 
a decrease in CFTR total protein expression, and ASL depth measurements 
showing that ASL depth is decreased by CS extract. Interestingly, Sloane and 
colleagues utilized ivacaftor, to potentiate CFTR, and found that both CS extract 
reduced CFTR- mediated Cl- secretion and ASL depth recovered in the presence of 
ivacaftor. However, effects of ivacaftor on CS extract exposed CFTR total protein 
levels were not determined. In 2006, Cantin and colleagues demonstrated 
diminished Cl- secretion in both Calu-3 cells, a human respiratory airway cell line, 
and T84 cells from the human intestine (Cantin et al., 2006b). Furthermore, Cantin 
and colleagues also determined that CFTR gene expression in T84 cells and Calu-
3 cells was sensitive to oxidative stress (Cantin et al., 2006a). CS itself is a known 
oxidant and decreased the levels of transcription of CFTR in Calu-3 and T84 cells 
(Cantin et al., 2006b). Changes in mRNA expression levels do not always directly 
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result in changes in levels of translated protein. In fact, the majority of studies have 
shown a weak correlation between mRNA expression data and protein levels 
(Maier et al., 2009). However, Cantin and colleagues also demonstrated by western 
blot that CFTR protein levels appear to decrease in Calu-3 cells following exposure 
to CS. This data has also been reinforced by Cormet-Boyaka’s group (Hassan et 
al., 2014), who have shown that exposure to CS extract results in a time-dependent 
decrease in both CFTR mRNA expression and protein expression levels in 
16HBE14o- cells. In 2009, Cohen and colleagues presented data in murine and 
human sinonasal epithelial cultures that forskolin-mediated Cl- secretion was 
reduced in response to CS extract (Cohen et al., 2009). This was accompanied by 
a study demonstrating that ciliary beat frequency was also diminished by CS 
extract. Finally in Xenopus Oocytes, Moran and colleagues demonstrated by whole 
cell patch clamp that CS extract induced reductions in Cl- are voltage-dependent 
(Moran et al., 2014). 
Thus, CS-induced reduction Cl- secretion has been confirmed across a number 
of different cell types, by different methods of smoke exposure. A large number of 
studies have investigated the changes in chloride secretion by CS, and subsequent 
effects on mucociliary clearance. However, the underlying cause of reduced Cl- 
secretion by CS has not been addressed. Our lab have shown using western blot 
that CFTR protein levels are reduced following smoke exposure in preparations 
with a low concentration detergent such as NP40. However, when a detergent with 
a higher concentration is utilized (1% and 10% SDS) the CFTR the reduction of 
CFTR protein levels was ablated, suggesting that rather than a decrease in CFTR 
protein expression, CFTR becomes insoluble after CS smoke exposure. 
Supplementary to this, Clunes et al. (2012) demonstrated using surface labeling 
and confocal imaging that CS causes the specific removal of CFTR from the 
plasma membrane of airway cells leading to intracellular accumulation of CFTR, 
suggesting that CFTR is internalized following CS exposure. CFTR accumulated in 
the perinuclear region of the cell, and colocalized with vimentin, an intermediary 
filament used to identify the location of aggresomes in the microtubule organizing 
center. Later work from our lab have determined that this internalization of CFTR is 
dependent on an increase in  intracellular Ca2+ caused by CS (Rasmussen et al., 
2014). Inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase inhibitor 
had no effect on CS-induced Ca2+ release, the endoplasmic reticulum was ruled out 
as a source for the rapid release of intracellular Ca2+ caused by smoke exposure. 
However, transfected with LAMP1 tagged with a  Ca2+-sensitive FRET pair 
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demonstrated increased Ca2+ concentrations in the vicinity of the lysosomes upon 
CS exposure.   
The in vitro studies presented in this section confirm that CS can directly affect 
the function of CFTR, and studies on ASL height and mucociliary transport 
(Rasmussen et al., 2014, Sloane et al., 2012) provide further evidence that CS-
diminished Cl- secretion  may be associated with the mucociliary transport defects 
observed in COPD pathology (Hogg, 2004). Thus, investigation into the the cellular 
mechanisms of CS-induced CFTR internalization will provide valuable insight into 
the   
1.6.2 Components of cigarette smoke 
In the original studies of smoke effects on Cl- secretion, Welsh employed two 
different smoke exposure protocols for in vivo versus in vitro work. To smoke the 
mongrel dogs in vivo, puffs of whole cigarette smoke were delivered through an 
endotracheal tube. In contrast for in vitro experiments, whole cigarette smoke was 
bubbled through mucosal or submucosal bathing solution. This discrepency in 
smoke exposure methods has been addressed somewhat over the last 25 years 
although inconsistencies still remain today. This is, in part, due to the complexity of 
the composition of CS, with over 7000 different compounds identified. At least 69 of 
these components are known carcinogens, and many others have been identified 
as toxicants (USDHHS, 2010). CS has two phases; a gaseous phase which 
accounts for 95% of whole cigarette smoke by weight, and a particulate phase 
which comprises the remaining 5% of whole cigarette smoke (Keith, 1965). The two 
phases of CS have different properties. For example, the gaseous phase is strongly 
oxidizing, whereas in the particulate phase the reducing properties dominate 
(Church and Pryor, 1985). 
The most common in vitro methods for smoke exposure, CS extract and CS 
condensate, isolate the gaseous phase and the particulate phase respectively. CS 
extract is produced by bubbling smoke through bathing solution or growth medium, 
whereas CS condensate is produced by smoking the cigarette through a 
Cambridge filter pad to collect particles larger than 0.1 µm. The collected 
particulates are then dissolved in a DMSO vehicle. Even within these methods, 
there are no standards in place to define how many cigarettes or how long the 
cigarettes should be smoked to produce a response. For example, in their studies 
of the effects of CS extract on Cl- secretion in HBECs, Sloane and colleagues 
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(2012) bubbled the smoke from one reference cigarette (please see section 2.6 for 
more information on reference cigarettes) through DMSO to make 100% extract, 
which was then diluted in cell media. Kreindler and colleagues (2005) bubbled 8 
reference cigarettes through warmed bath solution to produce 100% CS extract for 
their studies on CS extract reduced Cl- secretion in HBECs. For their studies on 
voltage-dependent reduction in Cl- secretion using Xenopus oocytes, Moran and 
colleagues (2014) prepared their extract by bubbling the smoke from 50 cigarettes 
through 50 mL of Frog Ringer solution. Although drastically different methods to 
produce CS extract were used, both groups observed a reduction in CFTR-
mediated Cl- secretion. Although CS extract is the most commonly used method of 
CS exposure, St-Laurent and colleagues (2009) demonstrated that the process of 
bathing HBECs in CSE produced a different inflammatory response to that of whole 
CS. Thus, in order to use a method of smoking that closely mimics that of the 
typical smoker, in this thesis, the gaseous phase of cigarette smoke was used to 
treat the cultures, without the use of a diluent. Although this method closely mimics 
that of smokers, the removal of the particulate phase by collection on a Cambridge 
filter pad prevents the cultures from exposure to chemicals only present in the 
particulate phase. According to data from our lab, the level of nicotine deposition in 
the lung is reduced following exposure to the gaseous phase of smoke compared 
to whole CS (Clunes et al., 2008). However, the removal of the particulate phase is 
necessary to allow fluorescent imaging of the cultures, since the particulate phase 
of CS contains autofluorescent particles which interfere with the signal.  
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1.7  Aims 
Over the last ten years, increasing evidence suggests that CS can have a direct 
effect on ion transport across airway epithelium. Specifically, CS causes calcium 
sensitive internalization of CFTR, resulting in a decrease in CFTR-mediated Cl- 
secretion (Clunes et al., 2012, Rasmussen et al., 2014). Given that ASL 
dehydration and inefficient mucus clearance can lead to symptoms of CB in 
smokers, elucidating the cellular mechanisms behind diminished Cl- secretion, as 
well as the effects on other plasma membrane proteins, in response to CS is an 
important step towards the discovery of potential new therapies for patients with 
COPD. To this end, the overall aims of this thesis were to: 
1) Investigate the temporal profile of CS-induced CFTR internalization. 
 
2) Elucidate the effects of CS on other plasma membrane proteins. 
 
3) Understand the cell signalling components required for CS-induced 
internalization. 
 
4) Determine the endocytic route and the terminal destination of CS-
internalized CFTR. 
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2.0 Methods and Materials 
2.1  Materials 
All cell culture flasks and plates were purchased from Corning Costar. All cell 
culture medium and supplements were purchased from Life Technologies unless 
otherwise specified. GFP-CFTR and RFP-CFTR were acquired from Bruce Stanton 
at Dartmouth College. Anoctamin 1 (Ano1)-mCherry was acquired from C. Hartzell 
at Emory University. STIM1 labelled on the c-terminus with YFP was acquired from 
T. Meyer at Stanford University. STIM1-mCherry was created by replacing the YFP 
tag with mCherry (Park et al., 2009). The following plasmids were acquired as 
bacteria in agar stabs: mRFP-clathrin light chain was a gift from Ari Helenius 
(Addgene plasmid # 14435). wt-rab5-DsRed; wt-rab11-DsRed and wt-rab7-
DsRed were a gift from Richard Pagano (Addgene plasmid # 13050, # 12679 and # 
12661, respectively); wt HA-dynamin 1 pcDNA3.1 and K44A HA-dynamin 1 
pcDNA3.1 was a gift from Sandra Schmid (Addgene plasmid # 34682 and # 34683, 
respectively); Orai1 YFP was a gift from Anjana Rao (Addgene plasmid # 19756). 
BHK cells stably expressing CFTR15SA were kindly provided by Dr Jack Riordan 
(UNC). BHK cells stably expressing wtCFTR were kindly provided by Dr Martina 
Gentzsch. 
2.2  Solutions  
Pyruvate Ringer’s solution: 120 mM NaCl, 12 mM NaHCO3, 24 mM HEPES, 1.2 
mM MgCl2, 5.2 mM KCl, 1 mM NaPyruvate, 10 mM Glucose, 1.2 mM CaCl2, 0.25 
mM EGTA, 0.1% Albumin (w/v), pH 7.4 
Phosphate-buffered saline (PBS): 2.7 mM KCl, 1.8 mM KH2PO4, 137 mM NaCl, 
9.9 mM Na2HPO4, pH 7.4 
PBS supplemented with MgCl2 and CaCl2 (PBS++): 2.7 mM KCl, 1.8 mM 
KH2PO4,  137 mM NaCl, 9.9 mM Na2HPO4, 1 mM MgCl2, 1 mM CaCl2, pH 7.4 
Pierce’s lysis buffer: 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-
40 (v/v) and 5% glycerol (v/v) 
Biotinylation lysis buffer: 0.4% sodium deoxychlorate (w/v), 50 mM EGTA, 10 
mM Tris HCl, 1% NP40 (v/v) and 1X protease inhibitor 
Borate buffer: 85 mM NaCl, 4 mM KCl, 15 mM NaB4O2 
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Tris-buffered saline with Tween 20 (TBST): 137 mM NaCl, 20 mM Tris, 0.1% 
Tween-20, pH 7.4 
2.3  Routine cell culture  
All cell culture work was performed in a sterile laminar flow hood. Cells were 
cultured in 75 cm2 culture flasks at 37°C, 5% CO2 in a sterile humidified incubator.  
Human embryonic kidney (HEK)293T cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) with 4.5 g/L glucose, supplemented with 100 Units/mL 
penicillin, 100 µg/mL streptomycin, and 10% foetal bovine serum (FBS, Sigma 
Aldrich, v/v). Baby Hamster Kidney (BHK) cells stably expressing wild type CFTR or 
mutated CFTR lacking all 15 PKA phosphorylation sites (CFTR15SA) were cultured 
in DMEM:F12 medium supplemented by 100 Units/mL penicillin and 100 µg/mL 
streptomycin, 10 % FBS (v/v) and 50 mg/mL methotrexate (Teva Pharmaceuticals). 
All cells were passaged every 2-4 days upon reaching confluency. Once confluent, 
the growth medium was removed and the cells were washed once with phosphate-
buffered saline (Corning) to remove excess FBS. The cells were then incubated for 
2-5 min at 37°C in 5% CO2 with 2 mL trypsin-ethylenediaminetetraacetic acid 
(EDTA)  until cells began to detach from the base of the cell culture flask. At this 
point, fresh growth medium was added to neutralize trypsin-EDTA. The cells were 
then mechanically rinsed with growth medium to form a cell suspension. The cell 
suspension was transferred to a 50 mL conical and centrifuged at 800 rpm for 5 
min to remove any remaining trypsin-EDTA. The supernatant was removed and the 
cells were resuspended in fresh growth medium. From here, continuation flasks 
were prepared with a subcultivation ratio of 1:10. Cells were counted and seeded 
directly on 6 well plates for western blots or on 22 mm number 1 glass coverslips 
(Fisherbrand) in 6 well plates for imaging as appropriate. HBECs were obtained 
from main stem and lumbar bronchi from human excess donor lungs under protocol 
previously approved by the University of North Carolina Medical School Institutional 
Review Board (Fulcher et al., 2005). Primary HBECs were seeded on collagen 
coated 0.4 µm polyester membrane semi-permeable 12 mm culture inserts 
(Corning, transwell-clears) and maintained at air liquid interface in 37°C and 5% 
CO2. The cultures were 3 weeks post-seeding after becoming fully differentiated. 
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2.4  Transfections 
Approximately 24 h after seeding, at 70-80% confluency HEK293T cells were 
transiently transfected with appropriate plasmids using Lipofectamine 2000 
(Invitrogen). The transfection mix was prepared according to manufacturer’s 
instructions in Opti-MEM (Life Technologies) using a ratio of 3 µL Lipofectamine 
2000 to every 1 µg DNA. The growth medium of the cells was switched to antibiotic 
free medium (DMEM + 4.5 g/L glucose and 10 % FBS (v/v). The transfection mix 
was added dropwise to the cultures which were then incubated at 37°C and 5% 
CO2 for 4 h prior to the replacement of antibiotic free medium with normal growth 
medium (DMEM + 4.5 g/L glucose, 10 % FBS, 1 x penicillin/streptomycin solution). 
The cultures were then returned to the incubator at 37°C and 5% CO2 for 48 h 
before experiments were performed. 
2.5  Construction of CFTR mutants 
C-terminal truncation mutants of CFTR were constructed to investigate the role 
of the C-terminal interactions in CS-induced internalization of CFTR. Human wt-
CFTR was previously tagged N-terminally with green fluorescent protein (GFP) and 
a 23 amine acid linker sequence. This construct was subcloned into vector 
pcDNA3.1 (Moyer et al., 1998).  Truncation mutations of CFTR (K1174X and 
L1254X) were created using polymerase chain reaction (PCR)-based site-directed 
mutagenesis to introduce site specific stop codons at lysine 1174 and leucine 1254. 
Site-directed mutagenesis was performed using the Quick Change Site Directed 
Mutagenesis Kit (Agilent Technologies) according to manufacturer’s instructions. 
Primers (Table 2-1) were designed using Quick Change Primer Design program 
(Agilent Technologies) and purchased from Eurofins/MWGOperon. Site-directed 
mutagenesis requires a series of thermal cycling which allows denaturing of 
plasmid DNA, annealing of the primers to introduce the mutation and the elongation 
of primers using a Pfu-based polymerase, yielding both parental DNA and daughter 
DNA complete with the mutation. Methylated parental DNA was digested with 10 µL 
Dpn 1 for 10 min at room temperature to increase the yield of mutated DNA. The 
plasmid was then transformed into XL 10-Gold Ultracompetent cells (Agilent 
Technologies) according to manufacturer’s protocol. The plasmid was then 
amplified by miniprep (Qiagen) and all mutant plasmids were subsequently verified 
by sequencing across the open reading frame before use.  
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Table 2-1. Forward and reverse primers designed for the construction of CFTR point mutations 
2.6  Cigarette smoke exposure 
Kentucky 3R4F Reference Cigarettes were used in all smoke exposure 
experiments (University of Kentucky, 2016). Kentucky Reference Cigarettes are 
produced for research purposes only. The constituents of Kentucky Reference 
Cigarettes indicated in Table 2-2 undergo tight regulation to allow for reproducibility 
between experiments. An LM1 smoke machine (Borgwaldt) was used to perform all 
CS exposure (Figure 2-1). The smoke machine functions by automated syringe 
action to draw CS from a lit cigarette. The CS is then pumped down tubing, through 
a Cambridge filter pad, into a chamber containing cell cultures. The Cambridge filter 
pad is designed to capture the particulate phase of smoke. It captures up to 99% of 
0.1 µg diameter particulates to ensure that only the gaseous phase of smoke is 
exposed to the cells.  Automation of the smoke machine allowed for reproducible 
CS puff volume, puff time, and length of time between puff. All cigarettes were 
smoked with a puff volume of 35 mL over a duration of 2 s. Approximately 13 puffs 
of CS were applied at a rate of 1 puff every 30 s until the entire cigarette was 
smoked. This volume of CS is considered standard by the International 
Organization for Standardization (ISO, 2000) and closely mimics the volume of CS 
and length of CS intake taken by the typical smoker.  
For smoke exposure experiments, HEK293T, BHKCFTR or BHK15SA-CFTR cells 
were cultured in 6 well plates on glass coverslips and transfected as described in 
section 2.4 as necessary. Transfected HEK293T cells were utilized for smoke 
exposure 48 h following transfection, and BHKCFTR and BHK15SA-CFTR were utilized 
48 h after seeding. In all CS exposure experiments, normal growth medium 
appropriate for each cell type (section 2.3) was aspirated from cultures and 
replaced with 1 mL pyruvate Ringer’s solution. All cultures were incubated at 37°C 
for 5 min to equilibrate to the experimental conditions. After incubation, the plates 
Mutation Direction Primer 
Annealing 
Temp (°C) 
K1174X Forward 
ACATGCCAACAGAAGGTTAACCTACCA
AGTCAACC 
69.4 
K1174X Reverse 
GGTTGACTTGGTAGGTTAACCTTCTGTT
GGCATGT 
69.4 
L1254X Forward 
GATCAGGGAAGAGTACTTTGTAATCAG
CTTTTTTGAGACTACT 
68.5 
L1254X Reverse 
AGTAGTCTCAAAAAAGCTGATTACAAA
GTACTCTTCCCTGATC 
68.5 
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were tipped to remove excess Ringer’s solution providing a thin film of liquid on the 
coverslips to mimic thin film conditions present in the airway. The plates were 
placed in a CS only, or air only chamber and exposed to CS as described above. 
After CS exposure, the cultures remained in the smoke chamber for a further 5 min 
before removal of the thin film and replacement of original cell media. Cells were 
then incubated in a CO2 incubator at 37°C. For internalization time course assays 
the cultures were incubated at 37°C for 0, 5, 15, 30, 60, or 120 min prior to fixation. 
All other smoke exposures were carried out with 60 min incubation at 37°C prior to 
fixation unless otherwise specified. Air exposed cells underwent the same steps, 
but were kept in an air only chamber, and no cigarette smoke was exposed. Where 
indicated, HEK293T cells were pre-treated with pharmacological agents including 
forskolin (5 µM), dynasore (80 µM), nocodazole (33 µM), U0126 (10 µM), AG1478 
(30 µM) or cytochalasin D (2 µM). Treatments were maintained throughout the 
smoke exposure and incubation periods. 
 
Cigarette 
Reference 
Tobacco 
Component 
Amount of each 
component (%) 
3R4F 
Flue Cured 35.41 
Burley 21.62 
Oriental 12.07 
Maryland 1.35 
Reconstituted (Schweitzer Process) 29.55 
Glycerine (dry-weight basis @ 11.6% OV) 2.67 
Isosweet (sugar) 6.41 
 
Table 2-2. Tobacco constituents of Kentucky Reference Cigarettes.  
The ingredients present in Kentucky Reference Cigarettes closely resemble that of commercial 
cigarettes, and are maintained from batch to batch to allow for reproducibility across experiments 
(University of Kentucky, 2016). 
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A cigarette is placed in the smoke machine and lit. CS is taken in through an automated syringe and 
pumped down output tubes, through a Cambridge filter pad and into a chamber containing the cells.  
2.7  Immunocytochemistry 
Immunocytochemistry was used to detect wt-CFTR and CFTR15SA in BHK cells 
stably transfected with each construct. Additionally, immunocytochemistry was 
used to detect natively expressed calreticulin in HEK293T cells. For labelling, cells 
were treated as appropriate and washed once in ice cold PBS prior to fixation in 4% 
paraformaldehyde (v/v) for 5 min at room temperature, or 100% methanol for 10 
min at -20°C. Following fixation, the cultures were blocked at room temperature 
with agitation for 1 h in blocking buffer consisting of 10% (v/v) normal goat serum, 
5% (v/v) bovine serum albumin and PBS. Wild-type CFTR and CFTR15SA were 
labelled with monoclonal anti-CFTR 596 IgG2b antibody, obtained via Cystic 
Fibrosis Foundation Therapeutics and were kindly provided by Dr J. Riordan 
(UNC). Antibodies were diluted 1:300 in blocking buffer for 3 h at room 
temperature. Calreticulin was labelled with polyclonal anti-calreticulin antibody 
(Affinity Bioreagents) at 1:1000 in blocking buffer for 3 h at room temperature. 
Following incubation with primary antibody, the cultures were washed using PBS 
for a minimum of 3 x 10 min prior to incubation with secondary antibody goat anti-
mouse IgG diluted at 1:300 for 1 h at room temperature. For CFTR labelling, an 
anti-mouse secondary antibody conjugated to Alexa 488 (Life Technologies) was 
utilized. For calreticulin labelling, an anti-rabbit secondary antibody conjugated to 
Alexa 647 (Life Technologies) was utilised. After labelling with secondary antibody, 
the cultures were washed for a minimum of 3 x 5 min, prior to imaging on the 
confocal microscope as described in Section 2.8.1. 
Figure 2-1. Experimental set up for cigarette smoke exposure.   
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2.8  Fluorescence microscopy 
2.8.1 Confocal microscopy 
For all internalization time course assays the cells (HEK293T and BHKCFTR) 
were seeded at 75,000 cells per well on 25 mm glass coverslips in a 6 well plate. 
The HEK293T cells were transfected 24 h after seeding with 0.5-1 µg DNA 
according to manufacturer’s instructions. Experiments were performed 48 h after 
transfection. BHKCFTR cells were used for experiments 48 h post-seeding. All cells 
were exposed to CS or air as described previously (Section 2.3). After CS or air 
exposure the cells were incubated for 0, 5, 15, 30, 60 or 120 min in 1 mL normal 
media before fixing in 4% paraformaldehyde for 5 min at room temperature or 
100% methanol for 15 min at -20°C. The cells were then washed three times with 
PBS and stored at 4°C in PBS until ready for imaging. For imaging, the coverslips 
were removed from the six well plate and mounted in a metal ring, with 400 µL PBS 
covering the cells. All cultures were imaged on a Leica SP8 confocal microscope 
using a 63x 1.40 numerical aperture (NA) plan apochromatic Leica objective. To 
quantify the internalization of plasma membrane proteins 6 images per coverslip 
were taken as indicated in Figure 2-2 A. Using Image J (NIH Freeware, 
http://rsb.info.nih.gov/ij/), 6 regions of interest (ROI) were assigned to measure the 
fluorescence intensity of the entire plasma membrane, and 6 ROIs to measure the 
fluorescence intensity of the entire cytosol were taken from all cells present in the 
image. Examples of the ROIs selected for each cell are presented in Figure 2-2B. 
The mean fluorescence intensity of the 6 plasma membrane ROIs and 6 
intracellular ROIs were calculated to provide an average plasma membrane and an 
average intracellular fluorescence intensity for each cell. To normalize the data, the 
mean fluorescence intensity of the plasma membrane and cytosol from all cells on 
air exposed control coverslips were measured and taken as a value of one, and all 
other conditions were expressed as a fraction of this value. Data presented as 
mean ± SEM unless stated otherwise. 
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Figure 2-2. Cell and region of interest selection for image analysis.  
A diagram outlining the method of data acquisition during confocal imaging. (A) The pink circle indicates a 
cover slip, and numbers represent the 6 areas of the coverslip in which a confocal image was taken. (B) A 
representative image taken at ROI 2. All complete cells within the frame are quantified. (C) In each cell, 6 
ROIs from the plasma membrane and 6 ROIs from the intracellular region  were measured for an average 
of fluorescence intensity of the entire plasma membrane and the entire intracellular content, respectively. 
2.8.2 Acceptor photo bleaching Förster resonance energy 
transfer 
HEK293T cells were seeded in 6 well plates on 25 mm glass coverslips at a 
density of 75,000 cells per well. The cells were co-transfected with 0.5 µg wt-GFP-
CFTR and 0.5 µg wt-RFP-CFTR 24 h after seeding (transfection performed as 
described above in section 2.4). Cultures were treated with air or CS and fixed 48 h 
after transfection as described in Section 2.6. Förster resonance energy transfer 
(FRET) experiments were performed using a Leica SP5 confocal microscope with a 
63x 1.30 NA plan apochromatic glycerol immersion objective. The donor, wt-GFP-
CFTR or Ano1-GFP, was excited at 488 nm and the emission collected between 
495 nm to 549 nm, and the acceptor, wt-RFP-CFTR or Ano1-mCherry, was excited 
at 561 nm and emission collected between 580 nm to 654 nm. Acceptor 
photobleaching FRET was measured using ImageJ by measuring a change in 
donor fluorophore fluorescence intensity after photobleaching of the acceptor 
fluorophore, using the following calculation: 
 FRET efficiency (%E) = ((donorpostbleach – donorprebleach) / donorpostbleach) x 100  
All data presented as mean FRET efficiency (%) ± (standard error of 
measurement). 
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2.8.3 Colocalization assay 
HEK293T cells were seeded at a density of 75,000 cells per well on a 25 mm 
glass coverslip. The cells were transiently co-transfected (Section 2.4) with 0.5-1 µg 
wt-GFP-CFTR and the organelle markers rab5-DsRed, rab7-DsRed, rab11A-
DsRed, mRFP-clathrin light chain, and STIM1-mCherry. The cells were exposed to 
CS 48 h after transfection, as described in section 2.4, and incubated at 37°C and 
5% CO2 for 0, 5, 15, 30, 60 or 120 min before fixing with 4% paraformaldehyde. For 
colocalization studies of CFTR and calreticulin, a marker of the endoplasmic 
reticulum, or GM130, a marker of the Golgi apparatus, the cells were fixed in the 
same manner prior to blocking in 10 % normal goat serum and 1% bovine serum 
albumin. Calreticulin was detected with anti-calreticulin polyclonal IgG antibody 
(Affinity BioReagents) and GM130 was detected with anti-GM130 D6B1 rabbit 
monoclonal IgG antibody (Cell Signalling Technology). Cells were washed a 
minimum of 3 x 10 min in PBS and incubated with secondary antibody anti-rabbit 
labelled with Alexa 633. A Leica SP8 confocal microscope was used to take 6 
images per coverslip. To measure wt-GFP-CFTR, the cells were excited at 488 nm 
and the emission collected between 495 to 549 nm. To measure the ds-Red tagged 
constructs, the cells were excited at 561 nm and the emission was collected 
between 580 and 654 nm. For mRFP the cells were excited at 555 nm and the 
emission was collected between 565 nm and 655 nm. For mCherry, the cells were 
excited at 587 nm and the emission collected between 600 nm and 662 nm. For 
cultures labelled with Alexa 633, the cells were excited at 633 nm and collected 
between 640 and 700 nm. The images were overlaid, and the percentage 
colocalization was quantified using the Leica Application Suite: Advanced 
Fluorescence (LAS AF) software. Background was set at 20%. A region of interest 
(ROI) was selected by hand around each cell, and the colocalized pixels 
(foreground) were presented as white, whilst background pixels were presented as 
black. The following calculation was automatically used by the LAS AF software to 
determine the percentage colocalization rate between colocalized areas and 
background within the ROI.  
Percent colocalization = colocalization area / area foreground, where area 
foreground = image area / area background.  
An average of each coverslip was taken and all data are presented as mean 
colocalization ± SEM.  
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2.8.4 Intracellular calcium imaging 
HEK293T cells were seeded at a density of 100,000 cells per well on 25 mm 
glass coverslips in 6 well plates. 24 h after seeding, the cells were loaded with 5 µM 
Fura-2, AM in pyruvate Ringer’s (Section 2.3) for 30 min at 37°C in 5% CO2 before 
rinsing with pyruvate Ringer’s. Briefly, Fura-2, AM is a ratiometric Ca2+-sensitive, 
membrane permeable dye. Measurements of Ca2+-stimulated fluorescence can be 
taken at excitation wavelengths of 340 and 380 nm and the emission collected at 
collected at 510 nm. The ability to excite the dye at two different wavelengths 
allows for accurate measurement of [Ca2+]i by minimizing the effects of 
photobleaching, uneven loading and cell thickness. During the load process 1 µL 
DMSO or MEK/ERK inhibitor U0126 (10 µM final concentration) was added to the 
loading solution. To measure changes in intracellular Ca2+ after CS exposure, the 
coverslips were moved to a metal imaging chamber. Pyruvate Ringer’s solution 
(150 µL) was added to mimic thin film conditions as described above, and cultures 
were exposed to air or CS as described in Section 2.6. Fura-2, AM fluorescence 
was collected using a Nikon Ti-S microscope with Orca CCD camera (Hamamatsu), 
Ludl Filter wheels and a 40x 1.3 NA plan fluor oil immersion lens. Fluorescence 
intensity was measured and presented as mean fluorescence ratio 340/380 ± SEM, 
mean area under the curve ± SEM and mean maximum change in fluorescence 
ratio 340/380 ± SEM. Data were collected using HCImageLive software, and 
GraphPad Prism 4.00 for Windows (GraphPad Software).  
2.8.5 Plate reader fluorescence intensity 
To estimate the total number of Orai1 transfected cells following CS exposure, 
HEK293T cells were seeded at a density of 75,000 cells per well on a 6 well plate, 
and were transfected with Orai1-YFP 24 h after seeding as described in section 
2.4. Cells were treated with air or CS 48 h after transfection. Fixation and 
permeablization with methanol was performed prior to staining with propidium 
iodide (20 µM) to according to manufacturer’s protocol. The fluorescence intensity 
of propidium iodide, excited at a wavelength of 535 nm and collected at a 
wavelength of 617 nm, was measured using a Tecan Infinite M1000 plate reader. 
To normalize the data, the mean fluorescence intensity of the air exposed control 
cultures were measured and taken as a value of one, and all other conditions were 
expressed as a fraction of this value. Data presented as mean ± SEM unless stated 
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otherwise. These cultures were also used for confocal imaging as described in 
Section 2.8.1.  
2.9  Cell surface biotinylation 
Biotin can bind primary amines and is not cell soluble; it can therefore be used 
to bind to cell surface proteins as a technique for the purification of plasma 
membrane bound proteins. For cell surface biotinylation of primary HBECs, cells 
were cultured at air liquid interface on semi-permeable culture inserts (Corning, 
transwell-clears) and exposed to air or CS as noted. Following air/CS exposure, the 
cultures were cooled to 4°C and washed 3x in ice cold PBS++. The cultures were 
then agitated at 4°C with 100 µg/µL biotin in borate buffer on the apical surface of 
the monolayer. FBS (10% v/v) was applied to the basolateral side and was 
maintained throughout incubation with biotin to ensure biotinylation of only the 
apical membrane. Excess biotins unable to bind to the cell surface glycoproteins 
were then quenched with 10% FBS. Cells were washed with ice cold PBS++ before 
lysis with 100 µL biotinylation lysis buffer at room temperature for 10 mins. The 
lysates were centrifuged for 5 min at 5000xg to remove cell debris. Protein 
concentrations were calculated using the Bradford assay (Pierce) and samples 
were diluted in lysis buffer to ensure the same amount of protein was loaded in 
each tube. The lysates were rotated overnight with NeutrAvidin beads 
(Thermofisher). The next day, the beads were washed 3 times with ice cold PBS 
and eluted with 10% 2-mercaptoethanol and 2x lithium dodecyl sulphate (LDS) 
buffer (Biorad; 40% glycerol (v/v), 4% lithium dodecyl sulfate, 4% Ficoll-400, 0.8 M 
triethanolamine-Cl pH 7.6, 0.025% phenol red, 0.025% Coomassie G250, 2 mM 
EDTA disodium). The membrane fractions were loaded on a gel and separated by 
western blot (for more details on western blot protocol, see Section 2.10). Briefly, 
the gel was run at 150 mV until the protein ladder reached the bottom of the gel. 
Gels were transferred wet to (polyvinylidene fluoride) PDVF membranes overnight 
at 4°C. Membranes were blocked in 5% milk for 1 h at room temperature and 
probed for total CFTR with primary anti-CFTR 596 IgG2b and for dephosphorylated 
CFTR with primary anti-CFTR 217 IgG1 acquired from the Cystic Fibrosis 
Foundation Therapeutics and kindly provided by Dr J. Riordan (UNC). The 
membranes were washed a minimum of 3 x 10 min in TBST and probed with anti-
mouse conjugated to horseradish peroxidase (Jackson ImmunoResearch). The 
PVDF membrane was visualised using a Chemidoc western blot imager (Biorad). 
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2.10  Western blot 
BHKCFTR and BHK15SA CFTR cells were seeded on six well plates (Corning) at a 
density of 75,000 cells per well. The cells were utilized for experiments 48 h after 
seeding. The cultures were lysed in Peirce’s lysis buffer. To quantify protein 
concentration, bicinchoninic acid (BCA) assay was performed according to 
manufacturer’s protocol. The BCA assay utilizes the biuret reaction (the reduction 
of Cu2+ to Cu+). The combination of two BCA molecules with one Cu+ molecule 
results in the production of a purple coloured reaction product. This product can be 
detected at an absorption of 562 nm, which is linear with protein concentration 
within the sample (Thermofisher, 2015). Total protein concentration in the sample 
was calculated from a standard curve generated from known concentrations of BSA 
(Figure 2-3). 
Lysates, or samples from biotinylation elution (Section 2.9) or were loaded on 4-
15% Mini-PROTEAN tris-glycine gel (Biorad) as well as 2 µL dual colour protein 
standard (Biorad). Gel electrophoresis was performed at 150 mV for 1 h. The gels 
were then transferred wet, overnight at 4°C, to nitrocellulose or PDVF membranes. 
Membranes were blocked in blocking buffer consisting of PBS + 0.01% Tween (v/v) 
and 3% (v/v) dried skimmed milk for 1 h at room temperature prior to incubation 
overnight at 4°C with primary anti-CFTR 596 monoclonal antibody (UNC CFTR 
Antibodies) in blocking buffer. The membrane was then washed in PBST for 3 x 5 
min at room temperature, prior to the addition of horseradish peroxidase tagged 
anti-mouse secondary antibody (Jackson ImmunoResearch) at a concentration of 
1:1000 in blocking buffer for 1 h. The membrane was then washed 3 x 5 min in 
PBST to remove any unbound secondary antibody. To detect HRP activity, two 
components of Clarity enhanced chemiluminescence (ECL) western substrate 
(Biorad), luminol/enhancer solution and peroxide solution, were combined in equal 
parts, and were added to the blot for 2 min before the blots were developed using 
the Chemidoc western blot imager (Biorad). 
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BCA protein standard curve was produced using BSA protein standards of known concentration (25, 
125, 250, 500, 750, 1000, 1500, 2000 µg/mL). This was utilized for the calculation of the concentration 
of unknown proteins using regression analysis. Data represents mean of samples ran in duplicate; r2 = 
0.9931. 
2.11 Image analysis and statistics 
Internalization, FRET assays and densiotometry of western blots were analyzed 
using ImageJ. All data were collected using Microsoft Excel 2007 (Microsoft 
Corporation, USA), and graphs were produced using GraphPad Prism 4.00 for 
Windows (GraphPad Software). All data are given as mean ± SEM unless stated 
otherwise. Where applicable, statistical significance was calculated using the 
Kruskal-Wallis test with Dunn’s multiple comparison post-test or two-way ANOVA 
with Dunn’s or Sidak’s multiple comparison post-test where appropriate. A P value 
of p < 0.05 was considered significant.  
 
 
 
 
 
 
Figure 2-3. Standard curve for BCA assay protein quantification.  
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3.0 The effect of cigarette smoke on the cellular location of 
CFTR and other plasma membrane proteins 
3.1  Introduction 
Airflow limitation and progressive loss of lung function are symptoms which 
characterize both CF and COPD. CF is an autosomal recessive disease in which 
mutations of CFTR lead to loss of function, affecting approximately 70,000 people 
worldwide (CFF., 2015). In contrast, there are more than 1 billion smokers 
worldwide, and as such, COPD also poses a prominent health risk to society 
(WHO., 2015). Genetic, epigenetic, and host factors likely contribute to the 
pathogenesis of COPD. However the primary risk factor is smoking tobacco. 
Patients with COPD can exhibit both emphysema, characterized by the destruction 
of the alveolar surface, and CB, characterized by recurrent cough, excessive 
mucus production and mucus accumulation of the airways (Kim and Criner, 2013). 
Approximately two-thirds of patients with COPD exhibit CB, which typically has a 
higher prevelence than that of emphysema (Rab et al., 2013). CB characteristically 
displays a similar phenotype to CF, with increased mucus accumulation, 
inflammation and chronic bacterial infection, indicating that there may be a 
commonality in the pathogenesis of both CF and CB.  
Our lab and others have shown blunted chloride secretion following acute CS 
exposure. This is associated with a rapid internalization of CFTR, leading to 
decreased ASL depth. Indications that internalization of CFTR and diminished Cl- 
secretion may be linked to mucus dehydration and accumulation in patients with 
COPD present an important challenge. Thus, better understanding of the cellular 
mechanisms required for this smoke response may reveal potential therapeutic 
targets to address the underlying causes of smoking related lung disease. To this 
end, the specific aims of this chapter are to: 
1) To develop a protocol to measure the kinetics of CS-induced internalization 
2) To determine the importance of the interaction of CFTR-CFTR interactions 
in CS-induced internalization 
3) To better understand the breadth of the effects CS has on plasma 
membrane proteins 
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3.2  Results 
3.2.1 Cigarette smoke causes time-dependent internalization 
of CFTR 
HEK cells are well suited for biochemical, pharmacological and genetic 
manipulation (Domingue et al., 2014), and have been shown to exhibit CS-induced 
calcium release and CFTR internalization much like that of airway epithelia 
(Rasmussen et al., 2014). This cell line has therefore been selected to carry out the 
majority of investigations in this thesis.  
To investigate the effects of CS on the cellular localization of CFTR, it was first 
necessary to establish a protocol for visualizing the internalization of CFTR after CS 
exposure. The N-terminally tagged GFP-CFTR used in this thesis exhibited typical 
plasma membrane expression and comparable activity in functional experiments to 
non-tagged CFTR (Moyer et al., 1998). To investigate the cellular location of CFTR 
following CS exposure, GFP-CFTR was transiently expressed in HEK293T cells. 
Cells were then exposed to a standard smoking protocol (see methods section 2.6) 
prior to incubation at 37°C for a series of time points, i.e. 0, 5, 15, 30, and 60 min 
after CS exposure to better understand CFTR trafficking post-CS exposure. Cells 
were fixed and visualized using confocal microscopy (Figure 3-1 A), and images 
were quantified as described in methods section 2.8.1 In Figure 3-1 B, 
quantification of each time point demonstrated no change in fluorescence intensity 
at the plasma membrane (PM; red, dashed line) or intracellularly (red, solid line) 
over 60 min following air exposure. However, following CS exposure CFTR PM 
fluorescence intensity (blue) decreased with a half-life of 10.5 min and a  of 15.2 
when fit with a single exponential with R2 value of 0.094 (n = 45 - 125 cells). 
Intracellular fluorescence intensity increased with a half-life of 27.7 min,  of 39.9 
and R2 value of 0.085 (n = 45 – 125 cells), consistent with data from Rasmussen et. 
al. which demonstrated that CFTR internalized following CS exposure. To confirm 
that the change in CFTR distribution within the cell was due to changes induced by 
CS rather than a result of expression, the transfection efficiency of GFP-CFTR was 
measured in HEK293T cells (Figure 3-1 C). The number of transfected cells was 
taken as a percentage of total cells in the frame after 15 min of air or CS exposure. 
No significant difference was observed in transfection efficiency between air and 
smoke exposed samples indicating that internalization measured is due to specific 
effects of CS rather than differences in expression. 
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Figure 3-1. Cigarette smoke-internalized CFTR accumulates intracellularly with a half-life of ~27 
min.  
HEK293T cells transfected with GFP-CFTR were exposed to CS and incubated at 37°C for specified 
time durations prior to fixation using 4% paraformaldehyde. A) Representative confocal images of 
GFP-CFTR (green) following air or CS exposure at incubation times 5, 15, 30, and 60 min.  B) Plasma 
membrane (PM; red) and intracellular (blue) fluorescence intensity over time of air (dashed lines) and 
CS (solid lines) exposed GFP-CFTR. Smoke exposed time points at the PM (r2 = 0.094) and 
intracellularly (r2 = 0.085) were fit with a single exponential (black line). n = 45 - 149 cells from four 
independent experiments. C) Percentage of cells in frame transfected with GFP-CFTR in air and CS 
exposed conditions. n = 26 – 30 images per condition.  Scale bar = 10 µm. 
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3.2.2 CFTR dissociates upon internalization by cigarette 
smoke 
CFTR can cluster into distinct microdomains with its interacting partners in the 
plasma membrane (Li and Naren, 2005). The formation of these microdomains 
allows CFTR molecules to accumulate in close proximity to one another, ensuring 
the tight regulation of CFTR and its binding partners. One technique to investigate 
the interaction of molecules within binding domains is Förster resonance energy 
transfer (FRET). FRET microscopy relies on the ability to capture fluorescent 
signals from the through-space interactions of labelled molecules (Sekar and 
Periasamy, 2003). This is based on the phenomenon that a donor fluorophore can 
become quenched by donating photons to an acceptor fluorophore, but only when 
the proximity between the two fluorophores is closer than 10 nm (100 Å). In 
acceptor-photobleaching FRET, the quenching of the donor is relieved when the 
acceptor fluorophore is photobleached, which can be measured as a change in 
apparent FRET efficiency (%).   
To investigate CS-induced changes in CFTR-CFTR interactions, the apparent 
FRET efficiency of GFP-CFTR (donor fluorophore) and RFP-CFTR (acceptor 
fluorophore) were measured at the plasma membrane of HEK293T cells after 
smoke exposure and incubation at 37oC for the previously defined time points 
(section 3.2.1). GFP- and RFP-CFTR were transiently transfected into HEK293T 
cells. 48 hours after transfection, both constructs expressed predominantly at the 
plasma membrane (Figure 3-2 A). Plasma membrane FRET levels 15, 30 and 60 
min post-CS exposure (Figure 3-2 B; 15.0 ± 1.2%, 16.2 ± 1.5%, and 10.8 ± 1.4%, 
respectively; n = 33 - 42 cells) remained unchanged compared to plasma 
membrane FRET levels of air exposed at the same time points (17.4 ± 1.6%, 12.7 ± 
1.1%, 12.3 ± 0.8%, respectively; n = 41 - 60 cells). As in previous experiments 
(Section 3.2.1), a large amount of CFTR accumulated in the perinuclear region of 
the cell following CS exposure (data not shown). However, upon measuring the 
apparent FRET efficiency of internal GFP-CFTR and RFP-CFTR post-CS 
exposure, the FRET efficiency measured at 15, 30, and 60 min (Figure 3-2 B; 4.8 ± 
0.6%, 7.6 ± 1.3%, 5.1 ± 0.5%; p < 0.001, n = 31 - 53) was significantly lower than 
plasma membrane FRET efficiency in air and smoke exposed conditions as 
reported above. It is possible that the high levels of FRET at the plasma membrane 
in both air and CS exposed conditions may be due to an overcrowding effect due to 
the overexpression of both RFP- and GFP-CFTR. To test for this, the donor 
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fluorescence intensity was plotted against the percentage FRET efficiency for each 
condition (Figure 3-3). The correlation of donor intensity and FRET efficiency in 
plasma membrane FRET efficiency after both air and CS exposure is slightly 
negative with r values of -0.47 and -0.24 respectively. A positive correlative 
relationship would indicate overcrowding, suggesting that the higher the expression 
of the proteins, the higher the FRET value observed. However, since the values 
demonstrated here are not positive, the possibility that FRET is occurring due to 
overcrowding can be ruled out. Therefore, these data suggest that intracellular 
FRET efficiency is decreased compared to plasma membrane FRET efficiency, 
suggesting that CFTR may dissociate from its macromolecular complex following 
CS exposure. 
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Figure 3-2. Cigarette smoke causes dissociation of CFTR-CFTR interactions. 
HEK293T cells co-expressing GFP-CFTR and RFP-CFTR were incubated at 37°C for 0, 15, 30 or 60 
min following smoke or air exposure prior to fixing in 4 % PFA. Acceptor photobleaching FRET was 
performed. (A) Typical confocal micrographs of GFP-CFTR (green) and RFP-CFTR (red) expressing 
air exposed cells before and after photobleaching of the acceptor fluorophore. (B) FRET efficiency of 
RFP-CFTR and GFP-CFTR measured at the PM (Red; Air = dashed line, CS = solid line) and 
intracellularly (Blue; Air = dashed line, CS = solid line) following air and CS exposure. *** = p < 0.001 
of CS PM compared to CS intracellular, ** = p < 0.001 of CS PM compared to CS intracellular, # = p < 
0.05 of air intracellular to CS intracellular, ### = p < 0.001 of air intracellular to CS intracellular, ††† = 
p < 0.001 of air PM to CS intracellular, †† = p < 0.01 of air PM to CS intracellular by two-way ANOVA 
with Sidak’s multiple comparison test. All n = 31 - 60 cells from four independent experiments. Scale 
bar = 10 µm. 
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Figure 3-3. The dependence of FRET efficiency on donor intensity.  
The FRET efficiency of donor (GFP) and acceptor (RFP) plotted in relation to donor fluorescence 
intensity after air exposure at the plasma membrane (A) and intracellularly (C) and after CS exposure 
at the plasma membrane (B) and intracellularly (D). Correlation relationships are indicated by the r 
value on each graph. Zero or negative correlation indicates that changes in FRET efficiency are not 
due to increased fluorescence intensity. 
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3.2.3 CS-induced internalization of CFTR occurs 
independent of nucleotide-binding domain 2 and the C-
terminal endocytic motifs  
The C-terminus of CFTR is host to a plethora of motifs important for CFTR 
regulation, including NBD2, C-terminal endocytic motifs, and the PDZ-binding motif. 
The PDZ-binding motif permits the interaction of CFTR to the actin cytoskeleton 
through NHERF1 and ezrin binding. In order to better understand the role of the 
actin cytoskeleton and CFTR-CFTR interactions, as well as the typical endocytic 
motifs of CFTR in CS-induced internalization, C-terminal truncation mutants of 
CFTR were constructed using site-directed mutagenesis. Premature stop codons 
were introduced to remove the PDZ-binding motif and the endocytic signals 
including tyrosine- and di-leucine-based motifs (GFP-CFTR-L1254X) and NBD2 
(GFP-CFTR-K1174X). After 48 h of expression, both mutants localized to the 
plasma membrane in HEK293T cells (Figure 3-4 A). After CS exposure, 
intracellular fluorescence intensity increased in GFP-CFTR-L1254X and GFP-
CFTR-K1174X expressing cells from 1.1 ± 0.1 to 2.5 ± 0.2 AU, and 1.2 ± 0.1 AU to 
3.4 ± 0.3 AU, respectively (p < 0.05, p < 0.01, and p < .001, n = 103 -213). These 
values were similar to that of wt-GFP-CFTR, which increased from 1.0 ± 0.1 AU to 
3.1 ± 0.3 AU following CS exposure, suggesting that removal of the C-terminal 
endocytic motifs or NBD2 had no effect on CS-induced internalization of CFTR. 
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 Figure 3-4. The C-terminus and NBD2 of CFTR are not required for CS-induced CFTR internalization.  
HEK293T cells on a glass coverslip were transiently transfected with the above constructs and exposed to air or 
CS, 48 h after transfection. Cells were fixed in 4% PFA at room temperature for 5 min and imaged on a confocal 
microscope. (A) Representative images of HEK293T cells expressing wt-GFP-CFTR, GFP-CFTR-K1174X or 
GFP-CFTR-L1254X after air and CS exposure. (B) Mean PM fluorescence intensity in air (open bars) or CS 
(grey bars) of HEK293T cells transfected with WT-, L1254X-, or K1174X-CFTR. * p < 0.05, ** p < 0.01, *** p < 
0.001 by Kruskal-Wallis test with Dunn’s multiple comparison post-test, n = 103 – 213 cells from three 
independent experiments. (C) Mean intracellular fluorescence intensity in air (open bars) or CS (grey bars) of 
HEK293T cells transfected with WT-, L1254X-, or K1174X-CFTR, * p < 0.05, ** p < 0.01, *** p < 0.001 by 
Kruskal-Wallis test with Dunn’s multiple comparison post-test, n = 103 - 213 cells from three independent 
experiments. Scale bar = 10 µm. 
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3.2.4 The effects of cigarette smoke on other membrane 
proteins 
Thus far, we have determined that C-terminal motifs including NBD2, endocytic 
domains, as well the PDZ domain of CFTR are not required for CS-induced 
internalization, and that CFTR-CFTR interactions dissociate following internalization 
by CS. For further investigation into the mechanisms behind CS-induced 
internalization, it is important to understand whether this phenomenon is specific to 
CFTR, or whether other ion channels or membrane proteins have an abnormal 
response to smoke. 
Another ion channel responsible for mediating correct hydration of the ASL is 
Ano1 (Section 1.3). Evidence provided by knockout mice have shown that Ano1 
has a distinctive role in the mediation of ASL and further to this, the CaCC has 
shown to have a minor yet important role in Cl- transport CF airway epithelia 
(Knowles et al., 1991, Mason et al., 1991, Stutts et al., 1992, Namkung et al., 
2011). Despite the reported role of CaCC in the regulation of Cl- secretion, 
observations in HBECs suggest that CS can alter the transepithelial electric 
potential difference in response to adenosine but not adenosine triphosphate (ATP) 
(Clunes et al., 2012). These data suggest that CS has a direct effect on the 
adenosine-mediated Cl- secretion by CFTR, rather than ATP-mediated Cl- secretion 
by CaCC. To investigate the effects of CS on Ano1 more directly, HEK293T cells 
co-transfected with GFP-CFTR and Ano1-mCherry were exposed to air or CS and 
incubated at 37oC for 60 min. Consistent with previous data, GFP-CFTR showed 
significant internal accumulation following CS exposure (4.0 ± 0.3 AU, p<0.001, 
n=174 cells) compared to air control (Figure 3-5 C; 1.0 ± 0.1 AU, n = 194 cells). 
However, no change in Ano1-mCherry PM fluorescence intensity was seen 
following air (1.0 ± 0.0 AU) or CS exposure (Figure 3-5 B; 1.1 ± 0.0 AU, n = 212 
cells), and no change in Ano1-mCherry intracellular fluorescence intensity was 
seen in air (1.0 ± 0.1 AU) or CS exposed conditions (1.1 ± 0.1 AU, n = 162 - 212 
cells). As no change in the plasma membrane or intracellular fluorescence intensity 
of Ano1 was observed following smoke exposure, these data suggest that the 
plasma membrane levels of Ano1 are not affected by smoke. 
In addition to internalization studies, acceptor photobleaching FRET efficiency 
was measured in cells expressing Ano1-GFP and Ano1-mCherry (Figure 3-6). 
Consistent with previous studies showing that CaCC secretion is not affected by 
CS, no change in Ano1-GFP - Ano1-mCherry PM FRET levels were measured after 
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CS exposure at all time points (Figure 3-6; baseline FRET was measured at 17.3 ± 
1.2%, n = 32). 
Another ion channel present in the airway epithelia is the calcium release-
activated calcium channel, Orai1. Store operated calcium entry was unaffected by 
CS exposure (Rasmussen et al., 2014). However, here, when HEK29T cells 
expressing Orai1-YFP, were exposed to CS, and incubated for 15 min at 37oC, 
Orai1-YFP plasma membrane fluorescence intensity decreased from 1.0 ± 0.02 to 
0.7 ± 0.02 AU (Figure 3-8 A; p < 0.001, n = 125 – 145 cells), and intracellular 
fluorescence intensity increased from 1.0 ± 0.1 AU to 3.9 ± 0.4 AU (p < 0.001, n = 
125 - 145). After a longer incubation period of 60 min, Orai1-YFP plasma 
membrane fluorescence again decreased from 0.9 ± 0.0 to 0.7 ± 0.1 AU and 
intracellular fluorescence intensity further increased from 1.1 ± 0.1 to 5.6 ± 0.7 AU 
(p < 0.001, n = 54 - 137 cells) indicating that Orai1 internalizes in a similar fashion 
to CFTR. However, in contrast to data published by Rasmussen et al. (2014) 
demonstrating that cell number did not decrease following CS exposure,  here, in 
Figure 3-8 C, the fluorescence intensity of propidium iodide stained Orai1 
transfected cultures decreased from 1.0 ± 0.1 AU (n = 9 wells) to 0.6 ± 0.1 AU (p < 
0.01, n = 9 wells) following CS exposure. The data suggest that the over-
expression of Orai1 may cause different effects to CS compared to cells over-
expressed with CFTR. 
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Figure 3-5. Cellular location of Ano1 is not affected by CS. 
HEK293T cells co-transfected with Ano1-mCherry and GFP-CFTR were exposed to smoke and 
incubated at 37°C for 60 min before fixation. (A) Representative confocal micrographs of Ano1-
mCherry (red) and GFP-CFTR (green) transfected cells following air and CS exposure. (B) Mean 
plasma membrane fluorescence intensity of Ano1-mCherry and GFP-CFTR following air (open bars) 
and CS (grey bars) exposure, normalized to air control for each construct.  (C) Mean intracellular 
fluorescence intensity of GFP-CFTR and Ano1-mCherry after air (open bars) and CS (grey bars) 
normalized to air control for each construct, *** p > 0.001 by Kruskal-Wallis test with Dunn’s multiple 
comparison post-test, n = 162 - 212 cells from four independent experiments. Scale bar = 10 µm. 
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Figure 3-6. Cigarette smoke exposure shows no effect on FRET efficiency of Ano1-GFP and 
Ano1-mCherry. 
HEK293T cells co-expressing Ano1-mCherry and Ano1-GFP were incubated at 37°C for 0, 15, 30 or 60 
min following CS or air exposure prior to fixing in 4% PFA. Acceptor photobleaching FRET was 
performed. (A) Typical confocal micrographs of Ano1-GFP (green) and Ano1-mCherry (red) expressing 
cells before and after photobleaching of the acceptor fluorophore. (B) Apparent FRET efficiency of 
Ano1-mCherry and Ano1-GFP measured at the plasma membrane (closed, open and grey bars) 
following air (open bars) and CS (closed bars). n= 39 - 45 cells from 3 independent experiments. No 
significant difference of FRET efficiency between air and smoke exposed cultures at all time points. 
Two-way ANOVA with Tukey’s multiple comparison post-test. Scale bar = 10 µm. 
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Figure 3-7. Cigarette smoke causes intracellular accumulation of Orai1. 
HEK293T cells expressed with Orai1-YFP exposed to air or CS were incubated for 15 or 60 min at 
37°C prior to fixation with 4% paraformaldehyde. Cells were stained post-fixation with propidium 
iodide (red). (A) Representative images of Orai1-YFP (green) and nuclei (red) following air or smoke 
exposure and 15 min incubation. (B) Representative images of Orai1-YFP and nuclei following air or 
smoke exposure and 60 min incubation. Scale bar = 10 µm. 
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Figure 3-8. Cigarette smoke causes intracellular accumulation of Orai1. 
HEK293T cells expressed with Orai1-YFP exposed to air or CS were incubated for 15 or 60 min at 
37°C prior to fixation with 4% paraformaldehyde. Cells were stained post-fixation with propidium 
iodide (red). (A) Mean plasma membrane fluorescence intensity of Orai-1 YFP following 15 min air 
(open bars) and CS (grey bars) exposure, normalized to air control for each construct.  (B) Mean 
intracellular fluorescence intensity of Orai1 following 60 min air (open bars) or CS exposure (grey 
bars) normalized to air control for each construct. *** p > 0.001 Kruskal-Wallis test with Dunn’s 
multiple comparison test, n =162 - 212 cells from four independent experiments. (C) Propidium iodide 
fluorescence intensity of cultures incubated with smoke or air was taken using a plate reader (Tecan), 
as an estimate of total cell number. ** p < 0.01 by Student’s t test, n = 9 wells per condition from 3 
independent experiments.   
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3.3  Discussion 
Diminished CFTR function following CS exposure has now been well 
documented, and has been attributed to internalization of CFTR as evidenced by 
surface labelling (Rasmussen et al., 2014).  To investigate the dynamics of CS-
induced CFTR internalization, in this chapter, we have developed a protocol to 
assess the temporal profile of CFTR internalization following smoke exposure. 
Furthermore, this protocol has been adapted to characterize CS-induced CFTR 
internalization by FRET and the internalization of other plasma membrane proteins. 
Thus, we have demonstrated that CFTR dissociates from its macromolecular 
complex following CS exposure, and that CS-induced CFTR internalization is 
independent of C-terminal endocytic motifs. Moreover, use of the internalization 
assay to investigate other membrane proteins revealed a similar response of Orai1 
to CS exposure.  
Rasmussen et al. (Rasmussen et al., 2014) used surface labelling of HA-tagged 
CFTR to assess internalization, however this technique requires a multistep 
protocol. The use of fluorescently tagged proteins allows the cells to be imaged 
directly after fixing, and reduces the protocol time by a number of days. Although 
surface labelling allows the tracking of the movement of CFTR from the plasma 
membrane into the cell, the technique used in this assay provides a broader 
analysis of internalization by intracellular accumulation. During the internalization 
assay, CFTR significantly accumulated intracellularly over time. Although GFP-
CFTR plasma membrane fluorescence intensity decreased steadily over time, the 
amount of GFP-CFTR reduction at the plasma membrane was far lower than the 
amount of intracellular accumulation, and the half-life for the removal of CFTR from 
the plasma membrane (10.5) was much faster than that of the half-life for CFTR to 
accumulate inside the cells (27.7 min). There are two main hypotheses for the 
reduced removal of CFTR from the plasma membrane following CS exposure. 
Firstly, the delivery of nascent or recycled CFTR to the plasma membrane may 
have increased the plasma membrane signal. Secondly, the close proximity of the 
ER, a potential destination for CS-internalized CFTR (see chapter 5.0), to the 
plasma membrane may result in plasma membrane fluorescence being intensified 
by that of ER fluorescence. Despite this limitation, intracellular GFP-CFTR 
consistently increased following CS exposure much like that seen by Rasmussen et 
al. therefore providing a quantifiable signal for measuring the effects of CS on the 
cellular localization of CFTR.  
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CFTR takes part in a variety of physical and functional interactions with different 
proteins including ion channels, transporters, kinases, phosphatases, cytoskeletal 
components and signaling factors (Li and Naren, 2005). Evidence suggests that 
CFTR and its interacting proteins are confined to specific microdomains in the 
plasma membrane. The compartmentalization of interacting proteins into 
macromolecular complexes allows for tight regulation of CFTR trafficking and 
activity, as well as the ability of CFTR to regulate other signaling pathways such as 
inflammation (Dudez et al., 2008). These macromolecular complexes not only 
function to bring CFTR in close proximity to a matrix of proteins including actin, 
NHERF1, and ezrin but also to bring CFTR molecules within close proximity to one 
another (Li, 2005). FRET, a tool to measure the proximity of proteins, functions as a 
molecular ruler, allowing the determination of distances between molecules based 
on the ability of the fluorophore to share photons with one another. Here, FRET 
efficiency of N-terminally tagged GFP-CFTR and RFP-CFTR was determined in 
HEK293T cells. Despite the previous report of no appreciable FRET efficiency 
between N- or C-terminally tagged CFP-CFTR and EYFP-CFTR (Berdiev, 2008), in 
air conditions membrane GFP-CFTR and RFP-CFTR FRET efficiency was between 
12.3 and 17.4%. The presence of different fluorescent tags may be responsible for 
the discrepancy between the reports of CFTR-CFTR FRET efficiency. Following CS 
exposure, membrane GFP-CFTR and RFP-CFTR FRET efficiency was unaffected, 
however, cytosolic CFTR-CFTR FRET efficiency was reduced compared to that of 
plasma membrane FRET efficiency air and smoke exposed samples. This data 
suggests that CFTR molecules become further apart upon internalization. In basal 
conditions, CFTR dissociates from NHERF1 within its microdomain, allowing the 
AP-2-clathrin complex to interact and leading to endocytosis of CFTR. It is 
reasonable to assume that the increased distance between the CFTR molecules is 
due to dissociation from its microdomain to allow the entry of endocytic machinery 
(Guggino and Stanton, 2006). However, the use of an agonist of endocytosis would 
give a clearer understanding of whether this phenomenon is specifically due to CS- 
induced internalization, or whether it is a feature of CFTR endocytosis in general. 
The role of actin in CS-induced CFTR internalization was further therefore 
investigated by the removal of the PDZ-binding motif, a region of CFTR that 
facilitates the interaction of CFTR with the actin cytoskeleton. The introduction of a 
stop codon at leucine 1254 produced a mutant of CFTR with the PDZ-binding motif 
removed. L1254X CFTR maintained normal levels of internalization following CS 
exposure, suggesting that the interaction of CFTR with the actin cytoskeleton is not 
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required for CS-induced internalization of CFTR. Furthermore, the C-terminus of 
CFTR is predominantly involved in the regulation of normal CFTR endocytosis. The 
L1174X CFTR mutant also had crucial endocytic motifs, including the tyrosine- and 
di-leucine based motifs, removed. Despite the necessity of the tyrosine and di-
leucine based motifs in normal endocytosis, these are not required for CS-induced 
CFTR endocytosis, suggesting that the mechanism of internalization by CS may be 
different from that of normal endocytosis. In addition to the C-terminal endocytic 
motifs of CFTR, NBDs have been implicated in maintaining the stability of CFTR at 
the plasma membrane (Cheng et al., 1990) Additional removal of NBD2 by the 
introduction of a stop codon at lysine 1174 had no effect on CS-induced CFTR 
internalization, suggesting that this domain is not necessary for CS-induced 
internalization.  
Having confirmed that the C-terminus of CFTR is not required for CS-induced 
internalization, other proteins were investigated to determine their response to CS 
exposure. CS caused reduction in ASL height, which has been attributed to 
internalization of CFTR from the plasma membrane. UTP-stimulated nasal PD was 
not affected by CS (Clunes et al., 2012), further to this CS has no effect on the 
cellular location of Ano1 at 5, 15, 30 or 60 min. Plasma membrane FRET efficiency 
of Ano1-mCherry and Ano1-GFP was not affected in air or CS conditions, 
confirming that CS has no effect on the cellular localization of Ano1. It is possible 
that much like in CF; CaCC activity provides a compensatory mechanism for 
chloride secretion in the absence of plasma membrane CFTR (Ousingsawat et al., 
2009, Rock et al., 2009)  
In native conditions Orai1 is activated by STIM1, an ER localized calcium 
sensor, following its aggregation induced by calcium store depletion. STIM1 
aggregation is unaffected by CS exposure (Rasmussen et al., 2014). In native 
conditions, Orai1 interacts with CFTR in a macromolecular complex, and the 
absence of CFTR leads to increased SOCE (Balghi et al., 2011). Despite this, 
previous research has shown that SOCE mediated by Orai1 is not responsible for 
increases in intracellular calcium observed during smoke exposure (Rasmussen et 
al., 2014). Furthermore, we have observed a rapid accumulation of Orai1 in the 
cytosol following CS exposure. A possible explanation for the CS-induced 
internalization of Orai1 observed in Section 3.2.4 is that internalization of Orai1 
functions to balance changes in SOCE caused by CFTR removal from the 
membrane by CS. However, since these cells do not endogenously express CFTR, 
it is more likely that Orai1 internalizes in response to increases in cytosolic calcium. 
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As such, Orai1 plasma membrane residence and activity is highly sensitive to 
intracellular Ca2+. For example, as previously mentioned, SOCE by Orai1 is 
stimulated by the depletion of Ca2+ by endoplasmic reticulum stores and interaction 
with STIM1. Furthermore, increases in intracellular calcium stimulate the 
recruitment of protein kinase C (PKC) β1 to the plasma membrane. PKCβ1 causes 
downregulation of SOCE by Orai1 through phosphorylation of the N-terminal sites, 
S527 and S30, of Orai1 (Hooper et al., 2015, Kawasaki et al., 2010). As CS 
exposure leads to dephosphorylation of CFTR at a PKA sensitive site (see section 
4.2.5), a literature review to reveal putative sites of phosphorylation was performed. 
Indeed, western blotting and co-immunoprecipitation of Orai1 with antibodies 
against both Orai1, and the phosphorylated consensus site RRXpS/T confirmed the 
presence of a putative site of PKA phosphorylation in this channel (Howe, 2011). 
Thus, investigation of the effects of CS on this site of phosphorylation would be 
extremely useful in determining whether Orai1 and CFTR are internalized by CS by 
a similar mechanism. In contrast to Orai1 and CFTR, Ano1 remained at the plasma 
membrane following smoke exposure. Ano1 is regulated by Ca2+/calmodulin 
dependent kinase II (Ho et al., 2001, Xie et al., 1996), and although its structure 
contains putative sites of phosphorylation by PKC, a range of inhibitors against 
PKC and PKA had no effect on Ano1-mediated chloride section (Tian et al., 2011). 
Thus, the lack of this site may provide an explanation for the lack of response of the 
channel to CS.  
The major findings of this chapter are summarized below: 
 CS causes rapid internalization of CFTR, with intracellular accumulation of 
CFTR occurring with a half-life of 27.7 min. 
 
 CFTR-CFTR interactions dissociate following internalization by CS 
exposure. 
 
 C-terminal endocytic motifs of CFTR are not required for CS-induced 
internalization, suggesting that C-terminal endocytic.  
 
 CS causes internalization of CFTR and Orai1, but not Ano1. 
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4.0 Cigarette smoke exposure causes dephosphorylation of 
CFTR leading to its internalization 
4.1 Introduction 
Despite clear evidence that CS causes rapid internalization of CFTR, little is 
known about the cell signalling pathways that initiate this phenomenon. Our lab has 
shown that CS-induced CFTR internalization is dependent on the release of Ca2+ 
from lysosomes following CS exposure (Rasmussen et al., 2014), but whether Ca2+ 
directly stimulates CFTR internalization, or works through downstream signalling 
pathways remains to be seen. 
Historically, CFTR has been considered a cAMP-mediated chloride channel 
which cannot be activated by calcium (Evans and Marty, 1986). However, more 
recently it has become known that CFTR may additionally be regulated by Ca2+. 
For example, cholinergic stimuli which mediate Ca2+ release from the endoplasmic 
reticulum cause activation of CFTR in BHK cells expressing the muscarinic receptor 
M3R (Billet et al., 2013). This response is partially due to the Ca2+-sensitive 
activation of adenylyl cyclase, which leads to phosphorylation and activation of 
CFTR by PKA. Some CFTR activity remained upon inhibition of PKA, indicating that 
Ca2+ stimulation of CFTR must additionally occur by an alternative mechanism. 
One proposed pathway suggests that Ca2+ causes upregulation of Src, a proto-
oncogene tyrosine kinase, which prevents dephosphorylation and deactivation of 
CFTR by inhibiting protein phosphatase (PP) 2A (Billet and Hanrahan, 2013). 
Furthermore, a more direct effect of Ca2+-loaded calmoduliin on CFTR has been 
reported in abstract form (Bozoky et al., 2015). 
It is therefore important to consider which Ca2+-mediated down stream effectors 
are responsible for the Ca2+-sensitive internalization of CFTR by CS.  Researchers 
have shown that CS stimulates mitogen-activated protein kinase (MAPK) pathways 
including the mitogen-activated protein kinase kinase/extracellular signal-regulated 
kinase (MEK/ERK1/2) pathway (Mercer and D'Armiento, 2006). The MAPK 
pathway is a potent regulator of cell survival and proliferation (McCubrey et al., 
2007). Furthermore, MEK/ERK can regulate the expression of ENaC through the 
interaction of E3 ubiquitin ligase Nedd4-2, resulting in the degradation of ENaC 
(Falin and Cotton, 2007, Booth and Stockand, 2003). The MEK/ERK1/2 pathway 
has been implicated in the upregulation of CFTR through INFɣ (Kulka et al., 2005). 
More recently, the Cormet-Boyaka group have demonstrated using CS extract that 
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the inhibition of MEK/ERK reduces CS-induced CFTR internalization, suggesting 
that CS-induced internalization is MAPK-dependent (Xu et al., 2015).  
The hypothesis that cytosolic kinases may regulate CFTR is not a new one. 
Hormonal stimulation of the airway epithelium activates CFTR through an increase 
in cytosolic cAMP. This increase in cAMP levels causes activation of the serine 
threonine kinase, protein kinase A (PKA) (Taylor et al., 1990). The coding 
sequence of CFTR contains many consensus sequences for PKA phosphorylation, 
many of which are located in the R domain (Figure 4-5). The phosphorylation of 
CFTR by PKA increases the affinity of CFTR to bind ATP, increases the channel 
bursting rate and increases the open probability of CFTR (Cheng et al., 1991). As 
well as PKA, a number of different kinases activate, inhibit or have a dual effect on 
CFTR including PKC (Li et al., 2007), casein kinase 2 (CK2) (Treharne et al., 2009), 
and Src (Billet et al., 2013). PKC, another serine threonine kinase, increases the 
magnitude of the PKA response (Jia et al., 1997, Liedtke and Cole, 1998, Middleton 
and Harvey, 1998, Tabcharani et al., 1991). CK2 regulates CFTR processing and 
membrane trafficking (Luz et al., 2011). Src kinase, a tyrosine kinase, activates 
CFTR by direct phosphorylation and indirectly by inhibiting PP2A (Billet et al., 
2013). Many of the kinases that regulate CFTR have been shown to be located in 
macromolecular complexes with CFTR (Luo et al., 1998). 
Several phosphatases regulate CFTR; serine and threonine phosphatases have 
two distinct functional classes, protein phosphatase (PP) 1 and PP2, and the latter 
class itself is categorised into three groups PP2A, PP2B and PP2C. All three 
classes of PP2 phosphatases interact with CFTR. PP2A can physically associate 
with CFTR via its C-terminus (1451-1476), leading to rundown of CFTR channel 
activity (Thelin et al., 2005). Not only does PP2A directly regulate CFTR, it may 
also lead to important signalling events by other proteins that regulate CFTR. For 
example, AMP-activated protein kinase (AMPK) directly interacts with both PP2A 
and CFTR and down regulates CFTR activity via residues 1420-1457 (Hallows et 
al., 2000). PP2B (otherwise known as calcineurin) is Ca2+-dependent., and 
inhibition of PP2B  with cyclosporin A and deltamethrin activates CFTR in cell-
attached patch clamp studies (Fischer et al., 1998). CFTR and PP2C co-
immunoprecipitate, and PP2C can co-purify with his-tagged CFTR using nickel 
affinity chromatography (Zhu et al., 1999), suggesting that CFTR and PP2C form a 
stable regulatory complex.  
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Investigation into the relationship of CS-induced calcium signalling and the role 
of the MAPK pathway will provide useful insights into the effects of CS on CFTR. 
Thus, the aims of this chapter were to: 
1) Determine the relationship between calcium signalling and MAPK regulation 
of CS-induced CFTR internalization. 
2) Understand the effects of CS on the phosphorylation state of CFTR. 
3) Determine which consensus sites of phosphorylation are important for CS-
induced CFTR internalization.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
70 
 
4.2  Results 
4.2.1 CS-induced internalization of CFTR is dependent on 
MEK signalling 
Activation of the MEK/ERK pathway is required for CS extract to internalize 
CFTR. (Xu et al., 2015). However, bathing cultures in CS extract has been shown 
to stimulate a number of abnormal responses compared to cells exposed to fresh 
CS. The method for fresh CS exposure developed by Phillips et al. (2005)  and 
used in this thesis is an established technique for the delivery of CS in vitro, which 
provides a similar volume and rate of smoke intake to that of human smokers. 
Therefore, to confirm the effects of MAPK inhibitors on the response of CFTR to 
gaseous CS U0126, an inhibitor of MEK, was used. HEK293T cells transiently 
transfected with GFP-CFTR were exposed to either air or CS (see methods section 
2.6) in the presence of vehicle (0.001 % DMSO) or 10 µM U0126 (Figure 4-1 A). In 
the presence of vehicle (Figure 4-1 B), plasma membrane fluorescence intensity 
significantly decreased from 1.0 ± 0.0 AU after air/vehicle exposure to 0.7 ± 0.04 
AU following CS/vehicle exposure (Figure 4-1 B; p < 0.001, n = 100 - 129 cells). 
Intracellular GFP-CFTR fluorescence intensity significantly increased from 1.0 ± 0.1 
AU after air/vehicle exposure to 4.9 ± 0.3 AU following CS/vehicle exposure (Figure 
4-1 C, n = 100 – 129 cells). However, in Figure 4-1 C, in the presence of U0126, 
the intracellular accumulation of CFTR by CS was significantly reduced by U0126 
from 4.9 ± 0.3 AU in CS/vehicle treated cells, to 1.3 ± 0.2 AU in CS/U0126 treated 
cells, consistent with data using CS extract from the Cormet-Boyaka group (Xu et 
al., 2015). However, a small but significant increase was measured in intracellular 
fluorescence intensity in CS/U0126 treated cells (1.3 ± 0.2 AU, n = 106 cells) 
compared to air/U0126 treated cells (p < 0.001, 0.8 ± 0.1 AU, n = 106 cells). 
However, the intracellular fluorescence intensity of CS/U0126 exposed cells was 
not significantly different from that of air/vehicle treated cells (1.0 ± 0.1 AU, n = 129 
cells). These data indicate that treatment with U0126 prevented CS-induced GFP-
CFTR internalization, confirming that MEK is an important regulator of CS-induced 
CFTR internalization. 
Since the CS-induced internalization of CFTR is dependent on both MEK 
activation and the release of lysosomal calcium, it was important to determine 
whether the two signalling pathways interact. To this end, we investigated the effect 
of MEK inhibitor U0126 on CS-induced calcium release in fura-2 loaded HEK293T 
cells (Figure 4-2). Following CS smoke exposure in vehicle treated cells, the mean 
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change in intracellular [Ca2+]i trended towards an increase in [Ca2+]i which was 
sustained over time, but was not significantly different  from that of air/vehicle 
treated cultures (n = 3 coverslip). CS exposed cells treated with U0126 exhibited a 
similar profile to that of vehicle/CS treated cells, suggesting that inhibition of U0126 
may not affect CS-induced Ca2+ release, but again the trend in increase of 
U0126/CS treated cells was not significantly different from U0126/air treated cells. 
Thus, increasing the number of cultures measured may reduce variability, and 
further clarify the effect of U0126 on CS-induced Ca2+ release.  
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Figure 4-1. Exposure to the MEK inhibitor, U0126, inhibits CS-induced CFTR internalization. 
HEK293T cells transiently transfected with GFP-CFTR were pre-treated for 30 min with vehicle 
(0.01% DMSO) or 10 µM U0126 prior to exposure to air or CS exposure. Following exposure, cells 
were incubated at 37°C for 60 min before fixation with 4% PFA. (A) Representative confocal images of 
GFP-CFTR in all conditions. (B) Mean plasma membrane fluorescence intensity in air (open bars) or 
CS (grey bars) of cells treated with vehicle or 10 µM U0126. (C) Mean intracellular fluorescence 
intensity in air (open bars) or CS (grey bars) of cells treated with vehicle or 10 µM U0126, *** p < 
0.001 by Kruskal-Wallis test with Dunn’s multiple comparison post-test. n = 106 - 120 cells from 3 
independent experiments. Scale bar = 10 µm. 
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4.2.2 The epidermal growth factor receptor regulates plasma 
membrane expression of CFTR 
The epidermal growth factor receptor (EGFR), an upstream regulator of the 
MAPK pathway, is endogenously expressed in low levels in HEK293T cells 
(Maegawa et al., 2009). Activation of EGFR by the binding of EGF leads to 
autophosphorylation of the receptors C-terminus. Phosphorylation at this site allows 
the downstream binding of docking proteins such as growth factor receptor bound 
protein 2 (GRB2) and son of sevenless (SOS). SOS promotes the binding of Ras to 
GTP, allowing its interaction with RAF, and subsequent activation of MEK (Ullrich 
and Schlessinger, 1990). Unlike MEK/ERK, EGFR has no reported effects on the 
activity or trafficking of CFTR. Therefore, the effects of AG1478 an EGFR 
antagonist on the cellular location of CFTR in both control and CS conditions were 
investigated. Inhibition of EGFR with AG1478 significantly increased the amount of 
GFP-CFTR at the plasma membrane in air control conditions (Figure 4-3 A and B; 
1.1 ± 0.1 AU, n = 117 cells) compared to vehicle (p < 0.01, 1.0 ± 0.0 AU, n = 101 
cells). These data suggest that EGFR may play a role in CFTR plasma membrane 
trafficking and surface density. Consistent with data demonstrating that CS can 
cause resistance of EGFR to AG1478 (Filosto et al., 2012), following CS exposure 
(Figure 4-3 B), AG1478 treatment no longer increased GFP-CFTR plasma 
membrane fluorescence intensity. Furthermore, plasma membrane fluorescence 
intensity was reduced to levels consistent with that of cells undergoing CS-induced 
CFTR internalization (Figure 4-3 B). Despite this, inhibition of EGFR with AG1478 
partially reduced intracellular accumulation of CFTR. The fluorescence intensity of 
intracellular GFP-CFTR following smoke exposure with was reduced from 5.7 ± 0.4 
AU (n = 82 cells) in CS/vehicle treated cells to 4.3 ± 0.3 AU (p < 0.001, n = 113 
cells). Thus, despite the resistance of EGFR to AG1478 in the presence of CS, 
some inhibition of internalization was recorded.  
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Figure 4-3. The EGFR regulates levels of CFTR in the plasma membrane and may influence CS-
induced CFTR internalization. 
HEK293T cells transiently transfected with GFP-CFTR were pre-treated for 30 min with vehicle (0.1 % 
DMSO) or 30 µM AG1478 prior to exposure to air or CS. Cells were subsequently incubated at 37°C 
for 60 min before fixation with 4% PFA. (A) Representative confocal images of GFP-CFTR in all 
conditions. (B) Mean plasma membrane fluorescence intensity in air (open bars) or CS (grey bars) of 
cells treated with vehicle or 30 µM AG1478. (C) Mean intracellular fluorescence intensity in air (open 
bars) or CS (grey bars) of cells treated with vehicle or 30 µM AG1478. ** p < 0.01, *** p < 0.001 by 
Kruskal-Wallis test with Dunn’s multiple comparison post-test. n = 82 - 117 cells from 3 independent 
experiments. Scale bar = 10 µm. 
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4.2.3 Forskolin inhibits CS-induced CFTR internalization 
Given that kinases play an important role in CFTR internalization by CS, we 
next investigated the role of phosphorylation in CS-induced CFTR internalization. 
PKA phosphorylation activates CFTR (Anderson et al., 1991a), and has been 
identified as an agonist of endocytosis in T84 cells expressing CFTR (Bradbury et 
al., 1992). Forskolin, an adenylyl cyclase agonist, stimulates the phosphorylation of 
CFTR through the production of cAMP, leading to maximal phosphorylation of the 
channel by PKA (Anderson et al., 1991a). GFP-CFTR was predominantly located at 
the plasma membrane in HEK293T cells in the presence of both vehicle (0.05 % 
DMSO) and 5 µM forskolin (Figure 4-4 A). Following air exposure, no significant 
difference in plasma membrane expression levels were observed in the presence 
of forskolin (Figure 4-4 C, 1.0 ± 0.0 AU, n = 180 cells) compared to vehicle (1.00 ± 
0.03 AU, n = 192 cells). As previously reported, GFP-CFTR accumulated internally 
following CS exposure (Figure 4-3 D, p < 0.001, 2.9 ± 0.1 AU, n = 137 cells) 
compared to air (1.0 ± 0.1 AU, n = 192 cells). However, in the presence of forskolin, 
there was no significant difference in plasma membrane GFP-CFTR fluorescence 
intensity in air conditions (1.0 ± 0.0 AU, n = 180 cells) compared to CS exposed 
cells (1.0 ± 0.0 AU, n = 142 cells). Additionally, in the presence of forskolin, no 
significant difference in intracellular GFP-CFTR fluorescence intensity was 
measured following CS exposure (1.4 ± 0.1 AU, n = 143 cells) compared to air (1.1 
± 0.1 AU, n = 180 cells). Therefore, phosphorylation of CFTR prevents CS-induced 
internalization. These results suggest that CFTR is likely to be in a 
dephosphorylated state to undergo CS-induced internalization. 
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Figure 4-4. Forskolin-dependent phosphorylation of CFTR prevents CS-induced internalization. 
HEK293T cells transiently transfected with GFP-CFTR were pre-treated for 30 min with vehicle (0.05 
% DMSO) or 5 µM forskolin prior to exposure to air or CS exposure. Next, cells were incubated at 
37°C for 60 min before fixation with 4% paraformaldehyde. (A) Representative confocal micrographs 
of GFP-CFTR in the presence of 5 µM forskolin in air and CS exposed conditions. (B) Mean plasma 
membrane fluorescence intensity in air (open bars) or CS (grey bars) of cells treated with vehicle or 5 
µM forskolin. (C) Mean intracellular fluorescence intensity in air (open bars) or CS (grey bars) of cells 
treated with vehicle or 5 µM forskolin. *** p < 0.001 by Kruskal-Wallis test with Dunn’s multiple 
comparison post-test. n = 137 - 192 cells from 3 independent experiments. Scale bar = 10 µm. 
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4.2.4 PKA-unresponsive CFTR has an altered pattern of 
expression 
CFTR has a plethora of conserved phosphorylation sites, with a large 
proportion of sites located in the R domain (Figure 4-5). Many of these sites are 
specific to PKA phosphorylation (Hegedus et al., 2009). As discussed in section 
4.1, phosphorylation of CFTR by PKA plays an important and complex role in the 
activation of CFTR. The removal of any one of the PKA consensus phosphorylation 
sites does not abolish PKA-mediated CFTR activity. However, when multiple 
consensus sites were mutated, PKA-mediated CFTR activity was reduced 
(Hegedus et al., 2009). Previously, the Riordan group demonstrated that 
replacement of all nine serine/threonine sites in the R domain with the addition of a 
tenth site in NBD1 to alanine residues (10SA CFTR) failed to remove all PKA-
mediated CFTR activity (Chang et al., 1993). However, further replacement of an 
additional five sites of serine/threonine PKA phosphorylation (CFTR15SA, Figure 4-5 
A) resulted in a CFTR channel that is unresponsive to PKA (Hegedus et al., 2009).  
Here, BHK cells stably expressing wt-CFTR or CFTR with 15 sites of 
phosphorylation replaced with alanine residues (CFTR15SA, see methods section 
2.3) were used to investigate the role of PKA phosphorylation in CS-induced CFTR 
internalization. Western blot was performed to characterize expression of WT- and 
CFTR15SA. The same amount of protein was loaded for each sample (15 µg), and 
total expression of CFTR15SA was significantly higher (43 %) than wt-CFTR (Figure 
4-5 B, p < 0.05 by student’s t-test, n = 3). The expression of band C (mature, fully 
glycosylated CFTR) and band B (immature, core glycosylated CFTR) was 
measured as a percentage of total CFTR expression (Figure 4-5 C). Both WT and 
CFTR15SA demonstrated significantly more band C expression than band B (p < 
0.001, n = 3). However, no change was observed in the proportion of band C to 
band B in either wt-CFTR (73.9 ± 1.1 % and 26.5 ± 1.1 %, respectively) and or 
CFTR15SA (80.2 ± 3.4 % and 19.8 ± 3.4 %, respectively), suggesting that the 
maturation of CFTR15SA is not different from that of wt-CFTR. 
To investigate the effects of CS on the cellular localization of 15SA-CFTR, BHK 
cells expressing wt-CFTR or CFTR15SA were exposed to CS, incubated for 60 min, 
and fixed in 100% MeOH (methods section 2.6). The cells were blocked in bovine 
serum albumin and normal goat serum, prior to probing with anti-CFTR (596) and 
anti-mouse Dylight 488. In Figure 4-6 A, wt-CFTR expressed primarily at the 
plasma membrane after air exposure, and was internalized following CS exposure. 
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The expression pattern of CFTR15SA was similar to that of wt-CFTR following CS 
exposure (Figure 4-6A), suggesting that phosphorylation may have important role 
in maintaining CFTR at the plasma membrane. The intracellular fluorescence 
intensity of CFTR15SA did not increase following CS exposure, rather the 
fluorescence intensity significantly decreased from 1.4 ± 0.04 AU in air conditions to 
1.1 ± 0.1 AU (p < 0.01, n = 80 - 236 cells) following CS exposure, implying an 
important role of the 15 sites of PKA phosphorylation in the CS-induced 
internalization of CFTR.  
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Figure 4-5. PKA-unresponsive CFTR has a different expression pattern and response to CS 
exposure compared to wt-CFTR. 
(A) A schematic showing fifteen consensus sites of serine/threonine phosphorylation in CFTR which are 
mutated to alanine residues to produce CFTR15SA. (Adapted from Billet et. al. (2015)). (B) BHK cells stably 
expressing wt-CFTR (WT) or CFTR15SA (15SA) were seeded at a density of 100,000 cells per 35 mm dish. 
The cells from three 35 mm dished were lysed in Pierce lysis buffer and combined. Protein concentration 
was measured using BCA assay and 15 µg per sample was loaded on a 7-15 % gel (Biorad, USA). The 
gel was transferred to PDVF by wet transfer and the blots were blocked for 1 hr in 3% milk and TBST, and 
probed with anti-CFTR (596) (1:1000). Blots were washed 3 x 5 min in TBST and probed with HRP 
conjugated anti-mouse secondary antibody and developed using the Chemidoc (Biorad, USA). Bands 
shown are representative of three individual experiments. (C) Densiotometry of WT and CFTR15SA band C 
(mature) and band B (un-glycosylated). Combined Band C and Band B expression was measured as total 
CFTR expression. Expression of Band C and Band B were calculated as a percentage of total CFTR 
expression. n = 3. Statistics were calculated using Kruskal-Wallis test with Dunn’s multiple comparison 
post-test. n = 137 - 192 cells from 3 independent experiments 
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Figure 4-6. PKA-unresponsive CFTR has a different expression pattern and response to CS 
exposure compared to wt-CFTR. 
BHK cells stably expressing either wt-CFTR or CFTR15SA were exposed to air or CS prior to 60 min 
incubation at 37°C and 5% CO2. The cells were fixed and permeablized in methanol. Cells were 
blocked for 1 h in 5 % normal goat serum and 1 % bovine serum albumin in PBS. The cells were 
incubated with primary antibody (anti-CFTR 596) for 3 h at room temperature, followed by three 
washes with PBS, and labelling with anti-mouse secondary antibody conjugated to Dylight 488. (A) 
Representative confocal micrographs of wt- and CFTR15SA in air and CS exposed conditions. (B) 
Ratios of CS/air at the plasma membrane and intracellularly were calculated for each condition. (C) 
Mean plasma membrane fluorescence intensity in air (open bars) or CS (grey bars) of cells 
transfected with WT- or CFTR15SA. (D) Mean intracellular fluorescence intensity in air (open bars) or 
CS (grey bars) of cells transfected with WT- or CFTR15SA. * p < 0.05, *** p < 0.001 by Kruskal-Wallis 
test with Dunn’s multiple comparison post-test., n = 80 - 236 cells from three independent 
experiments. Scale bar = 10 µm. 
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4.2.5 Cigarette smoke exposure causes dephosphorylation 
of CFTR 
Having established the importance of kinases and phosphorylation by PKA in 
CS-induced internalization of CFTR, we employed primary human bronchial 
epithelial cells (HBECs) and an R domain specific antibody whose epitope binding 
is sensitive to phosphorylation by PKA to investigate the phosphorylation state of 
CFTR. HBECs were exposed to whole CS generated from 0-3 cigarettes, and 
plasma membrane CFTR was recovered by surface biotinylation. Consistent with 
previous findings (Rasmussen et al., 2014), total surface membrane CFTR 
(measured by anti-CFTR 596) decreased after CS exposure. However, the amount 
of inactive, dephosphorylated CFTR measured by probing with phosphorylation 
sensitive anti-CFTR 217 antibody increased following CS exposure, suggesting that 
CS causes CFTR dephosphorylation which is potentially linked to internalization.  
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Figure 4-7. Cigarette smoke causes dephosphorylation of CFTR. 
HBECs cultured at the air liquid interface on semi-permeable culture inserts (Corning, transwell-
clears) were biotinylated, with FBS on the basolateral side. The cells were then lysed in Pierce’s lysis 
buffer and were then spun down to remove cell debris. The remaining lysates were rotated overnight 
with neutravidin beads. Protein concentrations were calculated using Bradford assay and samples 
were diluted to ensure the same amount of protein was loaded in each tube. Beads were centrifuged 
at 14,000xg and pellet was collected. The beads were denatured with sample buffer and 2-
mercaptoethanol at 37°C for 1 h. Membrane fractions were loaded on a biorad gel and ran at 150 mV 
until the protein ladder reached the bottom of the gel. Gels were transferred wet to PDVF membrane 
overnight at 4°C. Membranes were blocked in 5 % milk and probed for dephosphorylated CFTR with 
primary anti-CFTR 217 antibody. The membranes were washed a minimum of 3 x 10 min and probed 
with anti-ms conjugated to horseradish peroxidase. The PVDF membrane was visualised using a 
Biorad Chemidoc (USA). This work was carried out by Dr Chong Da Tan at the University of North 
Carolina, at Chapel Hill. 
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4.3  Discussion 
Recently, studies into the effects of cigarette smoke on airway epithelia have 
lead to the discovery that CS causes the release of lysosomal calcium, leading to 
internalization of CFTR (Rasmussen et al., 2014). This internalization causes 
dehydration of the airway surface liquid, which is hypothesized to be an important 
risk factor for mucus accumulation in smokers and patients with COPD (Clunes et 
al., 2012). In the previous chapter, it was determined that the normal motifs which 
signal CFTR for endocytosis are not necessary for its internalization by smoke. 
Thus understanding the cell signaling pathway(s) that do lead to CS-induced 
calcium release and CFTR internalization are important steps towards the 
development of new therapeutics for COPD. The aims of this chapter were to better 
understand the relationship between the CS response and the MAPK pathway, and 
to determine how CS-induced calcium release and CFTR internalization is affected 
by phosphorylation of CFTR. 
The Cormet-Boyaka group have provided evidence that CS extract, produced 
by bubbling whole CS through growth medium, can directly activate the MAPK 
pathway. CS-induced internalization of CFTR is dependent on the activation of this 
pathway (Xu et al., 2015). Our lab has previously demonstrated using nicotine as a 
marker of CS, that the effects of smoke on the airway epithelium differ depending 
on the preparation technique of the smoke (Clunes et al., 2008). Furthemore, whole 
CS exposure using the exposure chambers as developed by Phillips et al. (2005), 
exposes the epithelia to concentrations of nicotine comparable to nicotine levels in 
vivo (Clunes et al., 2008). To this end, we assessed the effects of the MAPK 
pathway on CS-induced CFTR internalization using whole CS. Consistent with 
results from Estelle Cormet-Boyaka’s group (Xu et al., 2015), U0126, an antagonist 
of MEK, diminished the internalization of CFTR by CS thus confirming that CS-
induced CFTR internalization is reliant on the activation of MEK. Furthermore,  
although the CS-induced change in [Ca2+] trended towards an increase in [Ca2+]i, 
these results were not significantly different from air exposed cells. Despite this, CS 
exposure cultures treated with U0126 displayed a remarkably similar [Ca2+]i profile 
to that of CS/vehicle treated cells. These data lead to the speculation that 
MEK/ERK may evoke its effects on CFTR downstream of CS-induced Ca2+ release. 
However, further investigation into this matter must be performed. Furthermore, in 
collaboration with the Cormet-Boyaka group, it was observed that the CS-induced 
phosphorylation and activation of ERK (Xu et al., 2015) is calcium-dependent 
85 
 
(personal communication with Estelle Cormet-Boyaka, data not shown), further 
confirming that the MAPK pathway is downstream of calcium signaling, and 
upstream of CFTR internalization.  
The MAPK pathway is upregulated by EGFR, a tyrosine kinase receptor. To 
investigate the possibility that the tyrosine kinase receptor may be an important 
factor in the MAPK regulation of CS-induced CFTR internalization, AG1478, an 
inhibitor of tyrosine kinase receptors was used to investigate CS-induced CFTR 
internalization. Although the EGFR has been shown to regulate trafficking of the 
Na+/K+-ATPase (Lee et al., 2015),  extensive search of the literature revealed that 
EGFR has no known effects on CFTR trafficking. In the present study, AG1478 
treatment alone increased plasma membrane expression of CFTR compared to 
vehicle control. This effect could be due to a number of different aspects of CFTR 
trafficking including reduced CFTR trafficking to the plasma membrane, a decrease 
in native endocytosis, or reduced recycling. Since CS can cause EGFR to exhibit 
resistence to some tyrosine kinase inhibitors such as AG1478 (Filosto et al., 2012), 
in the presence of CS, AG1478 no longer increased the plasma membrane 
abundance of CFTR, rather the levels of plasma membrane CFTR resembled that 
of smoke exposed CFTR in vehicle conditions. In the presence of AG1478, CS 
caused significant internalization of CFTR. However, the level of this internalization 
was slightly reduced compared to vehicle control, suggesting that EGFR may have 
a role in CS-induced CFTR internalization. One explanation for the slight inhibition 
of CS-induced internalization by AG1478 despite the CS-induced resistance of 
EGFR to this drug may be provided by the high concentration of AG1478 (30 µ) 
utilized in this experiment. Thus, it is apparent that EGFR plays a significant role in 
CFTR trafficking in both control and CS exposed conditions. However, future 
experiments will need to determine the true extent of the role of EGFR in CS-
induced CFTR internalization. Since the resistance of EGFR to AG1478 can be 
prevented by PP1 and PP2 (Filosto et al., 2013), inhibitors of Src. These inhibitors 
could therefore be used to further investigate the role of EGFR in CFTR trafficking. 
However, since Src itself has been demonstrated to directly effect CFTR (Lepple-
Wienhues et al., 2001, Davenport et al., 1996), it is possible that the inhibition of 
Src may itself play a role in CS-induced internalization of CFTR. Therefore, a more 
reliable way to investigate the role of EGFR would be to use different antagonists of 
EGFR, express a dominant negative EGFR, or knockdown EGFR using siRNA. 
Additionally, stimulation of the cells with exogenous EGF would provide further 
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insight into the role of the EGFR in CFTR trafficking in both native, and CS exposed 
conditions. 
Given that kinases play an established role in CS-induced CFTR internalization, 
and that PKA is critically involved in the activation of CFTR, the role of 
phosphorylation by PKA in the CS response was investigated. Forskolin has 
previously been identified  as an antagonist of endocytosis, and that endocytosis 
can be regulated in a cAMP-dependent fashion (Bradbury et al., 1992). Bradbury 
and colleagues (1992) performed this investigation using T84 cells in which CFTR 
is natively expressed. However, their studies addressed the effects of global 
endocytosis by measuring fluid-phase uptake, and the direct effects of forskolin on 
the specific internalization of CFTR were not identified. Our data suggest that the 
phosphorylation of CFTR by PKA had inhibitory effects on CS-induced 
internalization of CFTR, and that phosphorylation of CFTR by PKA reduces the 
ability of CS to cause internalization of CFTR.  
To further investigate the effects of PKA phosphorylation on CFTR trafficking 
and CS-induced internalization, a PKA-unresponsive CFTR15SA with 15 sites of PKA 
phosphorylation mutated to alanine residues was used. The expression of wt-CFTR 
and PKA-unresponsive CFTR15SA in BHK cells was investigated using western 
blotting and confocal microscopy. The relative expression of both band C and band 
B CFTR were not signifcantly different in 15SA-CFTR compared to wt-CFTR, 
suggesting that the maturation of CFTR15SA is similar to that of wt-CFTR. Billet et. 
al. (2013) demonstrated that plasma membrane levels of surface biotinylated 
CFTR15SA were similar to wt-CFTR. However, here the level of immunolabelled 
plasma membrane CFTR15SA was slightly reduced compared to that of wt-CFTR 
following air exposure, and intracellular CFTR15SA was significantly increased 
compared to that of wt-CFTR. The expression pattern of CFTR15SA exposed to air 
was therefore remarkably similar to that of CS exposed wt-CFTR, suggesting that 
PKA phosphorylation may play an important role in maintaining CFTR at the 
plasma membrane, and that dephosphorylation of the PKA consensus sites may 
drive internalization of CFTR. Furthermore, the effects of CS on the cellular location 
of CFTR were investigated using confocal imaging. Compared to wt-CFTR, the CS-
induced internalization of CFTR15SA was reduced. Together, these data suggest 
that the lack of PKA phosphorylation on the R domain of CFTR causes 
internalization, and prevents further internalization of CFTR15SA by CS.  
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Since CS-induced CFTR internalization was inhibited by forskolin, and the 
removal of PKA phosphorylation sites causes a shift in the equilibrium to favor 
internalization of CFTR, the phosphorylation state of CFTR following CS exposure 
was investigated using a CFTR antibody specific to the R domain that conveys 
sensitivity to phosphorylation at the epitope. Total CFTR decreased with an 
increasing number of cigarettes. However, using cell surface biotinylation the 
amount of dephosphorylated plasma membrane CFTR increased following CS 
exposure, suggesting that CS causes dephosphorylation of CFTR. Since the 
phosphorylation-sensitive antibody used to detect dephosphorylated CFTR (anti-
CFTR 217) specifically recognizes amino acids  807-819, and the removal of 15 
sites of PKA phosphorylation caused CFTR endocytosis, it is possible to pinpoint 
CS-induced dephosphorylation to phosphorylation concensus sites present within 
the 807-819 region. There are three highly conserved phosphorylation sites in the 
807-819 region of the R domain; serine 809, serine 813 and serine 816. Further 
investigation of these sites by mutation to alanine, or mutation to a negatively 
charger amino acid such as glutamate would provide further information on the 
specific role of dephosphorylation at these sites.  Since maximal phosphorylation of 
CFTR by forskolin prevented internalization, and the removal of 15 sites of CFTR 
phosphorylation caused the accumulation of intracellular CFTR, suggesting that the 
phosphorylation state of CFTR, and specifically dephosphorylation, may be a novel 
physiological regulator of CFTR residence time in the plasma membrane. This data 
will be of general interest for both CS-mediated CFTR dysfunction, as well as other 
CFTR diseases such as CF.  
To better understand CS-induced dephosphorylation of CFTR, it is important to 
consider the mechanics of this dephosphorylation event. Dephosphorylation could 
be caused by activation of a phosphatase, inactivation of a kinase or the relative 
change in the activation levels of both. There are many kinases and phosphatases 
known to affect CFTR. PP2A is an important regulator of CFTR, causing its 
dephosphorylation at the apical surface or airway epithelia (Thelin et al., 2005). 
PP2A does not require the binding of any cofactors for its activation. However, CS 
increases the activity of PP2A in vivo and in patients with emphysema (Wallace et 
al., 2012). PP2A interacts with CFTR through its C terminus (1451-1476) (Thelin et 
al., 2005). However, in the previous chapter (Section 3.2.3) the removal of the C-
terminus of CFTR had no effect on CS-induced CFTR internalization, suggesting 
that dephosphorylation by PP2A does not underly the CS-mediated CFTR 
response. Assuming that dephosphorylation of CFTR leads to its internalization, we 
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can eliminate PP2A as a phosphatase of interest based on this information. PP2B 
is a Ca2+ dependent phosphatase whose inhibition in Calu-3 and 3T3 cells leads to 
the activation of CFTR (Fischer et al., 1998). The activation of PP2B by Ca2+ makes 
this phosphatase an interesting candidate for the dephosphorylation of CFTR by 
CS, and further investigation into the role of PP2B, and other kinases and 
phosphatases, in CS-induced CFTR internalization should be performed 
The major findings of this chapter are summarized below and in Figure 2-2. 
 CS-induced CFTR internalization is inhibited by MEK/ERK inhibitors but 
not through inhibition of CS-induced Ca2+-release.  
 CS causes dephosphorylation of CFTR leading to its internalization. 
 CS-induced CFTR internalization is inhibited by maximal phoshorylation 
of CFTR by forskolin. 
 The removal of 15 consensus sites for phosphorylation resulted in 
intracellular accumulation of CFTR, suggesting that dephosphorylation 
of CFTR may be a stimulus for internalization. Furthermore, the removal 
of these sites reduced the amount of CS-induced internalization 
compared to wt-CFTR. 
   
Figure 4-8. A proposed model for the effects of CS on the phosphorylation status of CFTR. 
(A) In air conditions, endogenous agonists stimulate the phosphorylation and activation of CFTR to 
maintain normal Cl- secretion. (B) In the presence of CS, CFTR is dephosphorylated resulting in 
augmented CFTR endocytosis, and decreased Cl- secretion. 
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5.0 Cigarette smoke-internalized CFTR takes an abnormal 
endocytic path 
5.1  Introduction 
The work presented in the previous chapter (4) of this thesis focused primarily 
on determining the cell signalling pathways leading to cigarette smoke induced 
CFTR internalization. Thus, CS caused dephosphorylation of CFTR, and maximal 
phosphorylation of CFTR by forskolin prevented its internalization by CS. The focus 
of this chapter is to examine CFTR post-internalization, and to determine the 
destination of CS-internalized CFTR. Thus far, data published by our lab 
demonstrates that CFTR total protein levels decrease in western blot studies 
following CS exposure. However, when high concentrations of detergent were 
utilized, CFTR total protein levels did not decrease in the presence of CS. 
Furthermore, colocalization studies of CFTR and LAMP1, a lysosomal marker, 
demonstrated that CFTR does not localize to the lysosomes following CS exposure 
(Rasmussen et al., 2014). These data suggest that CFTR is not degraded upon 
rapid internalization by smoke, and that CFTR remains in the cytosolic fraction in an 
insoluble form upon CS exposure. Studies by the Cormet-Boyaka group have 
determined that CS-internalized CFTR colocalizes with lysosomes upon inhibition 
of lysosomal activity with chloroquin (Xu et al., 2015). However, these experiments 
were performed with by bathing cultures in 100% CS extract, produced using 
cigarettes with no filter, which may explain the discrepancy between the two 
publications. CS-internalized CFTR internalizes to the perinuclear region of the cell 
(Clunes et al., 2012). Immunolabeling of vimentin, an intermediary filament which is 
known to play a role in aggresome formation, demonstrated a similar expression 
pattern to that of CS exposed CFTR (Clunes et al., 2012). However, no present 
data investigates the pathway of CFTR trafficking from the plasma membrane to 
the perinuclear region of the cell.  
Thus, it remains unclear whether CS-induced CFTR internalization occurs through 
the constitutive clathrin-mediated pathway, or whether it is endocytosed through an 
alternative mechanism. As such, the aims of this chapter were to:  
1) Determine the pathway of endocytosis of CS-induced CFTR internalization 
2) Determine the terminal location of the perinuclear accumulations of CFTR  
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5.2  Results 
5.2.1 CS-induced internalization of CFTR is reduced by 
inhibitors of endocytosis 
Hypertonic sucrose has been shown to inhibit endocytosis by causing reduction 
in the size and number of clathrin-coated pits and is associated with the formation 
of microcages of clathrin, which deplete the levels cytoplasmic clathrin necessary 
for endocytosis (Heuser and Anderson, 1989). To investigate the role of the 
endocytic machinery in the CS-induced internalization of CFTR, HEK293T cells 
were pre-treated with hypertonic sucrose (0.45M sucrose) for 15 min before 
exposure to air or CS. Hypertonic sucrose significantly reduced both the increase in 
intracellular fluorescence intensity and decrease in plasma membrane fluorescence 
intensity associated with CS-induced CFTR internalization (Figure 5-1). The post-
CS intracellular fluorescence intensity was significantly reduced from 1.5 ± 0.2 AU 
(n = 172 - 182) in CS/vehicle conditions to 0.7 ± 0.1 AU (p < 0.001, n = 91 - 147) in 
the presence of CS/hypertonic sucrose. Hypertonic sucrose treated levels of 
plasma membrane fluorescence intensity were not significantly different to that of 
air/hypertonic sucrose treated cells (n = 172 – 182). However, CS/hypertonic 
sucrose treated cells exhibited a small but significant increase in intracellular 
fluorescence intensity (1.5 ± 0.2 AU) compared to air/hypertonic sucrose (p < 0.01, 
0.7 ± 0.1 AU). These data suggesting that while hypertonic sucrose significantly 
reduces CS-induced CFTR internalization, it does not fully ablate it. 
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Figure 5-1. Hypertonic sucrose, an inhibitor of endocytosis, reduces CS-induced CFTR 
internalization. 
HEK293T cells were transfected with wt-GFP-CFTR. The cells were pre-treated 48 h after transfection 
with vehicle (pyruvate Ringer’s solution) or 0.45 M sucrose at 37°C for 15 min. The cells were then 
treated with CS and incubated at 37°C for 60 min before fixing in 4% PFA. A) Representative confocal 
images of GFP-CFTR in the presence of 0.45 M hypertonic sucrose in air and CS exposed conditions. 
(B) Mean plasma membrane fluorescence intensity in air (open bars) or CS (grey bars) of cells treated 
with vehicle or 0.45 M sucrose. (C) Mean intracellular fluorescence intensity in air (open bars) or CS 
(grey bars) of cells treated with vehicle or 0.45 M sucrose. ** p < 0.01, *** p < 0.001 by Kruskal-Wallis 
test with Dunn’s multiple comparison post-test. n = 91 - 182 cells from 3 independent experiments. 
Scale bar = 10 µm. 
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5.2.2 CS-internalized CFTR is taken in to the cell by clathrin 
coated vesicles 
CS-induced CFTR internalization was reduced by hypertonic sucrose, a 
chemical inhibitor known to prevent clathrin-dependent endocytosis. Since 
hypertonic sucrose is known to inhibit other types of endocytosis, including 
calceolate-mediated endocytosis in addition to clathrin-mediated endocytosis, 
colocalization studies with clathrin light chain were performed to further determine 
the internalization pathway of CS-exposed CFTR. As such, HEK293T cells were 
transiently co-transfected with GFP-CFTR and clathrin light chain tagged with the 
fluorescent marker mRFP (see methods section 2.8.3). Exposure to air or CS 
revealed a significant increase in colocalization of GFP-CFTR with clathrin light 
chain-mRFP after 5 minutes of CS exposure compared to air controls (Figure 5-2 B; 
p < 0.01, n = 49 - 84 cells). This increase was sustained across all time points and 
peaked at 60 min at 55.8 ± 1.9%, but was no longer maintained at 120 min. These 
data indicate that more CFTR is internalized in a clathrin-dependent manner 
following CS exposure, and that CS-induced CFTR internalization is therefore 
clathrin-dependent. 
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5.2.3 CS-induced CFTR internalization is dynamin-
dependent 
Dynamin is required for clathrin-mediated endocytosis, and inhibition of 
dynamin GTPase activity with dynasore provides a well-studied method for 
endocytic inhibition. To further investigate the endocytic path of CS-internalized 
CFTR, HEK293T cells transfected with GFP-CFTR were pre-treated with 80 µM 
dynasore for 30 min. The post-CS plasma membrane fluorescence intensity was 
significantly increased from 0.8 ± 0.04 AU in air/vehicle control conditions to 1.13 ± 
0.1 AU in CS/dynasore treated cells (Figure 5-3; p < 0.001, n = 122 - 172). 
Additionally, dynasore prevented the increase in intracellular fluorescence intensity 
typically seen following CS exposure. The post-CS intracellular fluorescence 
intensity was reduced from 1.5 ± 0.2 AU in CS/vehicle conditions to 0.6 ± 0.1 AU in 
the presence of CS/dynasore (p < 0.001, n = 123 - 172 cells). No changes were 
observed in air/dynasore or CS/dynasore plasma membrane or intracellular 
fluorescence intensity.  
Although dynasore is widely used across the literature to identify dynamin-
mediated endocytosis, it has low specificity due to its ability to inhibit the activity of 
other GTPases within the cell. To confirm the role of dynamin in CS-induced CFTR 
internalization a dominant negative dynamin plasmid, dynaminK44A, was transiently 
co-transfected with GFP-CFTR into HEK293T cells. In the presence of dynaminK44A, 
CS-induced CFTR internalization was inhibited as demonstrated by a reduction in 
both CS-stimulated plasma membrane removal and intracellular accumulation of 
CFTR (Figure 5-3 a). Post-CS exposure plasma membrane fluorescence intensity 
was increased from 0.70 ± 0.0 AU in GFP-CFTR only control cultures compared to 
0.093 ± 0.06 AU in cells co-transfected with dynaminK44A. Intracellular fluorescence 
intensity post-CS was decreased from 2.52 ± 0.2 AU in GFP-CFTR only control 
cultures compared to 1.1 ± 0.1 AU in cultures co-transfected with dynaminK44A. 
Furthermore, similar results were demonstrated in cultures co-transfected with wt-
dynamin and GFP-CFTR, in which post-CS exposed plasma membrane 
fluorescence intensity was increased from 0.8 ± 0.1 AU in wt-dynamin transfected 
cultures, compared to 0.9 ± 0.1 (p < 0.01, n = 63 – 105) in dynaminK44A expressing 
cultures. Post-CS exposed intracellular fluorescence intensity was decreased from 
2.2 ± 0.1 AU in wt-dynamin transfected cells to 1.1 ± 0.1 AU (p < 0.01, n = 63 – 
105). Together, these data suggest that dynamin GTPase activity is required for 
CS-induced CFTR internalization. 
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Figure 5-3. Dynasore, an inhibitor of dynamin, prevented the CS-induced internalization of 
CFTR. 
HEK293T cells were transfected with GFP-CFTR. The cells were pre-treated 48 h after transfection 
with 80 µM Dynasore at 37°C for 30 min. The cells were then exposed to CS or air and incubated at 
37°C for 60 min before fixing in 4% PFA. (A) Representative confocal images of GFP-CFTR in the 
presence of vehicle or 80 µM dynasore in air and CS exposed conditions. (B) Mean plasma 
membrane fluorescence intensity in air (open bars) or CS (grey bars) of cells treated with 80 µM 
dynasore. (C) Mean intracellular fluorescence intensity in air (open bars) or CS (grey bars) of cells 
treated with vehicle or 80 µM dynasore (n = 101 - 182 cells from three independent experiments, *** p 
> 0.001 by Kruskal-Wallis test with Dunn’s multiple comparison post-test). Scale bar = 10 µm.
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5.2.4 Endocytic trafficking of CS-exposed CFTR requires an 
intact cytoskeleton 
Microtubules have been implicated in the bidirectional long-range movement of 
both clathrin coated vesicles and recycling, early and late endosomes across 
different cells types (Soldati and Schliwa, 2006). However, in the context of CFTR 
most research has focused around the role of microtubules in the recycled delivery 
of CFTR to the plasma membrane. For example, in Xenopus laevis oocytes (Weber 
et al., 2001), colonic T-84 cells (Tousson et al., 1996) and the airway epithelial cell 
line 9HTEo- (Schwiebert et al., 1994), disruption of microtubule polymerisation by 
nocodazole reduced cAMP-mediated CFTR current by preventing intracellular 
pools of CFTR from returning to the plasma membrane. However, contradictory 
data  has been presented in both Calu3 cells (Loffing et al., 1998) and HEK293T 
cells (Domingue et al., 2014). In these latter cell types, cAMP-stimulated CFTR 
currents were unaffected by nocodazole, suggesting that microtubules do not play 
a role in CFTR exocytosis nor endocytosis in these cell types. In agreement with 
these data, no effect was observed on the cellular location of CFTR in the presence 
of nocodazole (Figure 5-5). However, when HEK293T cells were pre-treated with 
33 µM nocodazole, the accumulation of intracellular GFP-CFTR following CS 
exposure was reduced from 3.8 ± 0.4 AU (n = 122 cells) in CS/vehicle conditions to 
2.5 ± 0.3 AU (p < 0.001, n=90 cells) in the presence of nocodazole (Figure 5-5 c). 
Despite the reduction in post-CS intracellular fluorescence intensity after 
nocodazole treatment, this value was still significantly higher than the intracellular 
fluorescence intensity of air exposed vehicle treated cells (1.0 ± 0.2 AU; p<0.001, n 
= 120), suggesting that whilst CS-internalization of GFP-CFTR is reduced by 
nocodazole, it is not completely abolished in the presence of nocodazole. 
Furthermore, the reduction in plasma membrane fluorescence intensity in vehicle 
control cells following smoke exposure (from 1.0 ± 0.0 AU in air exposed conditions 
to 0.68 ± 0.0 AU in CS exposed conditions; p < 0.01, n= 120 - 122 cells) is not 
affected by nocodazole (Figure 5-5 B; 1.0 ± 0.03 AU air to 0.8 ± 0.03 AU CS; p < 
0.001, n = 90 - 120 cells). These data suggest that nocodazole does not fully 
prevent CS-induced removal of CFTR from the plasma membrane. However, given 
that post-CS internal fluorescence intensity of GFP-CFTR was partially reduced in 
the presence of nocodazole, and the expression pattern of internal GFP-CFTR 
(Figure 5-5 A) was different from that of vehicle treated post-CS cells, microtubules 
may be required for CS-induced CFTR internalization and the disruption of 
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microtubules with nocodazole may result in CFTR following an alternative 
internalization pathway to that of vehicle treated post-CS cells. 
Actin, through NHERF1 and ezrin, forms interactions with CFTR and plays an 
important role in regulating the ion channel. The presence of actin within CFTR 
microdomains and its effects on CFTR are well understood. In 1996, Cantiello’s 
group showed that organization of the actin cytoskeleton is necessary for the 
cAMP-dependent activation of CFTR (Prat et al., 1995). Furthermore, actin 
disassembly dramatically decreases the expression of CFTR at the plasma 
membrane, and upregulates its internalization (Ganeshan et al., 2007, Okiyoneda 
and Lukacs, 2007). Thus, cytochalasin D a potent inhibitor of actin polymerization 
was used to investigate the role of actin in CS-induced CFTR internalization. To this 
end, HEK293T cells transfected with GFP-CFTR were pre-treated with vehicle 
(0.02 % DMSO) or 2 µM cytochalasin D for 15 min and exposed to CS prior to 
fixation. As previously reported in control conditions, GFP-CFTR was located 
predominantly at the plasma membrane and internalized following CS exposure 
(Figure 5-6 A). However, in the presence of cytochalasin D, GFP-CFTR expressed 
predominantly in the cytosol in air control conditions (Figure 5-6 A), suggesting that, 
consistent with previously published data (Ganeshan et al., 2007, Okiyoneda and 
Lukacs, 2007), actin is important for the normal cellular distribution of CFTR. In the 
presence of cytochalasin D, no changes were observed in plasma membrane 
fluorescence intensity following air/cytochalasin D exposure (1.0 ± 0.0 AU) 
compared to CS/cytochalasin D exposure (0.8 ± 0.1 AU, n = 77 - 104 cells). 
Additionally, no changes were observed in intracellular fluorescence intensity 
following air/cytochalasin D exposure (2.9 ± 0.4 AU) compared to CS/cytochalasin 
D exposure (3.3 ± 0.2 AU, n = 77- 104 cells). These data demonstrate that 
cytochalasin D has a distinct effect on the distribution of CFTR in control conditions. 
Furthermore, CS-induced internalization of CFTR was ablated by cytochalasin D. 
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Figure 5-5. Disruption of microtubules alters the course of internalization of CS-exposed CFTR. 
HEK293T cells transfected with GFP-CFTR were pretreated with vehicle (0.1% DMSO) or 33 µM 
nocodazole at 37°C for 30 min. The cells were then exposed to CS or air and incubated at 37°C for 60 
min before fixing in 4% PFA. A) Representative confocal images of GFP-CFTR in the presence of 
vehicle or 33 µM in air and CS exposed conditions. (B) Mean plasma membrane fluorescence 
intensity in air (open bars) or CS (grey bars) of cells treated with vehicle or 33 µM nocodazole. (C) 
Mean intracellular fluorescence intensity in air (open bars) or CS (grey bars) of cells treated with 
vehicle or 33 µM nocodazole (n = 90 - 163 cells from 3 independent experiments). *** p < 0.001 by 
Kruskal-Wallis test with Dunn’s multiple comparison post-test. Scale bar = 10 µm. 
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Figure 5-6. Disruption of the cytoskeleton by cytochalasin D prevents CS-induced CFTR 
internalization. 
HEK293T cells were transfected with wt-GFP-CFTR. The cells were pre-treated 48 h after transfection 
with vehicle (0.02 % DMSO) or 2 µM cytochalasin D at 37°C for 30 and 15 min respectively. The cells 
were then exposed to air or CS and incubated at 37oC for 60 min prior to fixing in 4 % PFA. A) 
Representative confocal images of GFP-CFTR. B) Mean plasma membrane fluorescence intensity in 
air (open bars) or CS (grey bars) of cells treated with vehicle or 2 µM cytochalasin D. (C) Mean 
intracellular fluorescence intensity in air (open bars) or CS (grey bars) of cells treated with vehicle or 2 
µM cytochalasin D (n = 76 – 163 cells from 3 independent experiments, *** p > 0.001 by one-way 
ANOVA with Tukey’s post-test). Scale bar = 10 µm. 
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5.2.5 More CS-internalized CFTR traffics through the early 
endosomes than the late or recycling endosomes 
In typical CFTR endocytosis following uptake by clathrin coated vesicles, CFTR 
is trafficked to the early endosomes, and from here is sorted to the late or recycling 
endosomes (Gentzsch et al., 2004). To the understand effects of CS on this 
pathway of internalization, colocalization assays utilizing a series of endosomal and 
organelle markers were performed. Rab5A, a protein primarily expressed in the 
early endosomes, was transiently co-transfected with GFP-CFTR in HEK293T cells. 
Following CS exposure, the percentage of GFP-CFTR and rab5A colocalization 
significantly increased compared to air exposure over time (Figure 5-7). This CS-
induced increase was sustained at all time points and peaked at 120 min at 52.3 ± 
3.0% (Figure 5-7 B; p < 0.001, n = 71 - 100 cells). The colocalization rate of air 
exposed control cells was maintained between 28.6-35.4% across all time points. 
These data suggest increased uptake of CFTR by early endosomes following 
smoke exposure. Colocalization of GFP-CFTR with rab7-DsRed, a marker of late 
endosomes, increased significantly from 23.4 ± 2.6% following air exposure to 32.9 
± 2.1% 30 min following CS exposure and was sustained throughout the 120 min 
duration (Figure 5-8 B, p < 0.01, n = 73-81 cells). Furthermore, at all time intervals 
the percent colocalization of GFP-CFTR with the recycling endosome marker rab11 
was not affected by smoke exposure, suggesting that CS-internalized CFTR does 
not undergo increased recycling, despite increased levels of endocytosis (Figure 
5-9). The increase in colocalization of CFTR at the early endosomes post-CS was 
significantly higher than that of both rab7 and rab11 at all time points (Figure 5-10, 
p < 0.001), indicating that significantly more CFTR traffics through the early 
endosomes than the late and recycling endosomes.  
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Compiled data from Figure 5-7, Figure 5-8, and Figure 5-9 demonstrates significantly more GFP-CFTR 
colocalization with rab5A-DsRed than rab7-DsRed or rab11-DsRed. *** = p < 0.001 of early endosomes 
(EE) CS compared to EE air, * = p < 0.05 of EE CS compared to EE air, † = p < 0.05 of late endosomes 
(LE) CS compared to air, ### = p < 0.001 of EE CS compared to LE CS,  = p < 0.001 EE CS compared 
to recycling endosome (RE) CS, two-way ANOVA with Sidak’s multiple comparison test n = 25 - 108 cells. 
 
 
 
 
 
 
 
 
Figure 5-10. More CS-internalized CFTR traffics through the early endosomes than the late or 
recycling endosomes. 
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5.2.6 CFTR colocalizes with ER and Golgi markers following 
CS exposure – A hypothesis for retrograde transport 
To assess the colocalization of GFP-CFTR in the Golgi apparatus an antibody 
specific to the cis-Golgi protein, GM130, was utilized. Colocalization of GFP-CFTR 
with the Golgi apparatus significantly increased following CS-exposure compared to 
air controls from 0-60 min (Figure 5-11; p < 0.01, p < 0.001, n =43 - 135 cells). To 
assess the colocalization of CFTR in the ER, HEK293T cells were transiently co-
transfected with GFP-CFTR and STIM1-mCherry. Although STIM1 is present 
primarily in the ER (Smyth et al., 2010), it is not typically used as an ER marker. For 
this reason, these cultures were immunolabelled with anti-calreticulin, a secondary 
marker of the ER, to further assess colocalization. Post-CS exposure, both STIM1 
(Figure 5-12; p < 0.01 at 0 min and p < 0.001 through 5-120 min, n = 59 - 143) and 
calreticulin (Figure 5-13; p < 0.01 at 0 min and p < 0.001 through 5-120 min, n = 81 
- 142) had increased colocalization with GFP-CFTR from 0 – 60 min compared to 
air controls. Furthermore, the colocalization of both ER markers did not significantly 
differ from one another (Figure 5-14), suggesting that STIM1 provides a robust 
marker for the ER. Although CFTR colocalization was significantly increased in both 
the Golgi and the ER, there was a significantly higher percentage colocalization of 
CFTR with both ER markers (between 40.0 ± 2.3% and 49.5 ± 2.2%) compared to 
the Golgi (Figure 5-14; between 17.2 ± 1.3% and 24.6 ± 1.5%). 
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Figure 5-14. CFTR colocalizes significantly more with markers of the endoplasmic reticulum than 
the Golgi apparatus. 
Compiled data from Figure 5-7, Figure 5-8, and Figure 5-9 demonstrates significantly more GFP-CFTR 
colocalization with rab5A-DsRed than rab7-DsRed or rab11-DsRed. *** = p < 0.001 of EE CS compared to 
EE air, * = p < 0.05 of EE CS compared to EE air, † = p < 0.05 of LE CS compared to air, ### = p < 0.001 
of EE CS compared to LE CS,  = p < 0.001 EE CS compared to RE CS two-way ANOVA with Sidak’s 
multiple comparison test. n = 25 - 108 cells. 
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5.3  Discussion 
Substantial research has been carried out into the endocytic pathway of CFTR 
as described in section 1.4.3. However, the endocytic machinery required for the 
rapid internalization of CFTR by CS has yet to be determined. Thus, in this chapter 
the abnormal endocytic pathway of GFP-CFTR following CS exposure was 
investigated.  
Pre-treatment of HEK293T cells expressing GFP-CFTR with hypertonic sucrose 
had no effect on the cellular distribution of CFTR in air exposed control cells, but 
did blunt the CS-induced internalization of CFTR. Although hypertonic sucrose has 
been shown to disrupt the formation of clathrin lattices, it is also known to prevent 
endocytosis by other pathways including calveolae-mediated endocytosis and 
pinocytosis. Thus, the role of clathrin in CS-mediated CFTR internalization was 
assessed using colocalization studies. Colocalization of overexpressed 
fluorescently tagged CFTR and clathrin light chain increased significantly following 
CS exposure. Furthermore, inhibition of dynamin, a GTPase involved in the 
scission of clathrin coated-vesicles from the plasma membrane, ablated the 
internalization of CFTR by CS. These data were complemented by the use of 
dominant negative K44A-dynamin. Although these data provide clear evidence that 
CS-induced CFTR internalization is mediated by clathrin and dynamin, the data 
was limited by the fact that no inhibitors specific to calveolae-mediated endocytosis 
were utilized. Thus, whilst clathrin and dynamin are necessary for clathrin-mediated 
endocytosis, other endocytic pathways such as calveolae-mediated endocytosis 
cannot be ruled out.  
CFTR plasma membrane stability, activity, endocytosis and recycling is 
sensitive to changes in both microfilament and microtubule regulation. Although 
nocodazole was unable to prevent the removal of CFTR from the plasma 
membrane by CS, the internalized portion of CFTR was significantly reduced, and 
internal CFTR displayed a different pattern of expression to that of vehicle exposed 
CFTR. While it is obvious that CFTR can still be internalized by CS when the 
microtubule network is disrupted, the pathway taken by the internalized CFTR is 
altered, and may be explained by the reliance of endosomal trafficking on the 
microtubule cytoskeleton. When HEK293T cells expressing GFP-CFTR, were pre-
treated with cytochalasin D, an inhibitor of actin polymerization, GFP-CFTR was 
located internally. This data is consistent with published data by the Ganeshan 
group (2007), showing that CFTR is not trafficked correctly after disruption of the 
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actin cytoskeleton. Firstly, like microtubules, the actin cytoskeleton is involved in the 
function and trafficking of the endosomal pathway (Gauthier et al., 2007, Tanabe et 
al., 2011). Thus, disruption of the actin cytoskeleton may prevent movement of CS-
exposed CFTR through the CS specific endocytic pathway. Secondly, the presence 
of large amounts of intracellular CFTR in the presence of cytochalasin D alone may 
overload the internalization pathway, and thus prevent further internalization of 
CFTR by CS. 
Internalized CFTR has been shown to localize in early, late and recycling 
endosomes (Gentzsch et al., 2004). Here, significantly more CFTR accumulated in 
the early endosomes compared to the late and recycling endosomes following CS 
exposure, suggesting that CS may cause disruption of the normal maturation of 
early endosomes, leading to abnormal intracellular accumulation of CFTR. 
Interestingly, upon overexpression of Rab11, the images of CFTR following CS 
exposure appear to show increased localization of CFTR to the plasma membrane, 
suggesting that the presence of increased levels of Rab11 may assist in the 
recycling of CS-internalized CFTR to the plasma membrane. This thesis has 
specifically focused on underpinning the mechanisms behind internalization of 
CFTR through endocytosis. However, these data suggest that normal levels of 
recycling are not enough to return CS-internalized CFTR to the plasma membrane. 
There are a number of hypothesis that could explain this recycling effect. Firstly, the 
recycling pathway may be dysfunctional after CS exposure, preventing CFTR from 
reaching the recycling endosomes, but the function is restored upon 
overexpression of rab11. Secondly, since a large accumulation of CFTR in the 
early endosomes is observed, the defect could be further upstream in the endocytic 
pathway, i.e. at the early endosomes, preventing CFTR from leaving the early 
endosomes in its typical manner. Lastly, simply the large volume and rate of CFTR 
internalized by CS may overwhelm the recycling system, preventing efficient 
recycling of CFTR back to the plasma membrane. Further investigations into the 
effect of CS on recycling may reveal important information regarding the 
intracellular accumulation of CFTR and reduced potential Cl- secretion by smoke. 
Unexpectedly, CFTR dramatically increased colocalization with two different 
markers of the endoplasmic reticulum following CS exposure, suggesting that CS 
causes internalized CFTR to reside in the endoplasmic reticulum. Transport of 
plasma membrane proteins to the ER, termed retrograde transport, can occur via 
three different pathways. At the early endosome, the secretory and endocytic 
routes of plasma membrane proteins converge. A large body of evidence suggests 
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that endosomes form contact sites with the ER to exchange cholesterol and to 
allow the endocytic cargo to be modified by proteins located in the plasma 
membrane of the ER (Friedman et al., 2013). Furthermore, contact between early 
endosomes and the ER can be maintained as the organelles are trafficked along 
microtubules (Friedman et al., 2010). These direct contact sites may also allow the 
transport of plasma membrane CFTR to the ER to allow the modification of any CS-
mediated structural changes. However, despite the documented contact sites 
between the early endosomes and the ER, transfer of mammalian proteins from the 
plasma membrane directly to the ER has not been recorded. Further experiments, 
including immunolocalization by confocal and super resolution microscopy, would 
determine whether CS increases endosomal-ER contact sites and give more insight 
into this phenomenon.  
The second potential pathway of retrograde transport from the plasma 
membrane to the ER may be explained by the observed colocalization of CFTR 
with the cis-Golgi marker GM130 following CS exposure. Retrograde transport 
between the endosomes (early and late) and the Golgi apparatus has been well 
documented, primarily in the context of bacterial toxins, transmembrane enzymes 
and cargo proteins. The trans-Golgi network receives approximately 5% of 
glycoproteins from the plasma membrane (Duncan and Kornfeld, 1988). In 
mammalian cells, transmembrane enzymes and cargo proteins such as furin and 
the mannose-6-phosphate receptor are shuttled bi-directionally between early and 
late endosomes and the Golgi apparatus. Furthermore, in S. cerevisiae, chitin 
synthase-III has been shown to cycle between the plasma membrane, the 
endosomes and the Golgi apparatus, allowing regulated expression of the enzyme. 
Not only does retrograde trafficking occur between the plasma membrane, the 
endosomes and the Golgi, bidirectional trafficking between the Golgi and the ER is 
also well documented, and is thought to be dependent on COPI and COPII 
vesicles. Thus, a prospective pathway of CFTR internalization by CS may begin by 
clathrin-mediated endocytosis at the plasma membrane, followed by trafficking to 
the early endosomes. From here, CFTR can either be trafficked through the late 
endosomes or directly to the Golgi apparatus, and finally to the endoplasmic 
reticulum.  
Either of the two pathways of retrograde transport, through early endosome-
endoplasmic reticulum contacts, or through the Golgi apparatus are plausible 
hypotheses for the deposition of plasma membrane internalized CFTR at the 
endoplasmic reticulum. There are two theories as to how CS could cause such an 
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abnormal endocytic response. Firstly, in addition to the dephosphorylation of CFTR 
by CS identified in Chapter 4.0, CS may further modulate the structure of CFTR in 
such a way that leads to the retrieval of CFTR to the endoplasmic reticulum for 
correction. Secondly, as discussed previously, overloading of internalized CFTR at 
the early endosomes and/or dysfunction of the early or recycling endosomes may 
prevent CFTR from being cleared in its normal manner by recycling to the plasma 
membrane, or degradation at the lysosomes. We have previously shown that CS 
causes release of calcium from lysosomes (Rasmussen et al., 2014) as well as an 
increase in lysosomal pH (unpublished data). These phenomena may be 
responsible for dysfunction of the lysosomes which could prevent CFTR delivery to 
the lysosomes for degradation, and subsequently cause upstream dysfunction of 
endosomal trafficking.  
Despite the clear colocalization of CFTR at the endoplasmic reticulum following 
CS exposure, the data presented here is limited in that it is assumed that the 
intracellular accumulation of CFTR has been internalized from the plasma 
membrane. This is likely correct due to the thorough work of Clunes et al. (2012), 
who demonstrated by tracking plasma membrane CFTR through surface labelling, 
that CFTR is rapidly internalized by smoke. Surface labelled internalized CFTR in 
BHKCFTR cells by Clunes and colleagues presented an identical expression pattern 
to that seen here of smoke exposed GFP-CFTR transfected HEK293T cells, thus 
allowing the conclusion that the internal CFTR present in HEK293T transfected 
cells is internalized. This is further confirmed by a reduction in cell surface 
biotinylated CFTR in CS exposed HBECs in section 4.2.5.  
Further experiments must therefore be performed in order to confirm the 
retrograde trafficking of CFTR to the endoplasmic reticulum by CS. For example, if 
CFTR is internalized from the plasma membrane to the endoplasmic reticulum, the 
presence of mature, fully glycosylated CFTR in the endoplasmic reticulum would 
provide a clear indication that retrograde trafficking had occurred. In fact, mature, 
fully glycosylated CFTR is found in the sarcoplasmic reticulum of airway smooth 
muscle, and is reported to play a role in the regulation of airway smooth muscle 
tone (Cook et al., 2016). However, they did no determine the pathway of mature 
CFTR into the sarcoplasmic reticulum. Ultimately, pulse chase experiments to allow 
the tracking of CFTR through the cellular compartments after smoke exposure 
would provide the clearest indication of the retrograde pathway undertaken by 
smoke exposed CFTR.  
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The major findings of this chapter are summarised below and in Figure 5-15.  
 Inhibition of CS-induced CFTR internalization by hypertonic sucrose and 
increased colocalization of CFTR with clathrin light chain following 
smoke exposure suggest that CS-internalized CFTR is taken up by 
clathrin coated vesicles. 
 
 CS-induced CFTR internalization was blunted by dynasore and 
overexpression of a dominant negative dynamin plasmid, suggesting 
that CFTR internalization by CS is dynamin-dependent. 
 
 Nocodazole and cytochalasin D did not ablate CS-induced CFTR 
internalization but did result in an altered pathway of internalization. 
 
 CS-internalized CFTR colocalized predominantly in the early and late 
endosomes, the Golgi apparatus, and the endoplasmic reticulum, but 
not in recycling endosomes. 
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6.0 General discussion 
6.1  Summary of main findings 
In this thesis, I sought to investigate the cellular mechanisms behind CS-
induced CFTR internalization. The majority of the experiments used in this study 
were performed using transfected HEK293T cells to observe the effect of CS on 
CFTR trafficking. I found that not only is CS-induced CFTR internalization traceable 
over time, but it can also be manipulated by mutation of CFTR, and by a series of 
pharmacological inhibitors. The data provided in this thesis contributes to the 
growing knowledgebase centred on understanding the diminution of Cl- secretion 
by CS in a variety of cell types, patients with COPD, and smokers (Kreindler et al., 
2005, Welsh, 1983, Cantin et al., 2006b, Sloane et al., 2012, Clunes et al., 2012).  
Previous work from our laboratory has demonstrated that CS caused a rapid 
internalization of CFTR in BHK cells stably expressing CFTR, HEK293T cells, Calu-
3 cells and in polarised HBECs. The reduction of plasma membrane CFTR leads to 
a decrease in Cl- secretion and ASL depth (Clunes et al., 2012). Here, the 
internalization of GFP-tagged CFTR was followed over time, and quantified by 
taking measurements of both plasma membrane, and intracellular fluorescence 
intensities. CFTR indeed internalized rapidly, plasma membrane fluorescence 
intensity decreased with a half-life of 10.5 min, and intracellular fluorescence 
intensity increased with a half-life of 27.7 min. In an effort to define the cellular 
processes that were necessary for CS-induced internalization, FRET was utilized to 
determine the importance of CFTR-CFTR interactions. Since CFTR is thought to 
become insoluble inside the cell following smoke exposure (Clunes et al., 2012), it 
was hypothesized that CFTR-CFTR FRET efficiency would increase post-CS 
exposure, like that of other aggregated proteins such as nocodazole-treated P23H-
rhodopsin (Rajan et al., 2001). Interestingly, intracellular FRET efficiency was 
decreased compared to that of plasma membrane FRET efficiency in both air and 
CS exposed conditions, indicating that the CFTR molecules actually decrease in 
proximity upon internalization or change their orientation. However, whether a 
decrease in CFTR-CFTR interactions upon internalization is specific to the smoke 
response, or if it is a function of normal endocytosis remains to be seen. 
To determine the domains of CFTR required for CS-induced internalization, two 
truncation mutants of CFTR were produced to remove the endocytic motifs, and to 
additionally remove NBD2 from the structure of CFTR. Interestingly, these 
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mutations had no effect on the CS-induced removal of CFTR from the plasma 
membrane, or the intracellular deposition of the mutants compared to wt-CFTR, 
suggesting that NBD2, and the C-terminal endocytic motifs in this region of CFTR 
are not required for CS-induced internalization. This data is interesting in that the 
tyrosine-based motif has been identified as a necessary signal on the C-terminus of 
CFTR for AP2 recruitment of clathrin coated vesicles (Weixel and Bradbury, 2000). 
As the data in Chapter 5 identify clathrin coated vesicles as the main form of 
vesicle for the uptake of CS-internalized CFTR into the cell, the fact that the typical 
endocytic motifs are not required leads to the speculation that another form of 
signalling, specific to CS-induced CFTR internalization, may be required for the 
uptake of CFTR into clathrin coated vesicles. Interestingly, in Chapter 4, CS caused 
dephosphorylation of CFTR. Furthermore, phosphorylation of CFTR by PKA 
prevented CS-induced internalization. As discussed in section 4.3, forskolin-
induced PKA activity has been previously been identified as an antagonist of 
endocytosis in CFTR expressing T84 cells (Bradbury et al., 1992). Thus, these data 
suggest that dephosphorylation of CFTR may in fact be a signal for CS-induced 
internalization by clathrin-mediated endocytosis. 
The data indicating that CFTR is dephosphorylated by smoke was verified by 
the use of a CFTR mutant with 15 consensus sites removed from the R domain and 
NBD1 and is not phosphorylated by PKA. Interestingly, immunostaining of these 
cells with a CFTR specific antibody after air exposure (control) demonstrated a 
large amount of intracellular CFTR15SA present within the cytosol. Furthermore, 
internalization of CFTR15SA was actually reduced compared to that of wt-CFTR. 
These data provide further evidence that dephosphorylation may be an important 
signalling factor for internalization, and lead to the speculation that 
dephosphorylation of CFTR may be a signal for internalization  
The effects of CS on the trafficking of other plasma membrane ion channels 
was also investigated. Interestingly, Ano1 remained at the plasma membrane upon 
smoke exposure, while Orai1 was internalized. Given that dephosphorylation of 
CFTR may be an important signalling event leading to the internalization of CFTR 
by smoke, and that Orai1 has putative phosphorylation sites for both PKA (Howe, 
2011) and PKC (Kawasaki et al., 2010), whilst Ano1 inhibitors of PKA and PKC had 
no effect on Ano1-mediated Cl- secretion (Tian et al., 2011), it is convenient to 
speculate that CS may cause changes to the phosphorylation status of Orai1, but 
not Ano1. 
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As mentioned previously, inhibition of CS-induced CFTR internalization with 
hypertonic sucrose, and colocalization with clathrin light chain identified clathrin-
mediated endocytosis as a potential major pathway for CS-induced CFTR 
internalization. Internalization was also dependent on dynamin. Once taken up by 
the cell, colocalization assays with endosomal markers revealed that a large 
amount of CFTR accumulated in the early endosomes compared to the late and 
recycling endosomes. Furthermore, CFTR colocalization with markers of the 
endoplasmic reticulum, STIM1 and calreticulin, dramatically increased following CS 
exposure leading to the speculation that internalized CFTR is trafficked retrograde 
from the plasma membrane to the endoplasmic reticulum. As discussed in section 
5.3, presence of CFTR in the late endosomes and Golgi apparatus give some 
indication that the retrograde pathway of internalization may be from the early 
endosomes, and either directly to the Golgi, or through the late endosomes from 
the Golgi, and finally from the Golgi to the endoplasmic reticulum. Although the 
concept of CFTR retrograde trafficking through direct contact points between the 
early endosomes and the endoplasmic reticulum cannot be ruled out. Data from our 
laboratory demonstrates that CS causes lysosomal calcium release (Rasmussen et 
al., 2014) and an increase in lysosomal pH (unpublished data). These data provide 
first insights into the concept that dysregulation of the lysosomal and endosomal 
pathway may play a role in the abnormal endocytic route of CFTR to the 
endoplasmic reticulum following CS exposure. Additionally, both the microtubule 
and the actin cytoskeleton are important for the movement and function of the 
endosomal pathway. Inhibition of both of these components caused disruption of 
CS-induced CFTR internalization pathway, further implicating the importance of 
endosomal function in CS-induced CFTR internalization.  
6.2  Clinical relevance of findings for patients with cigarette smoke 
related airway disease 
CS exposure leads to diminished CFTR-mediated Cl- secretion in smokers and 
patients with COPD alike. This decrease in Cl- secretion is associated with ASL 
dehydration, an increase in mucus percent solids content, mucus accumulation, 
and reduced mucocilliary clearance. This phenotype, as described in section 1.5.2, 
closely resembled that of patients with CF. Given the recent success of CFTR 
specific correctors and potentiators in the treatment of CF patients, and the 
identification of dysregulated CFTR as a potential cause for COPD, the use of 
CFTR potentiators and correctors in patients with COPD may improve Cl- secretion 
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and improve the mucus defects observed in these patients. To this effect, Sloane 
and colleagues have demonstrated that the use of ivacaftor, a CFTR potentiator, 
increases CFTR currents in both vehicle control and CS extract treated cells. 
Furthermore, ivacaftor increases the CS extract-induced reduction in ASL height 
and improves mucocilliary transport rates measured by assessing the mobility of 
fluorescent beads on primary epithelial cells. These data provide robust primary 
evidence for the use of therapeutics to improve Cl- transport and mucocilliary 
clearance in patients with Cl- secretion compromised by smoke. However, studies 
by Martina Gentzsch’s group demonstrated that while ivacaftor improved function in 
G551D cells, ivacaftor reduced wt-CFTR levels and function (Cholon et al., 2014). 
Furthermore, ivacaftor is an extremely expensive drug, with per patient costs of 
almost $300,000 per year (Condren and Bradshaw, 2013). Thus, the search for 
cheaper and more potent treatments to improve CFTR function in patients with 
COPD continues. As such, several compounds in this thesis function to reduce 
CFTR internalization by CS, and would therefore provide potential therapies of 
smoking related disease. For example, in section 4.2.3, forskolin blunted 
intracellular accumulation of CFTR by approximately 48%. Forskolin is an FDA 
approved compound used in the treatment of asthma (Gonzalez-Sanchez et al., 
2006). Thus, the use of forskolin in patients with CS diminished Cl- may provide a 
novel treatment for improved ASL hydration and mucocilliary clearance. 
6.3  Future experiments 
Inevitably, there are a wide range of future experiments that could be performed 
that would provide further insight into the effects of CS on CFTR trafficking, and 
strengthen the conclusions made in this thesis. A large majority of experiments in 
this thesis were performed using overexpression of CFTR in HEK293T cells. While 
this cell line provides a convenient model for the genetic and pharmacological 
manipulation of overexpressed proteins, there are a number of limitations that stem 
from the interpretation of data from immortalized cell lines. For instance, even 
within the same cell type, differing protocols can produce variability in results. For 
example, CFTRinh172 is able to fully abolish FSK-mediated CFTR currents in 
transiently transfected HEK293 cells (Mondini et al., 2012). However, in stably 
transfected HEK293 cells, CFTRinh172 is able to blunt forskolin-mediated CFTR 
currents but not fully abolish it  (Domingue et al., 2014). Furthermore, HEK293T 
cells provide a reductionist model for the study of CFTR. That is, many endogenous 
proteins that found in vivo in airway epithelial cells are not expressed in HEK293T 
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cells. While HEK293T cells provide an excellent platform for studying the effects of 
CS on CFTR in isolation, the lack of endogenous secretory and absorptive ion 
channels, as well as differential expression of regulatory proteins may induce a 
dissimilar response to that of native epithelia. Thus, reproduction of these data on a 
fully differentiated airway epithelial cell line would provide robust validation that the 
mechanisms of CFTR internalization identified in this thesis are recapitulated in 
native cells. Furthermore, measurement of ASL depth to test the effects of 
pharmacological inhibitors used in this study, such as dynasore, forskolin, and 
hypertonic sucrose, on CS-induced ASL dehydration would provide a first step to 
understanding the functional effects of inhibiting CS-induced CFTR internalization 
in secretory airway epithelial cells. Additionally, testing the inhibition of CS-induced 
CFTR internalization in vivo would provide valuable insight into whether the use of 
these inhibitors would prevent CS-induced reduction in Cl- secretion, and 
subsequently a relief from symptoms associated with this response including 
mucus accumulation and inflammation.   
Much of the work in this thesis was obtained by confocal microscopy. Previous 
studies of CFTR internalization performed using cell surface biotinylation 
demonstrated that normal endocytic rates of CFTR internalization are between 5-
7% per minute (Lukacs et al., 1997, Prince et al., 1994, Silvis et al., 2003). A time 
course of CS-induced CFTR internalization by cell surface biotinylation would thus 
allow the comparison of native and CS-induced endocytosis. In a study in 
Furthermore, direct comparison between the rate of CS-induced internalization in 
HEK293T cells versus polarized airway epithelial cells would provide further 
evidence to confirm that HEK293T cells are an appropriate model for monitoring 
the CS effects on CFTR.  
Confocal imaging of fluorescently tagged proteins is limited in that it is difficult to 
track a particular pool of CFTR over time. Moreover, the CS-induced decrease of 
CFTR from the plasma membrane measured during confocal imaging of GFP-
tagged CFTR was substantially smaller than the increase in intracellular 
accumulation of CS exposed CFTR. These data lead to the speculation that the 
removal of CFTR from the plasma membrane may be masked by recycling of 
subapical CFTR back to the plasma membrane, and/or by the delivery of nascent 
CFTR to the plasma membrane. There are a number of experiments that could be 
performed to dissect the CS effects on CFTR trafficking. Firstly, the use of 
cyclohexamide to inhibit protein synthesis of nascent CFTR would reveal whether 
the removal of CS-exposed CFTR from the plasma membrane is masked by 
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exocytosis. Secondly, an interesting study by Gergley Lukacs group utilized the pH-
sensitive fluorophore FITC conjugated to anti-mouse Fab and anti-HA primary 
antibody to label surface CFTR. The internalization of CFTR at real time in live cells 
was imaged. The presence of pH sensitive FITC allowed for the differentiation of 
the endocytic compartments by their specific internal pH (Barriere et al., 2009). This 
technique would be extremely useful to further analyze the internalization pathway 
of CS exposed CFTR in real time. Furthermore, monitoring the internal pH would 
provide critical information towards the function of these vesicles following CS. 
Since our laboratory has demonstrated that lysosomal pH is increased following CS 
exposure (unpublished data), determining pH changes in other endocytic vesicles 
would be extremely informative. Colocalization of CFTR with markers of the 
endoplasmic reticulum following CS exposure suggest that CFTR may be trafficked 
in retrograde manner from the plasma membrane to the endoplasmic reticulum. 
Surface labeling CFTR in this manner would also allow the visualization of 
retrograde trafficking of CFTR to the endoplasmic reticulum.  
Additionally, the presence of mature CFTR in the endoplasmic reticulum could 
be investigated by isolating the endoplasmic reticulum by differential centrifugation. 
Only immature, core glycosylated CFTR is typically found in the endoplasmic 
reticulum, so identification of mature, fully glycosylated CFTR here would be 
indicative of retrograde transport. However, it cannot be ruled out that CS may 
cause the removal of complex glycans from the extracellular face of CFTR, which 
would prevent the differentiation of nascent CFTR, and CFTR that has been 
trafficked to the plasma membrane and affected by smoke. Thus, control 
experiments, testing for the effects of CS on complex glycosylation must 
additionally be performed. 
Data in this thesis demonstrated that both CFTR and Orai1 are internalized by 
smoke, whilst Ano1 remains at the plasma membrane. Reproducing the data 
presented with Orai1 would allow determination of the cellular mechanisms behind 
Orai1 internalization and would determine whether Orai1 is internalized by the 
same mechanisms as CFTR, or whether the CS response of different plasma 
membrane proteins is more complex. Furthermore, although it has been 
determined previously that CS exposure does not affect SOCE (Rasmussen et al., 
2014). Functional experiments to determine the effects of Orai1 internalization on 
primary airway epithelial cells and in vivo may reveal pathologic effects of Orai1 
dysregulation in smokers and patients with COPD. 
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The constituents of CS are extremely complex with over 7000 compounds 
present in CS (USDHHS, 2010). It is therefore not surprising that the results 
presented in this study regarding the effects of CS on CFTR are themselves 
complex. Individual components of CS have been shown to have differing effects 
on CFTR and other CS-mediated responses (Alexander et al., 2012, Rennolds et 
al., 2010). For example, exposure of primary murine nasal septal epithelial cultures 
to concentrations of acrolein representative of concentrations of acrolein in the 
airways of smokers (~100 µM) surprisingly caused a significant increase in apical 
chloride secretion. However higher concentrations of acrolein (300 µM) actually 
inhibited FSK-mediated CFTR current (Alexander et al., 2012). Furthermore, 
cadmium decreases both total CFTR protein expression and biotinylated surface 
levels of CFTR in Calu-3 cells (Rennolds et al., 2010). CS is highly oxidizing 
(Cantin et al., 2006b), and oxidative stress decreases CFTR function (Cantin et al., 
2006a). Thus, screening other compounds found in CS should be performed to 
determine which constituents of CS are responsible for CS-induced internalization. 
Particularly since the mechanisms of CFTR internalization in response to smoke 
are extremely complex, as highlighted in this thesis, differing responses of CFTR to 
individual components of CS may provide further elucidation of the different cellular 
and endocytic components of CS-induced CFTR internalization. In addition to 
traditional cigarettes, new and emerging tobacco products are being produced at 
an extremely fast rate. E-cigarettes are becoming an extremely common form of 
smoking. They are promoted as safer than generic traditional cigarettes, and are 
even used as a tool to quit smoking in some countries (Rowell and Tarran, 2015). 
Investigation into the effect of e-cigarette smoke on CS-induced internalization 
would provide important predictions for the effects of e-cigarettes on lung function 
and mucus accumulation. 
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6.4  Final conclusions 
The present work has focused on assessing of the cellular mechanisms leading to 
internalization of CFTR by CS. Thus, we conclude that CS-induced internalization 
of CFTR is rapid, with a half-life of intracellular accumulation of 27.7 min. 
Furthermore, internalization of CFTR by CS does not require C-terminal endocytic 
motifs. However, an alternative signal by dephosphorylation of the protein leads to 
its internalization, which is preventable by forskolin-mediated phosphorylation. 
Much like native CFTR, CS-induced CFTR internalization occurs through a clathrin- 
and dynamin-dependent pathway, but once internalized, CFTR is trafficked in a 
retrograde manner, through the early and late endosomes and the Golgi apparatus 
to the endoplasmic reticulum. Further investigation of these mechanisms on the 
function of CFTR in a primary airway epithelial cell line or in mammalian tissue 
would provide useful insight into the role of these pathways in a more system which 
is more representative of CFTR pathophysiology in vivo, and provide a platform for 
the production of therapeutics to allow treatment CFTR dysfunction in smoking 
related airway disease.  
 
 
 
 
 
 
 
 
 
 
 
 
 
126 
 
7.0 References 
AGIUS, A. M., SMALLMAN, L. A. & PAHOR, A. L. 1998. Age, smoking and 
nasal ciliary beat frequency. Clin Otolaryngol Allied Sci, 23, 227-30. 
ALEXANDER, N. S., BLOUNT, A., ZHANG, S., SKINNER, D., HICKS, S. B., 
CHESTNUT, M., KEBBEL, F. A., SORSCHER, E. J. & WOODWORTH, 
B. A. 2012. Cystic fibrosis transmembrane conductance regulator 
modulation by the tobacco smoke toxin acrolein. Laryngoscope, 122, 
1193-7. 
AMEEN, N., SILVIS, M. & BRADBURY, N. A. 2007. Endocytic trafficking of 
CFTR in health and disease. J Cyst Fibros, 6, 1-14. 
AMEEN, N. A., MARINO, C. & SALAS, P. J. 2003. cAMP-dependent exocytosis 
and vesicle traffic regulate CFTR and fluid transport in rat jejunum in 
vivo. Am J Physiol Cell Physiol, 284, C429-38. 
ANDERSON, M. P., BERGER, H. A., RICH, D. P., GREGORY, R. J., SMITH, A. 
E. & WELSH, M. J. 1991a. Nucleoside triphosphates are required to 
open the CFTR chloride channel. Cell, 67, 775-84. 
ANDERSON, M. P., GREGORY, R. J., THOMPSON, S., SOUZA, D. W., PAUL, 
S., MULLIGAN, R. C., SMITH, A. E. & WELSH, M. J. 1991b. 
Demonstration that CFTR is a chloride channel by alteration of its anion 
selectivity. Science, 253, 202-5. 
BAI, A., EIDELMAN, D. H., HOGG, J. C., JAMES, A. L., LAMBERT, R. K., 
LUDWIG, M. S., MARTIN, J., MCDONALD, D. M., MITZNER, W. A. & 
OKAZAWA, M. 1994. Proposed nomenclature for quantifying 
subdivisions of the bronchial wall. J Appl Physiol (1985), 77, 1011-4. 
BALGHI, H., ROBERT, R., RAPPAZ, B., ZHANG, X., WOHLHUTER-HADDAD, 
A., EVAGELIDIS, A., LUO, Y., GOEPP, J., FERRARO, P., ROMEO, P., 
TREBAK, M., WISEMAN, P. W., THOMAS, D. Y. & HANRAHAN, J. W. 
2011. Enhanced Ca2+ entry due to Orai1 plasma membrane insertion 
increases IL-8 secretion by cystic fibrosis airways. FASEB J, 25, 4274-
91. 
BARNES, P. J. 2000. Mechanisms in COPD: differences from asthma. Chest, 
117, 10S-4S. 
BARNES, P. J. 2004. Small airways in COPD. N Engl J Med, 350, 2635-7. 
BARNES, P. J. 2009. Asthma and COPD basic mechanisms and clinical 
management. 2nd ed. Amsterdam ; Boston: Elsevier/Academic Press,. 
BARRIERE, H., BAGDANY, M., BOSSARD, F., OKIYONEDA, T., 
WOJEWODKA, G., GRUENERT, D., RADZIOCH, D. & LUKACS, G. L. 
2009. Revisiting the role of cystic fibrosis transmembrane conductance 
regulator and counterion permeability in the pH regulation of endocytic 
organelles. Mol Biol Cell, 20, 3125-41. 
BERDIEV, B. K., TOUSSON, A., OOSTERVELD-HUT, H.M.J., QADRI, Y. J., 
CORMET-BOYAKA, E., HONG, J.S., FULLER, C. M., SORSCHER, E. 
J., LUKACS, G. L. AND BENOS, D. J. 2008. FRET assessment of CFTR 
molecular assembly. FASEB J, 22. 
BILLET, A. & HANRAHAN, J. W. 2013. The secret life of CFTR as a calcium-
activated chloride channel. J Physiol, 591, 5273-8. 
BILLET, A., JIA, Y., JENSEN, T., RIORDAN, J. R. & HANRAHAN, J. W. 2015. 
Regulation of the cystic fibrosis transmembrane conductance regulator 
anion channel by tyrosine phosphorylation. FASEB J, 29, 3945-53. 
127 
 
BILLET, A., LUO, Y., BALGHI, H. & HANRAHAN, J. W. 2013. Role of tyrosine 
phosphorylation in the muscarinic activation of the cystic fibrosis 
transmembrane conductance regulator (CFTR). J Biol Chem, 288, 
21815-23. 
BOOTH, R. E. & STOCKAND, J. D. 2003. Targeted degradation of ENaC in 
response to PKC activation of the ERK1/2 cascade. Am J Physiol Renal 
Physiol, 284, F938-47. 
BOUCHER, R. C. 1994. Human airway ion transport. Part one. Am J Respir Crit 
Care Med, 150, 271-81. 
BOUCHER, R. C., STUTTS, M. J., KNOWLES, M. R., CANTLEY, L. & GATZY, 
J. T. 1986. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal 
basal rate and response to adenylate cyclase activation. J Clin Invest, 
78, 1245-52. 
BOZOKY, Z., AHMADI, S., KELLER, J. P., MILMAN, T., BEAR, C. E. & 
FORMAN-KAY, J. 2015. The Role of Regulatory Region on Calcium-
Induced Cftr Activation. Pediatric Pulmonology, 50, 195-195. 
BRADBURY, N. A., JILLING, T., KIRK, K. L. & BRIDGES, R. J. 1992. 
Regulated endocytosis in a chloride secretory epithelial cell line. Am J 
Physiol, 262, C752-9. 
BRODSKY, F. M., CHEN, C. Y., KNUEHL, C., TOWLER, M. C. & WAKEHAM, 
D. E. 2001. Biological basket weaving: formation and function of clathrin-
coated vesicles. Annu Rev Cell Dev Biol, 17, 517-68. 
BROWN, J. S., ZEMAN, K. L. & BENNETT, W. D. 2002. Ultrafine particle 
deposition and clearance in the healthy and obstructed lung. Am J Respir 
Crit Care Med, 166, 1240-7. 
BROWN, M. B., HUNT, W. R., NOE, J. E., RUSH, N. I., SCHWEITZER, K. S., 
LEECE, T. C., MOLDOBAEVA, A., WAGNER, E. M., DUDEK, S. M., 
POIRIER, C., PRESSON, R. G., GULBINS, E. & PETRACHE, I. 2014. 
Loss of cystic fibrosis transmembrane conductance regulator impairs 
lung endothelial cell barrier function and increases susceptibility to 
microvascular damage from cigarette smoke. Pulm Circ, 4, 260-8. 
BUTTON, B., CAI, L. H., EHRE, C., KESIMER, M., HILL, D. B., SHEEHAN, J. 
K., BOUCHER, R. C. & RUBINSTEIN, M. 2012. A periciliary brush 
promotes the lung health by separating the mucus layer from airway 
epithelia. Science, 337, 937-41. 
CALVERLEY, P. M., RABE, K. F., GOEHRING, U. M., KRISTIANSEN, S., 
FABBRI, L. M., MARTINEZ, F. J., M & GROUPS, M. S. 2009. Roflumilast 
in symptomatic chronic obstructive pulmonary disease: two randomised 
clinical trials. Lancet, 374, 685-94. 
CALVERLEY, P. M., STOCKLEY, R. A., SEEMUNGAL, T. A., HAGAN, G., 
WILLITS, L. R., RILEY, J. H., WEDZICHA, J. A. & INVESTIGATING 
NEW STANDARDS FOR PROPHYLAXIS IN REDUCTION OF 
EXACERBATIONS, I. 2011. Reported pneumonia in patients with COPD: 
findings from the INSPIRE study. Chest, 139, 505-12. 
CANTIN, A. M., BILODEAU, G., OUELLET, C., LIAO, J. & HANRAHAN, J. W. 
2006a. Oxidant stress suppresses CFTR expression. Am J Physiol Cell 
Physiol, 290, C262-70. 
CANTIN, A. M., HANRAHAN, J. W., BILODEAU, G., ELLIS, L., DUPUIS, A., 
LIAO, J., ZIELENSKI, J. & DURIE, P. 2006b. Cystic fibrosis 
128 
 
transmembrane conductance regulator function is suppressed in 
cigarette smokers. Am J Respir Crit Care Med, 173, 1139-44. 
CAPUTO, A., CACI, E., FERRERA, L., PEDEMONTE, N., BARSANTI, C., 
SONDO, E., PFEFFER, U., RAVAZZOLO, R., ZEGARRA-MORAN, O. & 
GALIETTA, L. J. 2008. TMEM16A, a membrane protein associated with 
calcium-dependent chloride channel activity. Science, 322, 590-4. 
CARAMORI, G., CASOLARI, P., DI GREGORIO, C., SAETTA, M., BARALDO, 
S., BOSCHETTO, P., ITO, K., FABBRI, L. M., BARNES, P. J., ADCOCK, 
I. M., CAVALLESCO, G., CHUNG, K. F. & PAPI, A. 2009. MUC5AC 
expression is increased in bronchial submucosal glands of stable COPD 
patients. Histopathology, 55, 321-31. 
CAZZOLA, M., PAGE, C 2014. Long-acting bronchodilators in COPD: where 
are we now and where are we going? Breathe, 10, 9. 
CFF. 2015. About Cystic Fibrosis [Online]. Available: https://www.cff.org/What-
is-CF/About-Cystic-Fibrosis/ [Accessed 10 Dec 2015]. 
CHANG, X. B., TABCHARANI, J. A., HOU, Y. X., JENSEN, T. J., KARTNER, 
N., ALON, N., HANRAHAN, J. W. & RIORDAN, J. R. 1993. Protein 
kinase A (PKA) still activates CFTR chloride channel after mutagenesis 
of all 10 PKA consensus phosphorylation sites. J Biol Chem, 268, 11304-
11. 
CHENG, J., MOYER, B. D., MILEWSKI, M., LOFFING, J., IKEDA, M., MICKLE, 
J. E., CUTTING, G. R., LI, M., STANTON, B. A. & GUGGINO, W. B. 
2002. A Golgi-associated PDZ domain protein modulates cystic fibrosis 
transmembrane regulator plasma membrane expression. J Biol Chem, 
277, 3520-9. 
CHENG, S. H., GREGORY, R. J., MARSHALL, J., PAUL, S., SOUZA, D. W., 
WHITE, G. A., O'RIORDAN, C. R. & SMITH, A. E. 1990. Defective 
intracellular transport and processing of CFTR is the molecular basis of 
most cystic fibrosis. Cell, 63, 827-34. 
CHENG, S. H., RICH, D. P., MARSHALL, J., GREGORY, R. J., WELSH, M. J. 
& SMITH, A. E. 1991. Phosphorylation of the R domain by cAMP-
dependent protein kinase regulates the CFTR chloride channel. Cell, 66, 
1027-36. 
CHOLON, D. M., QUINNEY, N. L., FULCHER, M. L., ESTHER, C. R., JR., 
DAS, J., DOKHOLYAN, N. V., RANDELL, S. H., BOUCHER, R. C. & 
GENTZSCH, M. 2014. Potentiator ivacaftor abrogates pharmacological 
correction of DeltaF508 CFTR in cystic fibrosis. Sci Transl Med, 6, 
246ra96. 
CHURCH, D. F. & PRYOR, W. A. 1985. Free-radical chemistry of cigarette 
smoke and its toxicological implications. Environ Health Perspect, 64, 
111-26. 
CLANCY, J. P., ROWE, S. M., ACCURSO, F. J., AITKEN, M. L., AMIN, R. S., 
ASHLOCK, M. A., BALLMANN, M., BOYLE, M. P., BRONSVELD, I., 
CAMPBELL, P. W., DE BOECK, K., DONALDSON, S. H., DORKIN, H. 
L., DUNITZ, J. M., DURIE, P. R., JAIN, M., LEONARD, A., MCCOY, K. 
S., MOSS, R. B., PILEWSKI, J. M., ROSENBLUTH, D. B., 
RUBENSTEIN, R. C., SCHECHTER, M. S., BOTFIELD, M., ORDONEZ, 
C. L., SPENCER-GREEN, G. T., VERNILLET, L., WISSEH, S., YEN, K. 
& KONSTAN, M. W. 2012. Results of a phase IIa study of VX-809, an 
129 
 
investigational CFTR corrector compound, in subjects with cystic fibrosis 
homozygous for the F508del-CFTR mutation. Thorax, 67, 12-8. 
CLUNES, L. A., BRIDGES, A., ALEXIS, N. & TARRAN, R. 2008. In vivo versus 
in vitro airway surface liquid nicotine levels following cigarette smoke 
exposure. J Anal Toxicol, 32, 201-7. 
CLUNES, L. A., DAVIES, C. M., COAKLEY, R. D., ALEKSANDROV, A. A., 
HENDERSON, A. G., ZEMAN, K. L., WORTHINGTON, E. N., 
GENTZSCH, M., KREDA, S. M., CHOLON, D., BENNETT, W. D., 
RIORDAN, J. R., BOUCHER, R. C. & TARRAN, R. 2012. Cigarette 
smoke exposure induces CFTR internalization and insolubility, leading to 
airway surface liquid dehydration. FASEB J, 26, 533-45. 
COHEN, N. A., ZHANG, S., SHARP, D. B., TAMASHIRO, E., CHEN, B., 
SORSCHER, E. J. & WOODWORTH, B. A. 2009. Cigarette smoke 
condensate inhibits transepithelial chloride transport and ciliary beat 
frequency. Laryngoscope, 119, 2269-74. 
COLLACO, A., MARATHE, J., KOHNKE, H., KRAVSTOV, D. & AMEEN, N. 
2010. Syntaxin 3 is necessary for cAMP- and cGMP-regulated 
exocytosis of CFTR: implications for enterotoxigenic diarrhea. Am J 
Physiol Cell Physiol, 299, C1450-60. 
CONDREN, M. E. & BRADSHAW, M. D. 2013. Ivacaftor: a novel gene-based 
therapeutic approach for cystic fibrosis. J Pediatr Pharmacol Ther, 18, 8-
13. 
CONE, R. A. 2009. Barrier properties of mucus. Adv Drug Deliv Rev, 61, 75-85. 
COOK, D. P., RECTOR, M. V., BOUZEK, D. C., MICHALSKI, A. S., 
GANSEMER, N. D., REZNIKOV, L. R., LI, X. P., STROIK, M. R., 
OSTEDGAARD, L. S., ABOU ALAIWA, M. H., THOMPSON, M. A., 
PRAKASH, Y. S., KRISHNAN, R., MEYERHOLZ, D. K., SEOW, C. Y. & 
STOLTZ, D. A. 2016. Cystic Fibrosis Transmembrane Conductance 
Regulator in Sarcoplasmic Reticulum of Airway Smooth Muscle 
Implications for Airway Contractility. American Journal of Respiratory and 
Critical Care Medicine, 193, 417-426. 
CORRADI, V., VERGANI, P. & TIELEMAN, D. P. 2015. Cystic Fibrosis 
Transmembrane Conductance Regulator (CFTR): CLOSED AND OPEN 
STATE CHANNEL MODELS. J Biol Chem, 290, 22891-906. 
CRUMP, R. G., ASKEW, G. R., WERT, S. E., LINGREL, J. B. & JOINER, C. H. 
1995. In situ localization of sodium-potassium ATPase mRNA in 
developing mouse lung epithelium. Am J Physiol, 269, L299-308. 
CSANADY, L., VERGANI, P. & GADSBY, D. C. 2010. Strict coupling between 
CFTR's catalytic cycle and gating of its Cl- ion pore revealed by 
distributions of open channel burst durations. Proc Natl Acad Sci U S A, 
107, 1241-6. 
DALEMANS, W., BARBRY, P., CHAMPIGNY, G., JALLAT, S., DOTT, K., 
DREYER, D., CRYSTAL, R. G., PAVIRANI, A., LECOCQ, J. P. & 
LAZDUNSKI, M. 1991. Altered chloride ion channel kinetics associated 
with the delta F508 cystic fibrosis mutation. Nature, 354, 526-8. 
DAVENPORT, S. E., MERGEY, M., CHERQUI, G., BOUCHER, R. C., 
GESPACH, C. & GABRIEL, S. E. 1996. Deregulated expression and 
function of CFTR and Cl- secretion after activation of the Ras and 
Src/PyMT pathways in Caco-2 cells. Biochem Biophys Res Commun, 
229, 663-72. 
130 
 
DECRAMER, M., RUTTEN-VAN MOLKEN, M., DEKHUIJZEN, P. N., 
TROOSTERS, T., VAN HERWAARDEN, C., PELLEGRINO, R., VAN 
SCHAYCK, C. P., OLIVIERI, D., DEL DONNO, M., DE BACKER, W., 
LANKHORST, I. & ARDIA, A. 2005. Effects of N-acetylcysteine on 
outcomes in chronic obstructive pulmonary disease (Bronchitis 
Randomized on NAC Cost-Utility Study, BRONCUS): a randomised 
placebo-controlled trial. Lancet, 365, 1552-60. 
DENNING, G. M., ANDERSON, M. P., AMARA, J. F., MARSHALL, J., SMITH, 
A. E. & WELSH, M. J. 1992. Processing of mutant cystic fibrosis 
transmembrane conductance regulator is temperature-sensitive. Nature, 
358, 761-4. 
DHARMSATHAPHORN, K., MCROBERTS, J. A., MANDEL, K. G., TISDALE, L. 
D. & MASUI, H. 1984. A human colonic tumor cell line that maintains 
vectorial electrolyte transport. Am J Physiol, 246, G204-8. 
DOMINGUE, J. C., AO, M., SARATHY, J., GEORGE, A., ALREFAI, W. A., 
NELSON, D. J. & RAO, M. C. 2014. HEK-293 cells expressing the cystic 
fibrosis transmembrane conductance regulator (CFTR): a model for 
studying regulation of Cl- transport. Physiol Rep, 2. 
DONALDSON, S. H. & BOUCHER, R. C. 2007. Sodium channels and cystic 
fibrosis. Chest, 132, 1631-6. 
DUDEZ, T., BOROT, F., HUANG, S., KWAK, B. R., BACCHETTA, M., 
OLLERO, M., STANTON, B. A. & CHANSON, M. 2008. CFTR in a lipid 
raft-TNFR1 complex modulates gap junctional intercellular 
communication and IL-8 secretion. Biochim Biophys Acta, 1783, 779-88. 
DUNCAN, J. R. & KORNFELD, S. 1988. Intracellular movement of two 
mannose 6-phosphate receptors: return to the Golgi apparatus. J Cell 
Biol, 106, 617-28. 
ERLE, D. J. & SHEPPARD, D. 2014. The cell biology of asthma. J Cell Biol, 
205, 621-31. 
EVANS, M. G. & MARTY, A. 1986. Calcium-dependent chloride currents in 
isolated cells from rat lacrimal glands. J Physiol, 378, 437-60. 
FABBRI, L. M., CALVERLEY, P. M., IZQUIERDO-ALONSO, J. L., 
BUNDSCHUH, D. S., BROSE, M., MARTINEZ, F. J., RABE, K. F., M & 
GROUPS, M. S. 2009. Roflumilast in moderate-to-severe chronic 
obstructive pulmonary disease treated with longacting bronchodilators: 
two randomised clinical trials. Lancet, 374, 695-703. 
FALIN, R. A. & COTTON, C. U. 2007. Acute downregulation of ENaC by EGF 
involves the PY motif and putative ERK phosphorylation site. J Gen 
Physiol, 130, 313-28. 
FILOSTO, S., BASTON, D. S., CHUNG, S., BECKER, C. R. & GOLDKORN, T. 
2013. Src mediates cigarette smoke-induced resistance to tyrosine 
kinase inhibitors in NSCLC cells. Mol Cancer Ther, 12, 1579-90. 
FILOSTO, S., BECKER, C. R. & GOLDKORN, T. 2012. Cigarette smoke 
induces aberrant EGF receptor activation that mediates lung cancer 
development and resistance to tyrosine kinase inhibitors. Mol Cancer 
Ther, 11, 795-804. 
FISCHER, H., ILLEK, B. & MACHEN, T. E. 1998. Regulation of CFTR by 
protein phosphatase 2B and protein kinase C. Pflugers Arch, 436, 175-
81. 
131 
 
FOTIN, A., CHENG, Y., SLIZ, P., GRIGORIEFF, N., HARRISON, S. C., 
KIRCHHAUSEN, T. & WALZ, T. 2004. Molecular model for a complete 
clathrin lattice from electron cryomicroscopy. Nature, 432, 573-9. 
FRIEDMAN, J. R., DIBENEDETTO, J. R., WEST, M., ROWLAND, A. A. & 
VOELTZ, G. K. 2013. Endoplasmic reticulum-endosome contact 
increases as endosomes traffic and mature. Mol Biol Cell, 24, 1030-40. 
FRIEDMAN, J. R., WEBSTER, B. M., MASTRONARDE, D. N., VERHEY, K. J. 
& VOELTZ, G. K. 2010. ER sliding dynamics and ER-mitochondrial 
contacts occur on acetylated microtubules. J Cell Biol, 190, 363-75. 
FULCHER, M. L., GABRIEL, S., BURNS, K. A., YANKASKAS, J. R. & 
RANDELL, S. H. 2005. Well-differentiated human airway epithelial cell 
cultures. Methods Mol Med, 107, 183-206. 
GAILLARD, E. A., KOTA, P., GENTZSCH, M., DOKHOLYAN, N. V., STUTTS, 
M. J. & TARRAN, R. 2010. Regulation of the epithelial Na+ channel and 
airway surface liquid volume by serine proteases. Pflugers Arch, 460, 1-
17. 
GANESHAN, R., NOWOTARSKI, K., DI, A., NELSON, D. J. & KIRK, K. L. 2007. 
CFTR surface expression and chloride currents are decreased by 
inhibitors of N-WASP and actin polymerization. Biochim Biophys Acta, 
1773, 192-200. 
GAUTHIER, N. C., MONZO, P., GONZALEZ, T., DOYE, A., OLDANI, A., 
GOUNON, P., RICCI, V., CORMONT, M. & BOQUET, P. 2007. Early 
endosomes associated with dynamic F-actin structures are required for 
late trafficking of H. pylori VacA toxin. J Cell Biol, 177, 343-54. 
GENTZSCH, M., CHANG, X. B., CUI, L., WU, Y., OZOLS, V. V., 
CHOUDHURY, A., PAGANO, R. E. & RIORDAN, J. R. 2004. Endocytic 
trafficking routes of wild type and DeltaF508 cystic fibrosis 
transmembrane conductance regulator. Mol Biol Cell, 15, 2684-96. 
GENTZSCH, M., DANG, H., DANG, Y., GARCIA-CABALLERO, A., 
SUCHINDRAN, H., BOUCHER, R. C. & STUTTS, M. J. 2010. The cystic 
fibrosis transmembrane conductance regulator impedes proteolytic 
stimulation of the epithelial Na+ channel. J Biol Chem, 285, 32227-32. 
GERASIMENKO, J. V., TEPIKIN, A. V., PETERSEN, O. H. & GERASIMENKO, 
O. V. 1998. Calcium uptake via endocytosis with rapid release from 
acidifying endosomes. Curr Biol, 8, 1335-8. 
GIRALDEZ, T., AFONSO-ORAMAS, D., CRUZ-MUROS, I., GARCIA-MARIN, 
V., PAGEL, P., GONZALEZ-HERNANDEZ, T. & ALVAREZ DE LA 
ROSA, D. 2007. Cloning and functional expression of a new epithelial 
sodium channel delta subunit isoform differentially expressed in neurons 
of the human and monkey telencephalon. J Neurochem, 102, 1304-15. 
GLOZMAN, R., OKIYONEDA, T., MULVIHILL, C. M., RINI, J. M., BARRIERE, 
H. & LUKACS, G. L. 2009. N-glycans are direct determinants of CFTR 
folding and stability in secretory and endocytic membrane traffic. J Cell 
Biol, 184, 847-62. 
GONZALEZ-SANCHEZ, R., TRUJILLO, X., TRUJILLO-HERNANDEZ, B., 
VASQUEZ, C., HUERTA, M. & ELIZALDE, A. 2006. Forskolin versus 
sodium cromoglycate for prevention of asthma attacks: a single-blinded 
clinical trial. J Int Med Res, 34, 200-7. 
132 
 
GRAY, M. A., GREENWELL, J. R. & ARGENT, B. E. 1988. Secretin-regulated 
chloride channel on the apical plasma membrane of pancreatic duct 
cells. J Membr Biol, 105, 131-42. 
GUGGINO, W. B. & STANTON, B. A. 2006. New insights into cystic fibrosis: 
molecular switches that regulate CFTR. Nat Rev Mol Cell Biol, 7, 426-36. 
HAERTEIS, S., KRUEGER, B., KORBMACHER, C. & RAUH, R. 2009. The 
delta-subunit of the epithelial sodium channel (ENaC) enhances channel 
activity and alters proteolytic ENaC activation. J Biol Chem, 284, 29024-
40. 
HALLOWS, K. R., RAGHURAM, V., KEMP, B. E., WITTERS, L. A. & 
FOSKETT, J. K. 2000. Inhibition of cystic fibrosis transmembrane 
conductance regulator by novel interaction with the metabolic sensor 
AMP-activated protein kinase. J Clin Invest, 105, 1711-21. 
HASSAN, F., XU, X., NUOVO, G., KILLILEA, D. W., TYRRELL, J., DA TAN, C., 
TARRAN, R., DIAZ, P., JEE, J., KNOELL, D., BOYAKA, P. N. & 
CORMET-BOYAKA, E. 2014. Accumulation of metals in GOLD4 COPD 
lungs is associated with decreased CFTR levels. Respir Res, 15, 69. 
HEGEDUS, T., ALEKSANDROV, A., MENGOS, A., CUI, L., JENSEN, T. J. & 
RIORDAN, J. R. 2009. Role of individual R domain phosphorylation sites 
in CFTR regulation by protein kinase A. Biochim Biophys Acta, 1788, 
1341-9. 
HEGEDUS, T., SEROHIJOS, A. W., DOKHOLYAN, N. V., HE, L. & RIORDAN, 
J. R. 2008. Computational studies reveal phosphorylation-dependent 
changes in the unstructured R domain of CFTR. J Mol Biol, 378, 1052-
63. 
HELENIUS, A., MELLMAN, I., WALL, D. & HUBBARD, A. 1983. Endosomes. 
Trends in Biochemical Sciences, 8, 245-250. 
HEUSER, J. E. & ANDERSON, R. G. 1989. Hypertonic media inhibit receptor-
mediated endocytosis by blocking clathrin-coated pit formation. J Cell 
Biol, 108, 389-400. 
HO, M. W., KAETZEL, M. A., ARMSTRONG, D. L. & SHEARS, S. B. 2001. 
Regulation of a human chloride channel. a paradigm for integrating input 
from calcium, type ii calmodulin-dependent protein kinase, and inositol 
3,4,5,6-tetrakisphosphate. J Biol Chem, 276, 18673-80. 
HOGG, J. C. 2004. Pathophysiology of airflow limitation in chronic obstructive 
pulmonary disease. Lancet, 364, 709-21. 
HOGG, J. C., CHU, F., UTOKAPARCH, S., WOODS, R., ELLIOTT, W. M., 
BUZATU, L., CHERNIACK, R. M., ROGERS, R. M., SCIURBA, F. C., 
COXSON, H. O. & PARÉ, P. D. 2004. The nature of small-airway 
obstruction in chronic obstructive pulmonary disease. N Engl J Med, 350, 
2645-53. 
HOOPER, R., ZHANG, X., WEBSTER, M., GO, C., KEDRA, J., MARCHBANK, 
K., GILL, D. L., WEERARATNA, A. T., TREBAK, M. & SOBOLOFF, J. 
2015. Novel Protein Kinase C-Mediated Control of Orai1 Function in 
Invasive Melanoma. Mol Cell Biol, 35, 2790-8. 
HOWE, A. K. 2011. Cross-talk between calcium and protein kinase A in the 
regulation of cell migration. Curr Opin Cell Biol, 23, 554-61. 
HU, W., HOWARD, M. & LUKACS, G. L. 2001. Multiple endocytic signals in the 
C-terminal tail of the cystic fibrosis transmembrane conductance 
regulator. Biochem J, 354, 561-72. 
133 
 
HUOTARI, J. & HELENIUS, A. 2011. Endosome maturation. EMBO J, 30, 
3481-500. 
HURST, J. R., VESTBO, J., ANZUETO, A., LOCANTORE, N., MULLEROVA, 
H., TAL-SINGER, R., MILLER, B., LOMAS, D. A., AGUSTI, A., 
MACNEE, W., CALVERLEY, P., RENNARD, S., WOUTERS, E. F., 
WEDZICHA, J. A. & EVALUATION OF, C. L. T. I. P. S. E. I. 2010. 
Susceptibility to exacerbation in chronic obstructive pulmonary disease. 
N Engl J Med, 363, 1128-38. 
HWANG, T. C. & SHEPPARD, D. N. 2009. Gating of the CFTR Cl- channel by 
ATP-driven nucleotide-binding domain dimerisation. J Physiol, 587, 
2151-61. 
ISO, I. S. O. 2000. Cigarettes - determination of total and nicotine-free dry 
particulate matter using a routine analytical smoking machine ISO 4387 
[Online]. Geneva, Switzerland. Available: 
https://www.iso.org/obp/ui/#iso:std:28323:en. 
JIA, Y., MATHEWS, C. J. & HANRAHAN, J. W. 1997. Phosphorylation by 
protein kinase C is required for acute activation of cystic fibrosis 
transmembrane conductance regulator by protein kinase A. J Biol Chem, 
272, 4978-84. 
KANELIS, V., HUDSON, R. P., THIBODEAU, P. H., THOMAS, P. J. & 
FORMAN-KAY, J. D. 2010. NMR evidence for differential 
phosphorylation-dependent interactions in WT and DeltaF508 CFTR. 
EMBO J, 29, 263-77. 
KAWASAKI, T., UEYAMA, T., LANGE, I., FESKE, S. & SAITO, N. 2010. Protein 
kinase C-induced phosphorylation of Orai1 regulates the intracellular 
Ca2+ level via the store-operated Ca2+ channel. J Biol Chem, 285, 
25720-30. 
KEITH, C. H. T., P.G. 1965. Measurement of the total smoke issuing from a 
burning cigarette. Tobacco Science, 9, 61-64. 
KENTUCKY, U. O. 2016. Center for Tobacco Reference Products [Online]. 
Available: https://ctrp.uky.edu/ [Accessed May 5 2016]. 
KIM, V. & CRINER, G. J. 2013. Chronic bronchitis and chronic obstructive 
pulmonary disease. Am J Respir Crit Care Med, 187, 228-37. 
KNOWLES, M. R. & BOUCHER, R. C. 2002. Mucus clearance as a primary 
innate defense mechanism for mammalian airways. J Clin Invest, 109, 
571-7. 
KNOWLES, M. R., CLARKE, L. L. & BOUCHER, R. C. 1991. Activation by 
extracellular nucleotides of chloride secretion in the airway epithelia of 
patients with cystic fibrosis. N Engl J Med, 325, 533-8. 
KREDA, S. M., GYNN, M. C., FENSTERMACHER, D. A., BOUCHER, R. C. & 
GABRIEL, S. E. 2001. Expression and localization of epithelial 
aquaporins in the adult human lung. Am J Respir Cell Mol Biol, 24, 224-
34. 
KREINDLER, J. L., JACKSON, A. D., KEMP, P. A., BRIDGES, R. J. & 
DANAHAY, H. 2005. Inhibition of chloride secretion in human bronchial 
epithelial cells by cigarette smoke extract. Am J Physiol Lung Cell Mol 
Physiol, 288, L894-902. 
KULKA, M., DERY, R., NAHIRNEY, D., DUSZYK, M. & BEFUS, A. D. 2005. 
Differential regulation of cystic fibrosis transmembrane conductance 
134 
 
regulator by interferon gamma in mast cells and epithelial cells. J 
Pharmacol Exp Ther, 315, 563-70. 
LE ROY, C. & WRANA, J. L. 2005. Clathrin- and non-clathrin-mediated 
endocytic regulation of cell signalling. Nat Rev Mol Cell Biol, 6, 112-26. 
LEE, S. J., LI, Z., LITAN, A., YOO, S. & LANGHANS, S. A. 2015. EGF-induced 
sodium influx regulates EGFR trafficking through HDAC6 and tubulin 
acetylation. BMC Cell Biol, 16, 24. 
LEPPLE-WIENHUES, A., WIELAND, U., LAUN, T., HEIL, L., STERN, M. & 
LANG, F. 2001. A src-like kinase activates outwardly rectifying chloride 
channels in CFTR-defective lymphocytes. FASEB J, 15, 927-31. 
LI, C. & NAREN, A. P. 2005. Macromolecular complexes of cystic fibrosis 
transmembrane conductance regulator and its interacting partners. 
Pharmacol Ther, 108, 208-23. 
LI, J., POULIKAKOS, P. I., DAI, Z., TESTA, J. R., CALLAWAY, D. J. & BU, Z. 
2007. Protein kinase C phosphorylation disrupts Na+/H+ exchanger 
regulatory factor 1 autoinhibition and promotes cystic fibrosis 
transmembrane conductance regulator macromolecular assembly. J Biol 
Chem, 282, 27086-99. 
LIEDTKE, C. M. & COLE, T. S. 1998. Antisense oligonucleotide to PKC-epsilon 
alters cAMP-dependent stimulation of CFTR in Calu-3 cells. Am J 
Physiol, 275, C1357-64. 
LINSDELL, P., ZHENG, S. X. & HANRAHAN, J. W. 1998. Non-pore lining 
amino acid side chains influence anion selectivity of the human CFTR Cl- 
channel expressed in mammalian cell lines. J Physiol, 512 ( Pt 1), 1-16. 
LOFFING, J., MOYER, B. D., MCCOY, D. & STANTON, B. A. 1998. Exocytosis 
is not involved in activation of Cl- secretion via CFTR in Calu-3 airway 
epithelial cells. Am J Physiol, 275, C913-20. 
LUKACS, G. L., CHANG, X. B., BEAR, C., KARTNER, N., MOHAMED, A., 
RIORDAN, J. R. & GRINSTEIN, S. 1993. The delta F508 mutation 
decreases the stability of cystic fibrosis transmembrane conductance 
regulator in the plasma membrane. Determination of functional half-lives 
on transfected cells. J Biol Chem, 268, 21592-8. 
LUKACS, G. L., MOHAMED, A., KARTNER, N., CHANG, X. B., RIORDAN, J. 
R. & GRINSTEIN, S. 1994. Conformational maturation of CFTR but not 
its mutant counterpart (delta F508) occurs in the endoplasmic reticulum 
and requires ATP. EMBO J, 13, 6076-86. 
LUKACS, G. L., SEGAL, G., KARTNER, N., GRINSTEIN, S. & ZHANG, F. 
1997. Constitutive internalization of cystic fibrosis transmembrane 
conductance regulator occurs via clathrin-dependent endocytosis and is 
regulated by protein phosphorylation. Biochem J, 328 ( Pt 2), 353-61. 
LUO, J., PATO, M. D., RIORDAN, J. R. & HANRAHAN, J. W. 1998. Differential 
regulation of single CFTR channels by PP2C, PP2A, and other 
phosphatases. Am J Physiol, 274, C1397-410. 
LUZ, S., KONGSUPHOL, P., MENDES, A. I., ROMEIRAS, F., SOUSA, M., 
SCHREIBER, R., MATOS, P., JORDAN, P., MEHTA, A., AMARAL, M. 
D., KUNZELMANN, K. & FARINHA, C. M. 2011. Contribution of casein 
kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein 
kinase A-induced activity. Mol Cell Biol, 31, 4392-404. 
MAEGAWA, M., ARAO, T., YOKOTE, H., MATSUMOTO, K., KUDO, K., 
TANAKA, K., KANEDA, H., FUJITA, Y., ITO, F. & NISHIO, K. 2009. 
135 
 
Epidermal growth factor receptor lacking C-terminal autophosphorylation 
sites retains signal transduction and high sensitivity to epidermal growth 
factor receptor tyrosine kinase inhibitor. Cancer Sci, 100, 552-7. 
MAIER, T., GUELL, M. & SERRANO, L. 2009. Correlation of mRNA and protein 
in complex biological samples. FEBS Lett, 583, 3966-73. 
MALL, M., GRUBB, B. R., HARKEMA, J. R., O'NEAL, W. K. & BOUCHER, R. 
C. 2004. Increased airway epithelial Na+ absorption produces cystic 
fibrosis-like lung disease in mice. Nat Med, 10, 487-93. 
MANNINO, D. M., HOMA, D. M., AKINBAMI, L. J., FORD, E. S. & REDD, S. C. 
2002. Chronic obstructive pulmonary disease surveillance--United 
States, 1971-2000. Respir Care, 47, 1184-99. 
MARTINEZ, F. J., CALVERLEY, P. M., GOEHRING, U. M., BROSE, M., 
FABBRI, L. M. & RABE, K. F. 2015. Effect of roflumilast on 
exacerbations in patients with severe chronic obstructive pulmonary 
disease uncontrolled by combination therapy (REACT): a multicentre 
randomised controlled trial. Lancet, 385, 857-66. 
MASON, S. J., PARADISO, A. M. & BOUCHER, R. C. 1991. Regulation of 
transepithelial ion transport and intracellular calcium by extracellular ATP 
in human normal and cystic fibrosis airway epithelium. Br J Pharmacol, 
103, 1649-56. 
MATHEWS, C. J., TABCHARANI, J. A., CHANG, X. B., JENSEN, T. J., 
RIORDAN, J. R. & HANRAHAN, J. W. 1998. Dibasic protein kinase A 
sites regulate bursting rate and nucleotide sensitivity of the cystic fibrosis 
transmembrane conductance regulator chloride channel. J Physiol, 508 ( 
Pt 2), 365-77. 
MAXFIELD, F. R. & YAMASHIRO, D. J. 1987. Endosome acidification and the 
pathways of receptor-mediated endocytosis. Adv Exp Med Biol, 225, 
189-98. 
MCCUBREY, J. A., STEELMAN, L. S., CHAPPELL, W. H., ABRAMS, S. L., 
WONG, E. W., CHANG, F., LEHMANN, B., TERRIAN, D. M., MILELLA, 
M., TAFURI, A., STIVALA, F., LIBRA, M., BASECKE, J., EVANGELISTI, 
C., MARTELLI, A. M. & FRANKLIN, R. A. 2007. Roles of the 
Raf/MEK/ERK pathway in cell growth, malignant transformation and drug 
resistance. Biochim Biophys Acta, 1773, 1263-84. 
MENSE, M., VERGANI, P., WHITE, D. M., ALTBERG, G., NAIRN, A. C. & 
GADSBY, D. C. 2006. In vivo phosphorylation of CFTR promotes 
formation of a nucleotide-binding domain heterodimer. EMBO J, 25, 
4728-39. 
MERCER, B. A. & D'ARMIENTO, J. M. 2006. Emerging role of MAP kinase 
pathways as therapeutic targets in COPD. Int J Chron Obstruct Pulmon 
Dis, 1, 137-50. 
MERCER, R. R., RUSSELL, M. L., ROGGLI, V. L. & CRAPO, J. D. 1994. Cell 
number and distribution in human and rat airways. Am J Respir Cell Mol 
Biol, 10, 613-24. 
MIDDLETON, L. M. & HARVEY, R. D. 1998. PKC regulation of cardiac CFTR 
Cl- channel function in guinea pig ventricular myocytes. Am J Physiol, 
275, C293-302. 
MOLLER, W., FELTEN, K., SOMMERER, K., SCHEUCH, G., MEYER, G., 
MEYER, P., HAUSSINGER, K. & KREYLING, W. G. 2008. Deposition, 
136 
 
retention, and translocation of ultrafine particles from the central airways 
and lung periphery. Am J Respir Crit Care Med, 177, 426-32. 
MONDINI, A., SASSONE, F., CIVELLO, D. A., GARAVAGLIA, M. L., BAZZINI, 
C., RODIGHIERO, S., VEZZOLI, V., CONTI, F., TORIELLI, L., 
CAPASSO, G., PAULMICHL, M. & MEYER, G. 2012. Hypertension-
linked mutation of alpha-adducin increases CFTR surface expression 
and activity in HEK and cultured rat distal convoluted tubule cells. PLoS 
One, 7, e52014. 
MONTERISI, S., FAVIA, M., GUERRA, L., CARDONE, R. A., MARZULLI, D., 
RESHKIN, S. J., CASAVOLA, V. & ZACCOLO, M. 2012. CFTR 
regulation in human airway epithelial cells requires integrity of the actin 
cytoskeleton and compartmentalized cAMP and PKA activity. J Cell Sci, 
125, 1106-17. 
MORAN, A. R., NORIMATSU, Y., DAWSON, D. C. & MACDONALD, K. D. 
2014. Aqueous cigarette smoke extract induces a voltage-dependent 
inhibition of CFTR expressed in Xenopus oocytes. Am J Physiol Lung 
Cell Mol Physiol, 306, L284-91. 
MORGAN, L., PEARSON, M., DE IONGH, R., MACKEY, D., VAN DER WALL, 
H., PETERS, M. & RUTLAND, J. 2004. Scintigraphic measurement of 
tracheal mucus velocity in vivo. Eur Respir J, 23, 518-22. 
MOYER, B. D., LOFFING, J., SCHWIEBERT, E. M., LOFFING-CUENI, D., 
HALPIN, P. A., KARLSON, K. H., ISMAILOV, I. I., GUGGINO, W. B., 
LANGFORD, G. M. & STANTON, B. A. 1998. Membrane trafficking of 
the cystic fibrosis gene product, cystic fibrosis transmembrane 
conductance regulator, tagged with green fluorescent protein in madin-
darby canine kidney cells. J Biol Chem, 273, 21759-68. 
NAMKUNG, W., PHUAN, P. W. & VERKMAN, A. S. 2011. TMEM16A inhibitors 
reveal TMEM16A as a minor component of calcium-activated chloride 
channel conductance in airway and intestinal epithelial cells. J Biol 
Chem, 286, 2365-74. 
OKIYONEDA, T. & LUKACS, G. L. 2007. Cell surface dynamics of CFTR: the 
ins and outs. Biochim Biophys Acta, 1773, 476-9. 
OUSINGSAWAT, J., MARTINS, J. R., SCHREIBER, R., ROCK, J. R., HARFE, 
B. D. & KUNZELMANN, K. 2009. Loss of TMEM16A causes a defect in 
epithelial Ca2+-dependent chloride transport. J Biol Chem, 284, 28698-
703. 
PARK, C. Y., HOOVER, P. J., MULLINS, F. M., BACHHAWAT, P., 
COVINGTON, E. D., RAUNSER, S., WALZ, T., GARCIA, K. C., 
DOLMETSCH, R. E. & LEWIS, R. S. 2009. STIM1 clusters and activates 
CRAC channels via direct binding of a cytosolic domain to Orai1. Cell, 
136, 876-90. 
PEARSE, B. M. 1976. Clathrin: a unique protein associated with intracellular 
transfer of membrane by coated vesicles. Proc Natl Acad Sci U S A, 73, 
1255-9. 
PEDEMONTE, N., LUKACS, G. L., DU, K., CACI, E., ZEGARRA-MORAN, O., 
GALIETTA, L. J. & VERKMAN, A. S. 2005. Small-molecule correctors of 
defective DeltaF508-CFTR cellular processing identified by high-
throughput screening. J Clin Invest, 115, 2564-71. 
137 
 
PETERS, K. W., QI, J., JOHNSON, J. P., WATKINS, S. C. & FRIZZELL, R. A. 
2001. Role of snare proteins in CFTR and ENaC trafficking. Pflugers 
Arch, 443 Suppl 1, S65-9. 
PHILLIPS, J., KLUSS, B., RICHTER, A. & MASSEY, E. 2005. Exposure of 
bronchial epithelial cells to whole cigarette smoke: assessment of cellular 
responses. Altern Lab Anim, 33, 239-48. 
PICCIOTTO, M. R., COHN, J. A., BERTUZZI, G., GREENGARD, P. & NAIRN, 
A. C. 1992. Phosphorylation of the cystic fibrosis transmembrane 
conductance regulator. J Biol Chem, 267, 12742-52. 
POOLE, P. J. & BLACK, P. N. 2006. Mucolytic agents for chronic bronchitis or 
chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 
CD001287. 
POPATIA, R., HAVER, K. & CASEY, A. 2014. Primary Ciliary Dyskinesia: An 
Update on New Diagnostic Modalities and Review of the Literature. 
Pediatr Allergy Immunol Pulmonol, 27, 51-59. 
PRAT, A. G., XIAO, Y. F., AUSIELLO, D. A. & CANTIELLO, H. F. 1995. cAMP-
independent regulation of CFTR by the actin cytoskeleton. Am J Physiol, 
268, C1552-61. 
PRINCE, L. S., WORKMAN, R. B., JR. & MARCHASE, R. B. 1994. Rapid 
endocytosis of the cystic fibrosis transmembrane conductance regulator 
chloride channel. Proc Natl Acad Sci U S A, 91, 5192-6. 
QUON, B. S. & ROWE, S. M. 2016. New and emerging targeted therapies for 
cystic fibrosis. BMJ, 352, i859. 
RAB, A., ROWE, S. M., RAJU, S. V., BEBOK, Z., MATALON, S. & COLLAWN, 
J. F. 2013. Cigarette smoke and CFTR: implications in the pathogenesis 
of COPD. Am J Physiol Lung Cell Mol Physiol, 305, L530-41. 
RAJAN, R. S., ILLING, M. E., BENCE, N. F. & KOPITO, R. R. 2001. Specificity 
in intracellular protein aggregation and inclusion body formation. Proc 
Natl Acad Sci U S A, 98, 13060-5. 
RAMSEY, B. W., DAVIES, J., MCELVANEY, N. G., TULLIS, E., BELL, S. C., 
DREVINEK, P., GRIESE, M., MCKONE, E. F., WAINWRIGHT, C. E., 
KONSTAN, M. W., MOSS, R., RATJEN, F., SERMET-GAUDELUS, I., 
ROWE, S. M., DONG, Q., RODRIGUEZ, S., YEN, K., ORDONEZ, C., 
ELBORN, J. S. & GROUP, V. X. S. 2011. A CFTR potentiator in patients 
with cystic fibrosis and the G551D mutation. N Engl J Med, 365, 1663-
72. 
RANDELL, S. H., BOUCHER, R. C. & UNIVERSITY OF NORTH CAROLINA 
VIRTUAL LUNG, G. 2006. Effective mucus clearance is essential for 
respiratory health. Am J Respir Cell Mol Biol, 35, 20-8. 
RASMUSSEN, J. E., SHERIDAN, J. T., POLK, W., DAVIES, C. M. & TARRAN, 
R. 2014. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis 
transmembrane conductance regulator (CFTR) dysfunction. J Biol Chem, 
289, 7671-81. 
REID, L. 1960. Measurement of the bronchial mucous gland layer: a diagnostic 
yardstick in chronic bronchitis. Thorax, 15, 132-41. 
RENNARD, S. I., CALVERLEY, P. M., GOEHRING, U. M., BREDENBROKER, 
D. & MARTINEZ, F. J. 2011. Reduction of exacerbations by the PDE4 
inhibitor roflumilast--the importance of defining different subsets of 
patients with COPD. Respir Res, 12, 18. 
138 
 
RENNARD, S. I. & VESTBO, J. 2006. COPD: the dangerous underestimate of 
15%. Lancet, 367, 1216-9. 
RENNOLDS, J., BUTLER, S., MALONEY, K., BOYAKA, P. N., DAVIS, I. C., 
KNOELL, D. L., PARINANDI, N. L. & CORMET-BOYAKA, E. 2010. 
Cadmium regulates the expression of the CFTR chloride channel in 
human airway epithelial cells. Toxicol Sci, 116, 349-58. 
ROBERTS, R. L., BARBIERI, M. A., PRYSE, K. M., CHUA, M., MORISAKI, J. 
H. & STAHL, P. D. 1999. Endosome fusion in living cells overexpressing 
GFP-rab5. J Cell Sci, 112 ( Pt 21), 3667-75. 
ROCK, J. R., O'NEAL, W. K., GABRIEL, S. E., RANDELL, S. H., HARFE, B. D., 
BOUCHER, R. C. & GRUBB, B. R. 2009. Transmembrane protein 16A 
(TMEM16A) is a Ca2+-regulated Cl- secretory channel in mouse airways. 
J Biol Chem, 284, 14875-80. 
ROGAN, M. P., STOLTZ, D. A. & HORNICK, D. B. 2011. Cystic fibrosis 
transmembrane conductance regulator intracellular processing, 
trafficking, and opportunities for mutation-specific treatment. Chest, 139, 
1480-90. 
ROWELL, T. R. & TARRAN, R. 2015. Will chronic e-cigarette use cause lung 
disease? Am J Physiol Lung Cell Mol Physiol, 309, L1398-409. 
RUBIN, B. K., RAMIREZ, O., ZAYAS, J. G., FINEGAN, B. & KING, M. 1992. 
Respiratory mucus from asymptomatic smokers is better hydrated and 
more easily cleared by mucociliary action. Am Rev Respir Dis, 145, 545-
7. 
SAETTA, M., TURATO, G., BARALDO, S., ZANIN, A., BRACCIONI, F., MAPP, 
C. E., MAESTRELLI, P., CAVALLESCO, G., PAPI, A. & FABBRI, L. M. 
2000. Goblet cell hyperplasia and epithelial inflammation in peripheral 
airways of smokers with both symptoms of chronic bronchitis and chronic 
airflow limitation. Am J Respir Crit Care Med, 161, 1016-21. 
SCHREIBER, R., HOPF, A., MALL, M., GREGER, R. & KUNZELMANN, K. 
1999. The first-nucleotide binding domain of the cystic-fibrosis 
transmembrane conductance regulator is important for inhibition of the 
epithelial Na+ channel. Proc Natl Acad Sci U S A, 96, 5310-5. 
SCHROEDER, B. C., CHENG, T., JAN, Y. N. & JAN, L. Y. 2008. Expression 
cloning of TMEM16A as a calcium-activated chloride channel subunit. 
Cell, 134, 1019-29. 
SCHWIEBERT, E. M., GESEK, F., ERCOLANI, L., WJASOW, C., GRUENERT, 
D. C., KARLSON, K. & STANTON, B. A. 1994. Heterotrimeric G proteins, 
vesicle trafficking, and CFTR Cl- channels. Am J Physiol, 267, C272-81. 
SEKAR, R. B. & PERIASAMY, A. 2003. Fluorescence resonance energy 
transfer (FRET) microscopy imaging of live cell protein localizations. J 
Cell Biol, 160, 629-33. 
SETHI, S., MALONEY, J., GROVE, L., WRONA, C. & BERENSON, C. S. 2006. 
Airway inflammation and bronchial bacterial colonization in chronic 
obstructive pulmonary disease. Am J Respir Crit Care Med, 173, 991-8. 
SHEPPARD, D. N. & WELSH, M. J. 1999. Structure and function of the CFTR 
chloride channel. Physiol Rev, 79, S23-45. 
SHORT, D. B., TROTTER, K. W., RECZEK, D., KREDA, S. M., BRETSCHER, 
A., BOUCHER, R. C., STUTTS, M. J. & MILGRAM, S. L. 1998. An apical 
PDZ protein anchors the cystic fibrosis transmembrane conductance 
regulator to the cytoskeleton. J Biol Chem, 273, 19797-801. 
139 
 
SILVIS, M. R., PICCIANO, J. A., BERTRAND, C., WEIXEL, K., BRIDGES, R. J. 
& BRADBURY, N. A. 2003. A mutation in the cystic fibrosis 
transmembrane conductance regulator generates a novel internalization 
sequence and enhances endocytic rates. J Biol Chem, 278, 11554-60. 
SLOANE, P. A., SHASTRY, S., WILHELM, A., COURVILLE, C., TANG, L. P., 
BACKER, K., LEVIN, E., RAJU, S. V., LI, Y., MAZUR, M., BYAN-
PARKER, S., GRIZZLE, W., SORSCHER, E. J., DRANSFIELD, M. T. & 
ROWE, S. M. 2012. A pharmacologic approach to acquired cystic fibrosis 
transmembrane conductance regulator dysfunction in smoking related 
lung disease. PLoS One, 7, e39809. 
SMYTH, J. T., HWANG, S. Y., TOMITA, T., DEHAVEN, W. I., MERCER, J. C. & 
PUTNEY, J. W. 2010. Activation and regulation of store-operated 
calcium entry. J Cell Mol Med, 14, 2337-49. 
SOLDATI, T. & SCHLIWA, M. 2006. Powering membrane traffic in endocytosis 
and recycling. Nat Rev Mol Cell Biol, 7, 897-908. 
ST-LAURENT, J., PROULX, L. I., BOULET, L. P. & BISSONNETTE, E. 2009. 
Comparison of two in vitro models of cigarette smoke exposure. Inhal 
Toxicol, 21, 1148-53. 
STENMARK, H., PARTON, R. G., STEELE-MORTIMER, O., LUTCKE, A., 
GRUENBERG, J. & ZERIAL, M. 1994. Inhibition of rab5 GTPase activity 
stimulates membrane fusion in endocytosis. EMBO J, 13, 1287-96. 
STUTTS, M. J., CHINET, T. C., MASON, S. J., FULLTON, J. M., CLARKE, L. L. 
& BOUCHER, R. C. 1992. Regulation of Cl- channels in normal and 
cystic fibrosis airway epithelial cells by extracellular ATP. Proc Natl Acad 
Sci U S A, 89, 1621-5. 
SWIATECKA-URBAN, A., DUHAIME, M., COUTERMARSH, B., KARLSON, K. 
H., COLLAWN, J., MILEWSKI, M., CUTTING, G. R., GUGGINO, W. B., 
LANGFORD, G. & STANTON, B. A. 2002. PDZ domain interaction 
controls the endocytic recycling of the cystic fibrosis transmembrane 
conductance regulator. J Biol Chem, 277, 40099-105. 
TABCHARANI, J. A., CHANG, X. B., RIORDAN, J. R. & HANRAHAN, J. W. 
1991. Phosphorylation-regulated Cl- channel in CHO cells stably 
expressing the cystic fibrosis gene. Nature, 352, 628-31. 
TAMASHIRO, E., XIONG, G., ANSELMO-LIMA, W. T., KREINDLER, J. L., 
PALMER, J. N. & COHEN, N. A. 2009. Cigarette smoke exposure 
impairs respiratory epithelial ciliogenesis. Am J Rhinol Allergy, 23, 117-
22. 
TANABE, K., OHASHI, E., HENMI, Y. & TAKEI, K. 2011. Receptor sorting and 
actin dynamics at early endosomes. Commun Integr Biol, 4, 742-4. 
TARRAN, R. 2004. Regulation of airway surface liquid volume and mucus 
transport by active ion transport. Proc Am Thorac Soc, 1, 42-6. 
TARRAN, R., BUTTON, B. & BOUCHER, R. C. 2006. Regulation of normal and 
cystic fibrosis airway surface liquid volume by phasic shear stress. Annu 
Rev Physiol, 68, 543-61. 
TARRAN, R., BUTTON, B., PICHER, M., PARADISO, A. M., RIBEIRO, C. M., 
LAZAROWSKI, E. R., ZHANG, L., COLLINS, P. L., PICKLES, R. J., 
FREDBERG, J. J. & BOUCHER, R. C. 2005. Normal and cystic fibrosis 
airway surface liquid homeostasis. The effects of phasic shear stress and 
viral infections. J Biol Chem, 280, 35751-9. 
140 
 
TARRAN, R., GRUBB, B. R., GATZY, J. T., DAVIS, C. W. & BOUCHER, R. C. 
2001a. The relative roles of passive surface forces and active ion 
transport in the modulation of airway surface liquid volume and 
composition. J Gen Physiol, 118, 223-36. 
TARRAN, R., GRUBB, B. R., PARSONS, D., PICHER, M., HIRSH, A. J., 
DAVIS, C. W. & BOUCHER, R. C. 2001b. The CF salt controversy: in 
vivo observations and therapeutic approaches. Mol Cell, 8, 149-58. 
TAYLOR, S. S., BUECHLER, J. A. & YONEMOTO, W. 1990. cAMP-dependent 
protein kinase: framework for a diverse family of regulatory enzymes. 
Annu Rev Biochem, 59, 971-1005. 
THELIN, W. R., KESIMER, M., TARRAN, R., KREDA, S. M., GRUBB, B. R., 
SHEEHAN, J. K., STUTTS, M. J. & MILGRAM, S. L. 2005. The cystic 
fibrosis transmembrane conductance regulator is regulated by a direct 
interaction with the protein phosphatase 2A. J Biol Chem, 280, 41512-20. 
THERMOFISHER. 2015. Peirce BCA protein assay kit [Online]. Available: 
https://tools.thermofisher.com/content/sfs/manuals/MAN0011430_Pierce
_BCA_Protein_Asy_UG.pdf [Accessed May 2 2016]. 
THIAGARAJAH, J. R. & VERKMAN, A. S. 2003. CFTR pharmacology and its 
role in intestinal fluid secretion. Curr Opin Pharmacol, 3, 594-9. 
THURLBECK, W. M. & ANGUS, G. E. 1964. A Distribution Curve for Chronic 
Bronchitis. Thorax, 19, 436-42. 
TIAN, Y., KONGSUPHOL, P., HUG, M., OUSINGSAWAT, J., WITZGALL, R., 
SCHREIBER, R. & KUNZELMANN, K. 2011. Calmodulin-dependent 
activation of the epithelial calcium-dependent chloride channel 
TMEM16A. FASEB J, 25, 1058-68. 
TOUSSON, A., FULLER, C. M. & BENOS, D. J. 1996. Apical recruitment of 
CFTR in T-84 cells is dependent on cAMP and microtubules but not 
Ca2+ or microfilaments. J Cell Sci, 109 ( Pt 6), 1325-34. 
TREHARNE, K. J., XU, Z., CHEN, J. H., BEST, O. G., CASSIDY, D. M., 
GRUENERT, D. C., HEGYI, P., GRAY, M. A., SHEPPARD, D. N., 
KUNZELMANN, K. & MEHTA, A. 2009. Inhibition of protein kinase CK2 
closes the CFTR Cl channel, but has no effect on the cystic fibrosis 
mutant deltaF508-CFTR. Cell Physiol Biochem, 24, 347-60. 
ULLRICH, A. & SCHLESSINGER, J. 1990. Signal transduction by receptors 
with tyrosine kinase activity. Cell, 61, 203-12. 
US CF FOUNDATION, J. H. U., HOSPITAL FOR SICK CHILDREN. 2015. The 
Clinical and Functional TRanslation of CFTR (CFTR2) [Online]. 
Available: http://www.cftr2.org/files/CFTR2_13August2015.pdf [Accessed 
April 29 2016]. 
USDHHS, U. S. D. O. H. A. H. S. 2010. How Tobacco Smoke Causes Disease: 
The Biology and Behavioral Basis for Smoking-Attributable Disease: A 
Report of the Surgeon General. Atlanta (GA). 
VAN GOOR, F., HADIDA, S., GROOTENHUIS, P. D., BURTON, B., STACK, J. 
H., STRALEY, K. S., DECKER, C. J., MILLER, M., MCCARTNEY, J., 
OLSON, E. R., WINE, J. J., FRIZZELL, R. A., ASHLOCK, M. & 
NEGULESCU, P. A. 2011. Correction of the F508del-CFTR protein 
processing defect in vitro by the investigational drug VX-809. Proc Natl 
Acad Sci U S A, 108, 18843-8. 
141 
 
VERGANI, P., LOCKLESS, S. W., NAIRN, A. C. & GADSBY, D. C. 2005. CFTR 
channel opening by ATP-driven tight dimerization of its nucleotide-
binding domains. Nature, 433, 876-80. 
VIGNOLA, A. M., CHANEZ, P., CHIAPPARA, G., MERENDINO, A., PACE, E., 
RIZZO, A., LA ROCCA, A. M., BELLIA, V., BONSIGNORE, G. & 
BOUSQUET, J. 1997. Transforming growth factor-beta expression in 
mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit 
Care Med, 156, 591-9. 
WAINWRIGHT, C. E., ELBORN, J. S., RAMSEY, B. W., MARIGOWDA, G., 
HUANG, X., CIPOLLI, M., COLOMBO, C., DAVIES, J. C., DE BOECK, 
K., FLUME, P. A., KONSTAN, M. W., MCCOLLEY, S. A., MCCOY, K., 
MCKONE, E. F., MUNCK, A., RATJEN, F., ROWE, S. M., WALTZ, D., 
BOYLE, M. P., GROUP, T. S. & GROUP, T. S. 2015. Lumacaftor-
Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del 
CFTR. N Engl J Med, 373, 220-31. 
WALDMANN, R., CHAMPIGNY, G., BASSILANA, F., VOILLEY, N. & 
LAZDUNSKI, M. 1995. Molecular cloning and functional expression of a 
novel amiloride-sensitive Na+ channel. J Biol Chem, 270, 27411-4. 
WALLACE, A. M., HARDIGAN, A., GERAGHTY, P., SALIM, S., GAFFNEY, A., 
THANKACHEN, J., ARELLANOS, L., D'ARMIENTO, J. M. & FORONJY, 
R. F. 2012. Protein phosphatase 2A regulates innate immune and 
proteolytic responses to cigarette smoke exposure in the lung. Toxicol 
Sci, 126, 589-99. 
WANG, F., ZELTWANGER, S., HU, S. & HWANG, T. C. 2000. Deletion of 
phenylalanine 508 causes attenuated phosphorylation-dependent 
activation of CFTR chloride channels. J Physiol, 524 Pt 3, 637-48. 
WANG, X., MATTESON, J., AN, Y., MOYER, B., YOO, J. S., BANNYKH, S., 
WILSON, I. A., RIORDAN, J. R. & BALCH, W. E. 2004. COPII-
dependent export of cystic fibrosis transmembrane conductance 
regulator from the ER uses a di-acidic exit code. J Cell Biol, 167, 65-74. 
WARD, C. L. & KOPITO, R. R. 1994. Intracellular turnover of cystic fibrosis 
transmembrane conductance regulator. Inefficient processing and rapid 
degradation of wild-type and mutant proteins. J Biol Chem, 269, 25710-8. 
WEBER, W. M., SEGAL, A., SIMAELS, J., VANKEERBERGHEN, A., 
CASSIMAN, J. J. & VAN DRIESSCHE, W. 2001. Functional integrity of 
the vesicle transporting machinery is required for complete activation of 
cFTR expressed in xenopus laevis oocytes. Pflugers Arch, 441, 850-9. 
WEIXEL, K. & BRADBURY, N. A. 2002. Analysis of CFTR endocytosis by cell 
surface biotinylation. Methods Mol Med, 70, 323-40. 
WEIXEL, K. M. & BRADBURY, N. A. 2000. The carboxyl terminus of the cystic 
fibrosis transmembrane conductance regulator binds to AP-2 clathrin 
adaptors. J Biol Chem, 275, 3655-60. 
WELSH, M. J. 1983. Cigarette smoke inhibition of ion transport in canine 
tracheal epithelium. J Clin Invest, 71, 1614-23. 
WHITSETT, J. A. & ALENGHAT, T. 2015. Respiratory epithelial cells 
orchestrate pulmonary innate immunity. Nat Immunol, 16, 27-35. 
WHO. 2015. Tobacco [Online]. Available: 
http://www.who.int/mediacentre/factsheets/fs339/en/ [Accessed 10 Dec 
2015]. 
142 
 
XIE, W., KAETZEL, M. A., BRUZIK, K. S., DEDMAN, J. R., SHEARS, S. B. & 
NELSON, D. J. 1996. Inositol 3,4,5,6-tetrakisphosphate inhibits the 
calmodulin-dependent protein kinase II-activated chloride conductance in 
T84 colonic epithelial cells. J Biol Chem, 271, 14092-7. 
XU, X., BALSIGER, R., TYRRELL, J., BOYAKA, P. N., TARRAN, R. & 
CORMET-BOYAKA, E. 2015. Cigarette smoke exposure reveals a novel 
role for the MEK/ERK1/2 MAPK pathway in regulation of CFTR. Biochim 
Biophys Acta, 1850, 1224-32. 
YAGHI, A., ZAMAN, A., COX, G. & DOLOVICH, M. B. 2012. Ciliary beating is 
depressed in nasal cilia from chronic obstructive pulmonary disease 
subjects. Respir Med, 106, 1139-47. 
YANG, Y. D., CHO, H., KOO, J. Y., TAK, M. H., CHO, Y., SHIM, W. S., PARK, 
S. P., LEE, J., LEE, B., KIM, B. M., RAOUF, R., SHIN, Y. K. & OH, U. 
2008. TMEM16A confers receptor-activated calcium-dependent chloride 
conductance. Nature, 455, 1210-5. 
ZHANG, L., ALEKSANDROV, L. A., RIORDAN, J. R. & FORD, R. C. 2011. 
Domain location within the cystic fibrosis transmembrane conductance 
regulator protein investigated by electron microscopy and gold labelling. 
Biochim Biophys Acta, 1808, 399-404. 
ZHENG, J. P., KANG, J., HUANG, S. G., CHEN, P., YAO, W. Z., YANG, L., 
BAI, C. X., WANG, C. Z., WANG, C., CHEN, B. Y., SHI, Y., LIU, C. T., 
CHEN, P., LI, Q., WANG, Z. S., HUANG, Y. J., LUO, Z. Y., CHEN, F. P., 
YUAN, J. Z., YUAN, B. T., QIAN, H. P., ZHI, R. C. & ZHONG, N. S. 
2008. Effect of carbocisteine on acute exacerbation of chronic 
obstructive pulmonary disease (PEACE Study): a randomised placebo-
controlled study. Lancet, 371, 2013-8. 
ZHU, T., DAHAN, D., EVAGELIDIS, A., ZHENG, S., LUO, J. & HANRAHAN, J. 
W. 1999. Association of cystic fibrosis transmembrane conductance 
regulator and protein phosphatase 2C. J Biol Chem, 274, 29102-7. 
 
